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ABSTRACT
This thesis explores three different applications of electrospray ionisation mass
spectrometry (ESI-MS) for protein analysis. An example of the identification ofproteins
following separation by 2-dimensional electrophoresis is presented with a study of
proteins released from mitochondria following low-conductance permeability transition
(LC-PT). A number of mitochondrial matrix proteins were identified from gels of the
supernatant of mitochondria that had not undergone LC-PT.

These findings raise

questions regarding the release of proteins from normally functioning mitochondria. A
second possibility is that the integrity of some of the mitochondrial membranes

in the

cell-free system may have been compromised. The identification ofperoxisomal proteins
in the mitochondrial preparations highlighted a major problem that is encountered with
subcellular fractionation of organelles, namely contamination from other cellular
components. This study also demonstrated the need for automated procedures to
minimise human contamination and obtain reproducible results.
Functional proteomics is aimed at obtaining information on binding partners and
protein function. An example of a functional proteomics approach developed here
involved the use of affinity and ion exchange chromatography in conjunction with MS to

identify proteins that associate with the T cell surface protein, CD4. The identification
of a known CD4-binding protein, p56c, provided evidence that the method was suitable
for the isolation of CD4-associating proteins. Identification of other interesting proteins
(tubulin, myosin, actin, B-cell receptor-associated protein and two ribosomal proteins)
has revealed potential CD4-binding partners for further immunological studies.
An interesting area in which ESI-MS has evoked significant interest has been in
the analysis of noncovalent complexes. The gentle nature of ESI results in the ability to
transfer complexes that are bound noncovalently into the gas phase under carefully
controlled conditions. There is, however, still debate as to what extent the gas phase
behaviour of complexes reflects their solution phase properties. Glutathione Stransferase (GST) is an ideal protein for investigating the applicability of ESI-MS to
this type of analysis. A study of the complexes formed between GST and various ligands
by ESI-MS

is also presented. This study showed the formation of GST dimers within

proteins of the same enzyme class. It was interesting that glutathione did not reveal the
expected binding of two molecules per GST dimer. The preferential binding of two Salkylglutathione molecules to the dimer, however, was clear from these data and the
increased binding strength with increasing alkyl chain length was also apparent.
Tandem mass spectrometry (MS/MS) was also found to be useful for investigating the
specificity of ligand binding and for identifying the ligands bound to the GST dimer.
MS/MS

also showed that S-alkylglutathione ligands with longer alkyl chains required

more energy to be removed from the complex that the S-alkylglutathiones of shorter
alkyl chain lengths.
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CHAPTER ONE: INTRODUCTION
1.1 MASS SPECTROMETRY
Mass spectrometry (MS) developed as a tool in atomic physics but has undergone
dramatic developments to make it a viable tool for the study of biomolecules. The
introduction of electron ionisation (EI), chemical ionisation (CI) and the coupling of
chromatography with mass spectrometry (GC-MS) were important developments in the
application of MS in chemistry. Further early developments in ionisation techniques
included field desorption, liquid desorption, plasma desorption and thermospray, which

had varying degrees of success for the analysis of involatile, thermally labile molecul
The introduction of the ionisation technique fast atom bombardment (FAB) by Barber

and colleagues in the early 1980s (Barber et al, 1981) marked the start of an expanding
field of biological mass spectrometry since it provided the first routine method for
ionising peptides and carbohydrates. The development of matrix assisted laser
desorption/ ionisation (MALDI) (Karas and Hillenkamp, 1988) and electrospray
ionisation (ESI) (Fenn et al, 1989) dramatically increased the mass range of
biomolecules that could be ionised (to approximately 150 kDa) and resulted in a rapid
expansion of the application of mass spectrometry to fields such as biochemistry,
immunology, molecular biology and biotechnology. Advances in instrumentation have
also had a large impact on the growth of biological mass spectrometry with the re-

emergence of time-of-flight (ToF) analysers, the introduction of new hybrid instruments
and improvements in electronics and computational methods.
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1.1.1 Electrospray Ionisation
The first reports on the use of electrospray for the production of gas-phase ions came
from Dole and co-workers in the late 1960s (Dole et al, 1968). Much later, two
separate groups reported the coupling of ESI to a mass spectrometer (Aleksandrov et
al, 1985; Yamashita and Fenn, 1984). The transfer of protein ions to the gas phase was
published several years later by Fenn and colleagues (Fenn et al, 1989). The

introduction of this ionisation technique has had an enormous impact on the use of mass

spectrometry for analysis of biomolecules such that it has now become an essential tool
in protein chemistry.
In ESI, a high voltage is applied to a capillary through which a solution of the
analyte is pumped. A mist of highly charged droplets is sprayed from the tip of the

capillary and the small droplets evaporate. The evaporation process is often assisted b

heating and the application of a counter-current flow of nitrogen gas. The mechanism of
the formation of gaseous ions from the small droplets is thought to occur by either of
two processes (discussed below). The gas phase ions then enter the mass spectrometer
for separation and detection according to their mass-to-charge ratios (m/z). (Mann and
Wilm, 1995)
A relatively small amount of internal energy is imparted to the analyte, so there is
very little (if any) fragmentation (Mann and Wilm, 1995; Cole, 2000). ESI is therefore
known as a "soft ionisation" technique and is suitable for the analysis of fragile,
thermally labile biomolecules. The multiple charging that is observed in ESI mass
spectra allows for the detection of high molecular mass molecules and complexes. As
the molecular mass increases so does the average number of charges (Smith et al.,

1990b) and, since separation and detection is based on m/z, the ions are brought into t
range of detection of most mass spectrometers. Multiple charging also improves the
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accuracy of the molecular mass measurement because the mass is sampled in a number

of different measurements (Smith et al, 1990b). Another advantage of ESI is the ability
to couple on-line solution separations with MS (see section 1.1.6).
Ion formation in electrospray ionisation
The electrospray process can be considered in a number of steps (Smith et al, 1990b;
Gaskell, 1997; Kebarle and Tang, 1993). These include the formation of highly charged

droplets from the spraying orifice, the decrease in size of these droplets by evaporat
and Coulombic fission and the formation of desolvated gas-phase ions from the
droplets. These processes are shown schematically in Figure 1.1.

1. Formation of charged droplets
2. Shrinkage of droplets
(fission and evaporation)
Capillary filled with
solution of analyte

~ ^ + T 7 i J-J. | , _
~.
_

,

" ° ° ! ; ' l ° r . *--„ •.•
3. Production of
gas-phase ions

\

\
\

Taylor cone
Figure 1.1 Schematic of the electrospray process (see text for details)

The electricalfieldat the capillary tip causes positive or negative ions (depending
on the polarity of the potential on the capillary) to accumulate at the surface of the
liquid (Smith et al, 1990b; Gaskell, 1997; Kebarle and Tang, 1993; Kebarle, 2000).

The repulsive forces experienced by the ions and the force of the electric field resul

the formation of a cone shape (the Taylor cone) that expands out to become a thin liqui
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filament (Wilm and M a n n , 1994; Gaskell, 1997; Kebarle and Tang, 1993; Kebarle, 2000).

When the electrostatic force becomes sufficiently strong, the surface tension is broke
droplets form. Owing to the surface tension dependence of droplet formation, it is more
difficult to achieve a stable spray with water than with an aqueous organic (usually
methanol or acetonitrile) solution.
Evaporation of the solvent occurs as the droplets move through the source. Droplets

may also undergo fission upon reaching or exceeding the 'Rayleigh' limit of the droplets

i.e. the radius at which the Coulombic repulsion of the charges equals the surface ten
forces holding the droplet together (Vestal, 2001). Repeated fissions and solvent
evaporation continue droplet shrinkage. Two models exist for the formation of ions from

these small droplets. The charge residue model (CRM) proposes that fission continues u

there is only a single analyte ion in the droplet and the remaining solvent is removed
evaporation (Smith et al, 1990b; Kebarle and Tang, 1993; Gaskell, 1997). Alternatively,
the ion evaporation model (IEM) proposes that an ion is ejected from the droplet when
Coloumbic repulsive forces between the charges within the droplet become too strong
(Iribarne and Thomson, 1976; Thomson and Iribarne, 1979; Smith et al, 1990b; Kebarle
and Tang, 1993). There is data to support both these mechanisms of gas-phase ion
formation and debate remains over which model best represents the process that is
occurring. However, there is mounting evidence indicating that globular proteins and
noncovalent biomolecular complexes form gaseous ions through the CRM (Kebarle, 2000).
Furthermore, the observation of non-specific complexes can best be accounted for by the
possibility of fission resulting in two or more ions in a single droplet, which form a
complex following evaporation of the last solvent molecules, providing support for the
CRM (Kebarle, 2000).
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Nanoelectrospray Ionisation
The ion current obtained in ESI-MS is dependent upon the concentration of the analyte
but not on the flow rate (Mann and Wilm, 1995; Cole, 2000). A reduction in the flow
rate therefore allows increased information to be obtained from a limited amount of
sample without loss of sensitivity. In nanoelectrospray ionisation (nanoESI), the

solution of analyte is introduced in a metal-coated capillary that is drawn out to a f
tip (Wilm and Mann, 1994; Valaskovic et al, 1995). Voltage applied to the capillary

results in an electrostatic flow of a fine spray of solution from the capillary at ver
flow rates (20-40 nL/min) (Wilm and Mann, 1994; Wilm et al, 1996b). The droplets
produced by nanoESI are approximately 100 times smaller than those produced by
conventional electrospray (Wilm et al, 1996b). Therefore high source temperatures and
the counter-current drying gas flow rates are not required. The smaller droplets have
enhanced surface-to-volume ratio so a large proportion of analyte molecules are
accessible for ionisation (Fligge et al, 1999). The capillary is placed close to the
sampling cone and the percentage of analyte molecules entering the next stage is much
higher than in conventional electrospray (Wilm and Mann, 1996). Sample consumption

is significantly lower and there is an improvement in sensitivity (Fligge et al, 1998).

The low flow rates also yield long analysis times, which improve the limit of detectio
and allows for successive analyses of a large number of components in a given mixture
by tandem mass spectrometry (more below).
ESI-MS is intolerant to salts and detergents owing to instability of the spraying
process and competition for charges that are introduced by ionic species (Mann and
Wilm, 1995; Cole, 2000). An additional advantage of the nanoESI source is the
increased tolerance for salts compared to conventional ESI (Wilm and Mann, 1996;
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Fligge et al, 1998). NanoESI is, therefore, more suitable for the introduction of analytes
to the mass spectrometer from solutions that are close to physiological conditions.

1.1.2 Matrix Assisted Laser Desorption/Ionisation
Matrix Assisted Laser Desorption/Ionisation (MALDI), unlike ESI, is a pulsed
ionisation technique. A solid matrix is mixed with the analyte to absorb energy from

laser pulse, which leads to excitation of the solid and desorption of the surface lay

matrix and analyte (Roepstorff, 2000; Spengler, 2001; Karas et al, 2000). Both matrix
and analyte molecules are carried into the gas phase. MALDI mass spectra are
characterised by little fragmentation and the majority of ions observed are singly
charged (Spengler, 2001).
The mechanism by which ions are produced in MALDI is not well understood,
although there are have been many proposals since the introduction of MALDI.
Ionisation most probably involves a number of different processes, which may be
dependent upon the analyte, matrix, sample preparation and laser wavelength and
energy (Zenobi and Knochenmuss, 1998; Karas et al, 2000). The processes involved
have recently been reviewed and may include multiphoton ionisation, proton transfer

from matrix to analyte, cationisation, pooling of energy from excited matrix species,
excited-state proton transfer, electron transfer, desorption of pre-formed ions and
thermal ionisation (Zenobi and Knochenmuss, 1998). A recent model encompasses a
number of suggested mechanisms to explain the formation of ions in MALDI and
explains the survival of singly charged molecular ions (Karas et al, 2000).
The ions formed by MALDI have a significant spread of velocities, which results

in a decrease of mass resolution. The use of an electrostatic mirror (reflector) in t
early MALDI instruments partly compensated for the velocity spread but prior to 1995
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M A L D I instruments had relatively poor resolution. The introduction of delayed
extraction (DE) has improved the resolution of MALDI analyses (Brown and Lennon,
1995; Spengler, 2001; Vestal, 2001; Roepstorff, 2000). DE developed from a technique
known as 'time-lag focussing' described by Wiley and McClaren in 1955 (McLuckey
and Wells, 2001). After ionisation, a short delay is allowed before the ions are
accelerated (Coles and Guilhaus, 1993). During the delay, ions with higher energy from
the ionisation process move further than those with less energy. A fixed accelerating
voltage is then applied, which results in ions of lower energy experiencing a higher
voltage than the ions of higher energy that have moved further down the gradient. The
small difference in accelerating potential that is applied to the ions compensates for
initial spread of velocities.
For protein and peptide analyses by MALDI-MS, sample preparation typically
involves co-crystallisation of analyte and excess matrix (Zenobi and Knochenmuss,

1998). The matrix absorbs the energy of the laser pulse and may play a direct role in t
ionisation of analyte molecules (Roepstorff, 2000; Karas et al, 2000). The matrix is
also important for dilution of the analyte and preventing aggregation of the analyte
(Karas etal, 2000).

1.1.3 Mass Analysers
Mass analysers use electric and/or magnetic fields to separate ions according to their
mass-to-charge ratio (m/z). Important aspects of the mass analyser include: i) mass
range, ii) mass accuracy, iii) sensitivity, iv) resolving power, v) scanning speed and
compatibility with the ionisation source (Jennings and Dolnikowski, 1990; McLuckey
and Wells, 2001). Electric sector, magnetic sector, ToF, quadrupole, ion trap and ion
cyclotron are the most common analysers. Many commercially available mass
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spectrometers combine more than one analyser, resulting in improved performance and
the ability to perform tandem mass spectrometry (MS/MS). In this research, two
different types of mass spectrometers were used, a MALDI-ToF instrument and a
hybrid instrument, the quadrupole-ToF.
Quadrupole analysers
A quadrupole analyser consists of four rods arranged in parallel where opposite rods are
electrically connected (Jennings and Dolnikowski, 1990). Application of a direct current
(DC) voltage and an alternating current (AC) voltage at radio frequencies (RF) to the
rods (opposite polarities on adjacent rods) creates an oscillating field (Siuzdak, 1996;
Yates, 1998). At a given DC and RF potential, only ions of a specific m/z are
transmitted through the quadrupole. The potentials can be varied, keeping their ratio
constant, to selectively transmit the full m/z range. Standard quadrupoles have an upper
m/z limit of approximately 2000-4000 but modified quadrupoles have been reported
that are able to scan higher m/z ranges (McLuckey and Wells, 2001).
Quadrupoles are ideal for coupling with ESI sources owing to their tolerance of
relatively high pressures (Siuzdak, 1996). Triple quadrupole instruments were the first
widely employed tandem mass analysers. In these instruments the first quadrupole is
used for precursor ion selection, the second is used as a cell for collision-activated
dissociation (with only an RF voltage) and the third quadrupole is used as a second

mass analyser. In practice, the use of a quadrupole for the central collision cell is not
essential and some commercial instruments employ either a hexapole or octapole, which
offer superior transmission.
Time-of-flight analysers
Time-of-flight (ToF) mass spectrometry relies on the principle that ions with the same
energy and different masses will have different velocities and hence different flight
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times in afield-freeregion. The velocity of an ion is inversely proportional to the square
of its m/z so ions of higher m/z will have longer flight times (Kinter and Sherman,
2000). With advances in electronics, ToF analysers now have high mass accuracy and
sensitivity. Unlike scanning instruments, ToF analysers theoretically do not have an
upper mass limit since larger ions merely take longer to traverse the flight tube. In

practice, it is therefore the detector rather than the analyser that limits the mass ran
owing to limitations with the detection of high mass ions with very low velocities
(Mirgorodskaya et al, 1994). ToF analysers detect the entire mass range
simultaneously, which results in fast acquisition times. Scanning analysers, such as the
quadrupole, scan small regions at a time and therefore the percentage of ions that are
actually detected can be quite low (poor duty cycle).
The measurement of the flight time of an ion requires a starting point (zero time).
With pulsed ion sources, such MALDI, the ions are accelerated through the flight tube
in packets and the pulse acts as the starting point. Sufficient time must be allowed for
the largest ion to reach the detector before the next ion packet is accelerated.

Continuous ion sources, such as ESI, require a storage device to provide a starting point
for the ToF. Success in coupling continuous ions sources to ToF analysers has been

achieved by accelerating the ions into a flight tube that is perpendicular to the ion be
(Guilhaus et al, 2000). This technique is known as orthogonal acceleration ToF
(oaToF). Duty cycles of 5-50% are typical for oaToF mass spectrometers (McLuckey
and Wells, 2001).
The initial range of velocities of the ions limits the resolution of a ToF analyser,
which is particularly significant with ions generated by MALDI. As mentioned in

section 1.1.2, there are a number of ways to correct for the initial energy spread of the

ions. With the use of a reflector, ions of the same mass but with higher energy penetrate
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the reflector more deeply and spend more time in the reflector, thereby compensating
for the velocity spread (Coles and Guilhaus, 1993; Yates, 1998; McLuckey and Wells,
2001; Kinter and Sherman, 2000). Ions of the same mass are focussed to one point in
time. The increase in path length that is introduced by the reflector is an added

advantage. Increasing the flight time causes a proportionate decrease in the difference
between two ions of the same mass but different energy. Similarly, higher accelerating

voltages increase the energy imparted to the ions and decrease the relative contributi
from the ionisation process (Coles and Guilhaus, 1993; Kinter and Sherman, 2000). The
use of an oaToF also minimises the spread of energies and results in improved
resolution (Guilhaus et al, 2000; Shukla and Futrell, 2000). Another technique
employed to reduce the velocity dispersion of the ions generated from MALDI is
delayed extraction (DE) (described in section 1.1.2).
The quadrupole-ToF
Glish and Goeringer published the first report of a hybrid quadrupole-ToF (Glish and

Goeringer, 1984). The instrument consisted of a quadrupole, collision cell and a linear

ToF. A lens stack prior to the ToF accelerated the ions from the collision cell into th
ToF. This instrument was limited to the analysis of small, volatile molecules owing to
the ionisation process and the linear arrangement of the ToF limited the attainable
resolution of the instrument. It was not until the introduction the oaToF, and the
development of ESI and MALDI, that interest in quadrupole-ToF instruments was again
evoked.
Current commercial quadrupole-ToF instruments combine the quadrupole mass

filter and hexapole or quadrupole collision cell of a standard triple quadrupole with a
oaToF incorporating a reflector (Figure 1.2) (Morris et al, 1996; Shevchenko et al,
1997). The first quadrupole can act either for mass selection in MS/MS (see below) or
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in RF-only m o d e to allow the transfer of all ions for M S analysis in the T o F analyser.
The ToF analyser is therefore used to acquire both MS and MS/MS data. The collision

cell is able to re-focus ions that are scattered through collisions with the collisi
(Yates, 1998). The quadrupole-ToF instruments were first coupled to ESI sources but
MALDI quadrupole-ToF instruments have more recently been developed (Loboda et
al, 2000; Shevchenko etal, 2000).

QUADRUPOLE MS

TOF MS

Figure 1.2 The Q - T o f ™ (Reprinted with permission from Micromass U.K)

1.1.5 T a n d e m M a s s Spectrometry ( M S / M S )
Tandem mass spectrometry (MS/MS) has become one of the most widely used
techniques for the characterisation of biologically important molecules. MS/MS uses

two stages of mass analysis. In the first stage an ion of interest (i.e. the precurso

3 0009 03276660 7
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mass selected. This precursor ion is then activated via collisions with an inert gas in a
reaction region or "collision cell". Ions that become sufficiently activated through

multiple low-energy collisions undergo fragmentation. This process is termed collisioninduced dissociation (CID) or collision-activated dissociation (CAD)1. The resulting
fragment (or product) ions are measured in a second mass analysis stage.
Tandem mass spectrometers can be divided into two types: tandem-in-space mass
spectrometers and tandem-in-time mass spectrometers (McLuckey and Wells, 2001).
Tandem-in-space instruments rely on a sequential path through two or more analysers
coupled together (Shukla and Futrell, 2000). In a quadrupole-ToF instrument, the
precursor is selected by the quadrupole, fragmented in an RF-only hexapole collision
cell and the ToF analyser separates the product ions for detection. Tandem-in-time
instruments (such as ion traps) are able to perform MS/MS within the same region and
are therefore separated by time rather than space.
The amount of energy imparted on an ion affects the fragmentation. In tandem-inspace instruments, the centre of mass collision energy (ECOm) is dependent on the

collision energy applied to the gas cell (Eiab), the mass of the collision gas (Mg) and t
mass of the selected precursor ion (Mi) in the relationship

Ecom = Eiab X Mg/(Mg+Mj) (1.1)

Low-energy collisions are generally defined as those with an E]ab of about 10-30 eV
(Hunt et al, 1986). Low energy CAD of peptides gives rise to fragmentation along the

It is also worth noting that C A D can be performed in the atmosphere-to-vacuum interface of an ESI instrument by
increasing the cone voltage albeit without prior mass selection Smith, R. D., Loo, J. A., Barinaga, C. J., Edmonds,
C. G. and Udseth, H. R. (1990a) The Journal of the American Society for Mass Spectrometry, 1, 53-65; Kilby, G.
W . and Sheil, M . M . (1993) Organic Mass Spectrometry, 28, 1417-1423.. This is termed 'in-source C A D ' and is
addressed in Chapter 5.

Chapter 1: Introduction

13

backbone of the peptide chain. High energy C A D of peptides results in backbone plus
side-chain fragmentation.
For MS/MS experiments with quadrupole-ToF instruments, the quadrupole is

typically set to allow the transfer of all isotopes of the precursor into the collision
The high resolution afforded by the ToF analyser allows the charge on the product ions
to be determined by the isotope spacing.
Another scan mode that has been found to be particularly useful for the

identification of modified (e.g. phosphorylated) peptides is the precursor ion scan. Wi
a triple quadrupole tandem mass spectrometer the first mass analyser scanned while the
second is set to transmit only a single m/z value (Wilm et al, 1996a; Annan and Carr,
1997; Yates, 1998). This way, precursor ions that result in specific fragments can be
identified. Quadrupole-ToF instruments are not able to perform precursor ions scans in
this way but similar information can be generated by integrating the data from a large

number of acquisitions, albeit with lower sensitivity than that available from the trip
quadrupole precursor ion experiment.
In MALDI-ToF MS, fragmentation information may be obtained from post source
decay (PSD) (Kaufmann et al, 1994). In this type of experiment, the unimolecular
(metastable) decompositions and collisions with background gas as the ions pass
through the drift tube produce fragments that are observed by stepwise reduction of the
potential on the reflector (Kaufmann et al, 1994; Devreese and Van Beeumen, 1998;
Zenobi and Knochenmuss, 1998; Chaurand et al, 1999). PSD experiments produce
high-energy CAD spectra that show greater diversity of product ions and are generally
more complex, than spectra from MS/MS experiments on an ESI instrument.
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MS/MS ofpeptides

The fragmentation of protonated peptides by MS/MS has been extensively

and low energy collisions resulting in fragmentation of the peptide ba

typically observed with triple quadrupole and quadrupole-ToF MS. The m

commonly observed ions from backbone fragmentation result from cleavag

amide bond with charge retention on the N-terminus (B-type ions) or th

(Y-type ions) as shown in scheme 1.1 (Papayannopoulos, 1995; Roepstorf
Fohlman, 1984; Hunt et al, 1986). The formation of sequential B and/or

peptide enables the sequence to be established from the mass differenc
sequential ions in the series.
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Scheme 1.1 Ions generated from fragmentation of the peptide backbone. A, B and C

ions are the result of charge retention on the N-terminus. X, Y and Z i

of charge retention on the C-terminus. The primes (") indicate addition
(Roepstorff and Fohlman, 1984)
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The distribution of charges plays a critical role in thefragmentationpathway and
affects the proportion of B and Y ions that are produced (Staudenmann and James,
2001; Tang et al, 1993; Downard and Biemann, 1994; Burlet et al, 1992). The
localisation of charge is dependent on the presence of amino acids that have high gas

phase basicity such as arginine, lysine, histidine, proline and tryptophan (Hunt et al

1986). Tryptic peptides (except for the C-terminal peptide) possess a basic C-terminus
owing to the cleavage specificity of trypsin, which cleaves on the C-terminal side of

lysine and arginine residues. The presence of the C-terminal arginine or lysine typic
results in charge retention on the C-terminal fragment ion, thereby favouring the
formation of Y-type sequence ions (Hunt et al, 1986). For multiply charged ions, the
charges may be distributed between the two types of ions (charge retention on the Cterminal arginine or lysine and the basic N-terminus) resulting in detection of both
Y ion and the complementary B ion (Smith et al, 1990b). Alternatively, the charges
may be retained by one fragment, resulting in multiply charged product ions.
Other ions that are commonly observed in MS/MS spectra include the loss of
neutral molecules such as water or ammonia from B or Y ions and the loss of CO from
B ions, which produces the A-type ions (scheme 1.1) (Hunt et al, 1986; Tang et al,
1993). Internal fragments are also observed, particularly when a proline residue is

present in the peptide (Hunt et al, 1986). These fragments result from the formation o
a Y ion, which then undergoes a second fragmentation to produce a B-type ion.
Immonium ions, which are of the form H2N=CHR+, are often observed in the low m/z

region and provide an indication of the amino acids present in the peptide (Hunt et al
1986).
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1.1.6 Capillary Liquid Chromatography - M a s s Spectrometry
Analytical liquid chromatography (LC) was coupled to ESI-MS soon after the

introduction of ESI (Bruins et al, 1987; Stults et al, 1996). The application of capill
LC has been slower, owing to problems with the construction and packing of such small
columns (< 0.5 mm internal diameter) and in the generation of the low flow rates
required (Moritz et al, 1994b). Advances in column design, column packing
techniques, flow-splitting and pumping techniques have made capillary LC a much
more accessible technique (Moritz and Simpson, 1992; Tong et al, 1997; Chervet et al,
1996). The introduction of a commercial pumping system that is capable of delivering
gradient elution with homogeneous mixing and reproducible delivery has removed the
need for flow-splitting (Holyoke et al, 1999). The use of standard flow-splitting
techniques with conventional pumping systems, however, continues to provide
comparable results in many laboratories.
A summary of the HPLC miniaturisation techniques and their analytical
properties is shown in Table 1.1. As the internal diameter (I.D.) of the column

decreases, the concentration of the analyte peak increases in proportion to the inver
square of the diameter (Stults et al, 1996). The optimum flow rate (and solvent
consumption) decreases with the decreasing column I.D. and the resolution of

components increases. Smaller columns have therefore resulted in improved sensitivity
when coupled with MS (Moritz and Simpson, 1992; Chervet et al, 1996; Haynes et al,
1998). There are, however, some practical limitations with smaller columns that must
also be considered. Leaks are more difficult to observe with lower flow rates and the
peak broadening caused by unions is more pronounced. Sample loading is also limited
and increased loads may result in peak broadening and detector saturation (Moritz and
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Simpson, 1992). Smaller columns are also more prone to clogging from particulates or
salt deposits.

Name
Conventional
HPLC
Microbore
HPLC

Column
I.D.
3.2-4.6 m m
1.5-3.2 m m

Micro L C

0.5-1.5 m m

Capillary L C

150-500 iim

Nano L C

10-150 ,um

Flow Rate
0.5-2.0
mL/min
100-500
)iL/min
10-100
uL/min
1-10
uL/min
10-1000
nL/min

Sample
Range
(pmol)

Relative Peak
Concentration

102-105

1

50-IO4

5

5-103

20

0.5-500

200

-

-

Table 1.1 Characteristics of miniaturised versions of H P L C

The coupling of capillary L C to M S has a number of advantages including: i) on-

line desalting of samples; ii) concentration of components in the samp

separation of components in a complex mixture (Moritz et al, 1994b). Te

increasing the available analysis time for a peak eluting from a colum

explored. "Peak parking" and variable flow chromatography may increase

time of a selected component by up to a factor of 10 (Davis and Lee, 19
Many examples of the use of capillary LC-MS and LC-MS/MS for the

identification of peptides are available. Application of capillary LC-

digested proteins from 2-dimensional electrophoresis has been particul

(Moritz et al, 1994a; Reid et al, 1998; Heller et al, 2000). More recen

focus on functional proteomics and to avoid the labour intensive use o

electrophoresis, capillary LC-MS has been used in conjunction with oth
such as 1-dimensional electrophoresis, size-exclusion chromatography,

Chapter 1: Introduction

18

chromatography and ultrafiltration (Marvin et al, 2000; Heller et al, 2000; Opitek et
al, 1998; McCormack etal, 1997; Raidaetal, 1999).

1.2 APPLICATION OF MASS SPECTROMETRY TO
CONVENTIONAL PROTEOMICS
The 'proteome' is defined as the total protein complement that is expressed by a

genome or tissue (Wilkins et al, 1997). Analysis of the proteome of a given cell typ

tissue, or organelle has typically involved separation and visualisation of the prot

2-dimensional electrophoresis, followed by excision and identification of the protei
Mass spectrometry is routinely used for identification of in-gel digested proteins,
usually in combination with database searching.

1.2.1 Two-dimensional electrophoresis
Two-dimensional electrophoresis (2DE) uses the combined techniques of isoelectric
focusing (IEF) and sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-

PAGE) to enable separation and visualisation of the proteins in a particular sample.

which is used for the first dimension, separates proteins by their pi, whilst SDS-PA
in the second dimension separates the proteins according to their molecular mass
(Herbert etal, 1997).
Many developments have occurred since the introduction of 2DE in the 1970s that

have resulted in vast improvements in the resolution and reproducibility of 2DE gels
IEF is now performed in precast gels that contain an immobilised pH gradient (IPG),

whereas previously this separation was dependent on carrier ampholytes (Hanash et al
1987; Gorg et al, 1988; Mackin et al, 1991). IPG gels have advantages over carrier
ampholytes including an increased loading capacity, improved stability in focusing,
ability to prepare narrow gradients, enhanced reproducibility and the absence of
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gradient drift (Hanash et al, 1987; Gorg et al, 1988; Bjellqvist et al, 1993; Herbert et
al, 1997; Herbert et al, 1998). The sample can be applied to.the entire IPG gel by
rehydrating the gel in sample solution (Rabilloud et al, 1994; Sanchez et al, 1997).
This in-gel, sample rehydration avoids precipitation problems, eliminates crosscontamination, maximises reproducibility and is suitable for small volumes.
Advances have also occurred in sample preparation techniques. Solubilisation of
hydrophobic membrane proteins, which have a tendency to aggregate and precipitate, is
typically achieved with detergents such as SDS. SDS, however, interferes with IEF by
masking the individual pis of the proteins. Solubilisation for IEF must therefore be
attained with non-ionic or zwitterionic detergents (such as 3-([3cholamidopropyl]dimethylammonio)-l-propanesulfonate (CHAPS)) (Schupbach et al,
1991). Further improvements in protein solubility have been achieved by using
tributylphosphine (TBP) rather than dithiothreitol as a reducing agent (Herbert et al,
1998). Combining chaotropes (urea and thiourea), detergents (CHAPS and sulfobetaine

3-10) and TBP in a stepwise extraction procedure (differential solubilisation) has also
been shown to improve representation of proteins (Molloy et al, 1998). Prefractionation
techniques have also been introduced to simplify samples prior to 2DE and thereby
achieve representation of increased numbers of proteins (Corthals et al, 1997; Zuo and
Speicher, 2000). Subcellular fractionation is often used to reduce the complexity of
samples (Herbert et al, 1997; Rabilloud et al, 1998; Jung et al, 2000).
Advantages of separating proteins on gels include: i) the ability to store proteins
in the gel for long periods of time; ii) qualitative and, in some cases, quantitative
information is obtained through visualisation of the proteins; iii) gels are capable of
separating complex samples; and iv) preliminary molecular mass and pi information is
obtained for the proteins (Corthals et al, 2000a). There are, however, limitations and
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disadvantages associated with 2 D E (Herbert et al, 1997). Proteins with high or low pis
(> 8 or < 4) and very large proteins are difficult to resolve. The separation of
hydrophobic proteins by 2DE is challenging, even with advances in solubilisation
techniques. Proteins of low abundance are often not detected by 2DE despite the use of
narrow range IPG gels, prefractionation and differential solubilisation. The widespread
use of similar techniques and implementation of automated procedures in large-scale
laboratories has resulted in improved reproducibility within and between laboratories.
Small changes in buffers, gel preparation or staining techniques, however, have a
marked effect on the resulting gels and often affect gel reproducibility. Furthermore,
2DE is a time-consuming and labour-intensive technique. Nonetheless, there is
currently no other technique that matches the ability of 2DE for separating and
visualising thousands of proteins. Therefore the role of 2DE in the characterisation of
the proteome continues to be crucial.

1.2.2 Database Searching with MS information
To identify proteins from 2DE gels, the spots are excised and enzymatically cleaved,
usually with trypsin. The "in-gel" digested proteins are then analysed by MS. There are
a number of ways in which protein or translated oligonucleotide sequence databases
may be interrogated with MS information. The two most widely used are: i) peptide
mass fingerprinting; and ii) peptide sequence tags. The use of sequence information
alone may also be used in a "sequence-only" search.
Databases
Table 1.2 shows some of the most widely used databases that are available via the
internet. Other databases are also available and often incorporate entries from a number
of different databases. Although Swiss Prot is one of the smallest databases, it is the
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most highly annotated and has low entry redundancy. After evaluation, entries from the
TrEMBL database are added to the Swiss Prot database (and removed from TrEMBL)
(Bairoch and Apweiler, 2000). The resulting database has a low frequency of errors,

with extensive information including species origin, post-translational modification
structural features of the sequence and references associated with the protein.

Database
name

SWISS P R O T

Type of
database
Protein and
translated
oligonucleoti
de sequence

U R L address

Features

w w w. expasy .ch/sprot/sprot
-top

Extensive annotation;
low error rate; low
redundancy
Translation of the E M B L
nucleotide sequence
database; extensive
annotation
Translation of the
GenBank nucleotide
sequence database;
Moderate error rate;
Significant redundancy;
little additional
annotation

TrEMBL

Translated
oligonucleoti
de sequence

www.expasy.ch/srs5

GenPept

Translated
oligonucleoti
de sequence

Download site from
GenBank site
www.ncbi.nlm.nih.gov
/GenBank/index

International
Protein
Sequence
Database
(PIR)

Protein
sequence

www.nbrf.georgetown.edu

High level of annotation;
low error rate; low
redundancy

w w w .bioinf.man .ac .uk/
dbbrowser/OWL

Composite of
S W I S S P R O T , GenBank,
PIR and N R L - 3 D ; low
redundancy

OWL
Protein
DataBank
dbEST

Protein and
translated
oligonucleoti
de sequence
Translated
oligonucleoti
de sequence
Expressed
sequence
tags

www.ddbj.nig.ac.jp/PDBre
triever/pdb_retriever

Translation of the D N A
DataBank of Japan

www.ncbi.nlm.nih.gov/db
EST/index

High error rate

Table 1.2 Protein and translated oligonucleotide sequences available via the Internet
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Expressed Sequence Tags (ESTs) are short nucleotide sequences (approximately
250-400 base pairs in length) generated by sequencing randomly selected portions of
DNA (Bairoch, 1997; Kinter and Sherman, 2000). A large amount of data is generated
by this approach but the error rates are high. ESTs can, however, be of use when other
databases do not result in retrieved sequences from the available information. Peptide
mass fingerprinting data cannot be used to search EST databases, however, since the
EST database information is fragmentary and does not represent whole proteins.

Peptide mass fingerprinting
MALDI-MS analysis of in-gel digested proteins provides molecular mass information

on the peptides from the digest. The list of peptide masses that is generated ("peptide

mass fingerprint") provides a specific tool that can be used to search databases (Henze
et al, 1993; Mortz et al, 1994; Patterson and Aebersold, 1995). The list of MALDI
masses is compared to theoretically generated lists of digested proteins from the
database ('in silico' digests). Proteins that have a specified number of peptides that
match the MALDI masses are retrieved by the search program and displayed in a
ranked list, along with information on the peptides that were matched. Peptide masses
from ESI data may also be used for peptide mass fingerprinting, providing the charge
on the peptides is known.
Table 1.2 lists some of the databases that are available via the internet for
database searching with MALDI mass fingerprint data. Different search programs may

contain different options for increasing the specificity of the search. These paramete
may include pi range, protein molecular mass range, amino acid modifications and
species identification.
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M A L D I massfingerprintingis a rapid technique that requires minimal sample
preparation following extraction of the peptides from the gel, although improved

coverage of the peptides is usually obtained if the samples are desalted prior to analy
(Erdjument-Bromage et al, 1998; Courchesne and Patterson, 1997; Kussmann et al,
1997). Peptide coverage by MALDI-MS is also dependent on the response factors of

individual peptides. It has been noted that peptides with C-terminal lysine residues ha
lower response factors compared to peptides with C-terminal arginine residues (Krause
et al, 1999; Brancia et al, 2000). To improve peptide coverage, derivatisation of
peptides has been successfully introduced (Brancia et al, 2000; Brancia et al, 2001).
If more than one protein is present in a particular gel-spot or sample, the protein
origin of the peptides generated by enzymatic cleavage cannot be determined. Therefore
MALDI-MS mass fingerprinting has limited ability for the analysis of mixtures of
proteins. In some cases, the correct identification of a protein may be obtained from
peptide mass fingerprinting with a mixture of peptides from different proteins. The

peptides that are not accounted for by the first protein identification can be searched
"second-pass" search to attempt to identify other components (Patterson and Aebersold,

1995). This type of search may not, however, result in a correct identification and fals
positive matches are also possible. With complex mixtures of proteins other search
strategies must be used.
Peptide Sequence Tags
Peptide sequence tags are generated from MS/MS of the peptides in a digest and consist
of three regions: i) the mass of the peptide fragment on the N-terminal side of the
chosen sequence; ii) a short sequence of amino acids; and iii) the mass of the peptide
fragment on the C-terminal side of the chosen sequence (Mann and Wilm, 1994). The
sequence tag, peptide mass and fragment ion type are entered in to a search program.
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Table 1.3 lists some database searching programs that are available via the internet.
Retrieved sequences are compared to the entire M S / M S spectrum for confirmation of
the correct match. Sequence tag searching is more specific than mass fingerprinting and
does not require a large representation of peptides from a parent protein. In some cases
one or two peptides m a y be sufficient for protein identification.
Sequence searching without mass information
M S / M S of tryptic peptides often generates extensive sequence information that can be
interpreted relatively easily with experience in peptide fragmentation. With a small
stretch of amino acids (usually five or more residues), specific searching of databases
m a y also be achieved. "Sequence only" searching does not use the masses on either side
of the stretch of sequence and does not require the peptide mass. The exclusion of mass
terms in the search eliminates problems that m a y be encountered w h e n modified
peptides are analysed.

Program
Name
Peptide
Search
(PepSea)

Mass fingerprint,
Sequence Tag,
Sequence only

pepsea.protana.com

MS-Fit

Mass fingerprint

jpsl.ludwig.edu.au/ucsfhtml3.4/msfit.

Search Type

U R L address

MS-Tag

Sequence Tag

jpsl.ludwig.edu.au/ucsfhtml3.4/mstag

MS-Seq

Sequence Tag

jpsl.ludwig.edu.au/ucsfhtml3.4/msseq

MS-Pattern

Sequence Only

jpsl.ludwig.edu.au/ucsfhtml3.4/mspattern

Tagldent

Sequence Only

au.expasy.org/tools/tagident

Peptldent

Mass fingerprint

au.expasy.org/tools/peptident

PepFrag

Sequence Tag

prowl 1 .rockefeller.edu/prowl/pepfragch.

ProFound

Mass Fingerprint

129.85.19.192/profound_bin/WebProFound.exe

Table 1.3 Search programs that are available via the Internet for interrogation of
databases with M S data (where possible, the Australian sites are listed).
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The application of M S for the identification of gel-separated proteins has resulted

in a flood of research papers detailing examples of proteomics applications. Interesti
examples have included the analysis of human melanoma proteins (Clauser et al,

1995), ion-channel proteins (Buhler et al, 1998), apoptosis-associated proteins (Otto et
al, 1998; Brockstedt et al, 1998; Gygi et al, 1999a) and human colon cancer (Ji et al,
1994). There have also been numerous reviews discussing the merits and weaknesses of
different search strategies (Patterson and Aebersold, 1995; Shevchenko et al, 1996b;
Jungblut et al, 1996; Humphrey-Smith et al, 1997; Jensen et al, 1998; Lahm and
Langen, 2000; Harry et al, 2000; Aebersold and Goodlett, 2001).

1.3 FUNCTIONAL PROTEOMICS
1.3.1 Limitations of Conventional Proteomics
Conventional proteomics, i.e. 2DE electrophoresis followed by MS identification of
proteins, has become a valuable tool for the identification of proteins in very complex
samples. The establishment of proteomes of different organisms (such as yeast)
(Shevchenko et al, 1996a), organelles (e.g. the mitochondrion) (Jung et al, 2000;
Rabilloud et al, 1998) and tissues (e.g. the myocardium) (Thiede et al, 1996; Otto et

al, 1996) will provide information to assist in discovery of proteins that are affected
particular treatments or in certain diseases. The high level of automation has improved
the throughput in large-scale laboratories and also increased reproducibility of the
results (Quadroni and James, 1999; Harry et al, 2000).
Conventional proteomics, however, does not provide information on protein

function and also has limitations in the analysis of low level proteins, highly basic or
acidic proteins, and proteins with high or low molecular weights (Corthals et al,
2000b). Hydrophobic proteins are also difficult to analyse with conventional proteomics
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further limitation in this approach is the difficulty of obtaining

quantitative representation of the proteins (Blackstock and Weir, 1999; Aebersold and
Goodlett, 2001).
The need for more information on the proteins that are identified by proteomics
has resulted in the development of new proteomic technologies and increasing interest
in methods that do not use 2DE. Moreover, attention has begun to focus on gathering

information on the protein function from techniques used to separate the proteins prio
to MS analysis.

1.3.2 Circumventing 2DE
The increasing use of LC-MS and LC-MS/MS data for database searching and the
ability of these techniques to analyse complex mixtures has begun to reduce the need
for separation of proteins prior to MS analysis. Chromatography-based methods are

emerging for the partial separation of proteins prior to MS analysis (Opitek et al, 19
Aebersold and Goodlett, 2001). The use of ion exchange chromatography and/or
affinity chromatography prior to LC-MS/MS results in simplification of complex
samples without the need for 2DE.
To obtain quantitative information on protein expression levels, techniques using
isotope labelling have been developed (Gygi et al, 1999b; Mann, 1999). Two forms (a
heavy isotope form and a light isotope form) of a derivatisation agent are used
separately to label a reference sample and a second (treated or diseased) sample. The
two samples are then combined, enzymatically cleaved and the labelled peptides
separated by affinity chromatography. MS analysis reveals peptides derivatised with

heavy labels and peptides derivatised with light labels. Equivalent peptides that diff

only by the label should behave the same way and the ratio of the heavy isotope form t

Chapter 1: Introduction

27

the light isotope form provides a measure of the change in abundance that has occurred.
In this way, quantitative information can be obtained from mass spectrometry of
proteins.

1.3.3 Functional Proteomics
The focus of genomics and proteomics has been the large-scale identification of gene
sequences and the proteins that are expressed by those genes. The main question that
left unanswered by these approaches is what is the function of the proteins that are
expressed? The main aim of functional proteomics is to develop methods for relating
the proteins that are expressed by a cell to their cellular function (GodovacZimmermann and Brown, 2001).
Assignment of protein function requires integration of a number of techniques
(Blackstock and Weir, 1999). Important information can be gained from analysis of

complexes formed between proteins. Approaches to the identification of protein bindin
partners have included cross-linking, co-immunoprecipitation (using antibodies), co-

precipitation (using an affinity tag) and affinity chromatography (with antibodies or
affinity tags) (Yu and Gaskell, 1998; Rudiger et al, 1999; Harry et al, 2000; Yates,
2000; Figeys et al, 2001). Following the use of one or more of these techniques to
isolate the protein complex, the sample can be analysed directly by LC-MS/MS or
subjected to 1-dimensional SDS-PAGE prior to MS analysis.
An example of an affinity method is the Tandem Affinity Purification (TAP)
method (Puig et al, 2001). A known protein is tagged and introduced to the cell. The
protein interacts with binding partners in the cell and the complex is recovered by
affinity chromatography prior to MS analysis. Proteins that act both directly and
indirectly with the tag protein are identified.
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Another example, reported by M c C o r m a c k et al., is the application of L C - M S / M S
in identification of proteins from a complex mixture isolated using an affinity
chromatography method (McCormack et al, 1997). The protein of interest was fused
with glutathione S-transferase (GST), which was then noncovalently bound to
immobilised glutathione. Cell lysate was passed over the column to retrieve proteins
that bound to the protein fused to GST. The bound proteins were then retrieved and
analysed by LC-MS/MS.
Biotinylation has also been used for the capture of protein complexes.
Identification of proteins in the spliceosome complex was obtained following affinity
isolation and separation of the complex by 2DE (Neubauer et al, 1998).
As an alternative to MS-based techniques, the yeast two-hybrid system has been
used for high screening of protein binding pairs. This system, however, suffers from a

high rate of false positives and does not identify indirect binding partners (Pandey a
Mann, 2000; Aronheim, 2001; Toby and Golemis, 2001). To overcome some of the
limitations of the yeast two-hybrid system, other methods have been introduced
including the Sos recruitment system (SRS) and the Ras recruitment system (RRS)
(Aronheim, 2001).

1.3.4 Future Directions
Techniques for the purification of protein complexes prior to mass spectrometry are
currently performed on a small scale. Further development of these methods, and the
application of automated procedures, should prove valuable in gaining insight into
protein binding partners and hence protein function. Developments in bioinformatics
will continue to support the development of functional proteomics.
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Anotherfieldof development that m a y prove integral in functional proteomics is

the use of protein chips. In its simplest form, proteins are immobilised on a chip and

sample of interest is applied to the surface. Proteins that bind to the immobilised p
are retained upon washing and can then be eluted and analysed by MS (Pandey and
Mann, 2000). Developments in this technology may lead to further advances in
functional proteomics.
Already 2DE is becoming a technique that is more and more confined to specialist
laboratories with high levels of automation ensuring maximised throughput and
reproducibility. Continued developments are predicted to result in less dependence of

2DE and an increased focus on techniques that provide information on protein function.

The use of mass spectrometry in the identification of proteins from isolated complexes

is of great interest. Furthermore, mass spectrometry has also proved useful in the dir
analysis of noncovalent complexes (see Chapter 5).

1.4 OUTLINE OF THIS WORK
The extensive use of mass spectrometry in protein chemistry is clear from the examples
mentioned above. The role of mass spectrometry in the characterisation of proteins in
proteomics applications is well established and the increasing numbers of functional
proteomics publications reveal the growing importance of mass spectrometry in this

area. The use of mass spectrometry in the analysis of the primary structure of peptides

and proteins is widespread as a result of the sequence information that is generated by
MS/MS. The application of mass spectrometry for studying higher order protein
structure, however, is not as widely accepted but has been, and continues to be,
explored by a significant number of research groups.
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The overall aim of this work is to provide insight into a number of applications to
which electrospray ionisation mass spectrometry (ESI-MS) can be applied and therefore
to address the advantages and disadvantages of the use of ESI-MS in these analyses.
Three different applications of ESI-MS are presented.
A cellular process that has evoked extensive research in recent years is apoptosis,
which is a highly regulated form of cell death. The importance of an increase in the
permeability of the mitochondrial membrane during apoptosis has been recognised but
the mechanism(s) by which this occurs are not fully understood. The subcellular
fractionation and comparison of normal mitochondria and mitochondria that have
experienced an increase in membrane permeability is an area well suited to proteomic

analysis. The application of conventional proteomics to the analysis of proteins release
from mitochondria is presented in Chapter 3.
Another area of extensive research interest is the entry of the human
immunodeficiency virus (HIV) into cells. The T cell surface protein CD4 is known to

be the main cellular receptor for HIV. The identification of proteins that associate wit
CD4 may therefore provide targets for the development of therapeutics to prevent the

entry of HIV into cells. The development of a method for the identification of potential
CD4-associating proteins and the results obtained are presented in Chapter 4. The
identification of proteins that co-elute with CD4 from an immunoaffinity column

provides an example of the use of functional proteomics and the potential that this type
of approach has in the characterisation of important binding partners.
The analysis of noncovalent complexes of the protein glutathione S-transferase
(GST) with various ligands is presented in Chapter 5. The GST enzyme system has
been extensively characterised by conventional methods for protein structure analysis
such as X-ray crystallography, nuclear magnetic resonance and fluorescence. GST is
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therefore a useful model protein for investigation of the behaviour of noncovalent
complexes by ESI-MS. Furthermore, a recent study of GST with a number of ligands by
ESI-MS, raised some interesting questions regarding the complexes that were apparent
in the ESI-MS spectra (Ishigai et al, 2000). The aims of the analysis of complexes of

GST and selected ligands were therefore to investigate ligands that had not previously

been used, to answer some of the questions raised by the previous study and to provide
further insight into the behaviour of noncovalent complexes in the gas phase.

CHAPTER TWO: MATERIALS AND METHODS
2.1 PREPARATION OF MITOCHONDRIAL PROTEINS FOR 2DIMENSIONAL ELECTROPHORESIS
2.1.1 Mitochondria and permeability transition
Treated and untreated mitochondria from mouse liver were kindly provided by
Associate Professor Mark Wilson and Ms Alison Smail (Department of Biological
Sciences, University of Wollongong). The mitochondria were prepared by differential
centrifugation and were induced to undergo permeability transition (FT) using
protoporphyrin IX (PPIX). To induce low conductance PT (LC-PT), PPIX was added

to the buffer to obtain a final concentration of 20 uM or 40 |JiM PPIX. To induce hi
conductance PT (HC-PT) the final concentration of PPIX was 4 mM. Following

treatment, the mitochondria were washed 3 times with isotonic media whilst they were

still intact and the supernatant was collected. The mitochondrial pellet and superna
were then frozen at -80°C until required.
Attempts to remove PPIX included precipitation of the protein with ethanol or

acetone (both of which caused precipitation of the PPIX along with the protein), dia
against 20% dimethyl sulphoxide (DMSO) and extraction with diethyl ether. Of these

attempts, the extraction with diethyl ether showed some success. The sample solution
was acidified with acetic acid (to a final concentration of 0.875 mM CH3COOH in a
volume of 50 uX) and extracted 3 times with 100 uL diethyl ether. A small amount of
bromophenol blue (BPB) was added to the solution to help visualise the aqueous and
organic layers. The aqueous layer was recovered and used for 2-dimensional
electrophoresis. The loss of some protein was apparent when extracted and non-
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extracted control samples were compared, hence it was performed only on samples from
HC-PT mitochondrial supernatants, which had a higher concentration of PPIX
compared to the LC-PT mitochondria.

2.1.2 Chemicals and consumables for electrophoresis
Precast immobilised pH gradient (IPG) gels (Immobiline™ DryStrip pH 3-10 NL) were
purchased from Amersham Pharmacia Biotech (Uppsala, Sweden) in 7 cm and 13 cm
formats. Pharmalyte™ 3-10 (which contains carrier ampholytes) was also purchased
from Amersham-Pharmacia Biotech.
Precast polyacrylamide mini-gels (Ready Gel® Tris-HCl gels, 10-20% resolving
gel, 4% stacking gel) were purchased from Bio-Rad Laboratories (Hercules, U.S.A.).
Molecular weight markers (Broad Range SDS-PAGE standards) were also purchased
from Bio-Rad Laboratories.
Urea, thiourea, rnj<hydroxymethyl)aminomethane (tris), sodium dodecyl
sulphate (SDS), dithiothreitol (DTT), 3-([3-Cholamidopropyl]dimethylammonio)-lpropanesulfonate (CHAPS), iodoacetamide, bromophenol blue (BPB), acrylamide,
N,N,N',N'-Tetramethylethylenediamine (TEMED), ammonium persulphate (APS),

agarose, glycerol and tributylphosphine (TBP) of electrophoresis grade or the highest
available grade were purchased from ICN Biomedicals (Costa Mesa, U.S.A).
CHAPS, SDS, sodium azide, N-decyl-N,N-dimethyl-3-ammonio-l-propanesulfonate
(SB 3-10) and 40% acrylamide/bisacrylamide solution of the highest purity were
purchased from Sigma-Aldrich (St Louis, U.S.A).
Thiosulphate, sodium carbonate, silver nitrate, formaldehyde, urea, ammonium

bicarbonate methanol, acetic acid, ethanol and acetonitrile were of the highest avail
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quality from the A j a x ™ range of chemicals (Asia Pacific Speciality Chemicals Seven
Hills, Australia).
Sequencing-grade modified trypsin was purchased either from Boehringer
Mannheim (Roche Diagnostics, Berkeley, U.S.A.) or from Promega Corporation
(Madison, U.S.A.)
MilliQ™ water (Millipore Corporation, Bedford, U.S.A.) was used in the
preparation of all solutions.

2.1.3 Extraction of proteins from mitochondria
Three extractions were performed on the pelleted mitochondria as described in the
Australian Proteome Analysis Facility (APAF) 2D Electrophoresis Manual (May 18th21st 1998) (APAF, 1998), which is similar to the method published by the same group
(Molloy et al, 1998). The first extraction used 40 mM tris and removed water-soluble
components from the mitochondria. Two hundred ixL of 40 mM tris and 150 units of
endonuclease were added to the pelleted mitochondria. The solution was vortexed and

sonicated then left at room temperature for 20 min. The mitochondria were centrifuged
at 12 000 rpm for 10 min (Eppendorf benchtop 5415C centrifuge). The supernatant was
removed and concentrated to less than 10 uL by vacuum centrifugation (SpeedVac
SCI 10, Thermo Savant, New York, U.S.A.). Buffer for IEF (8 M urea, 4% CHAPS, 2
mM TBP, 0.5% ampholytes and 40mM tris) was added to the concentrated sample.
The second extraction solution consisted of 8 M urea, 4% CHAPS, 2 mM TBP,
0.5% carrier ampholytes and 40mM tris. This solution (250 uL) was added to the
mitochondrial pellet from the previous extraction and the solution was left at room
temperature for 1 hour with occasional sonication. The solution was centrifuged for
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approximately 20 min at 14 000 rpm. The collected supernatant was used for rehydration of an IPG gel.
A solution (250 uL) containing 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB 3-10,
0.5% carrier ampholytes, 40 mM tris and 2 mM TBP was added to the mitochondrial

pellet following the second extraction. This solution was left at room temperature f

min with occasional sonication. The solution was then centrifuged for 15 min at 1400
rpm and the collected supernatant was used for re-hydration of an IPG gel.

2.2 TWO-DIMENSIONAL ELECTROPHORESIS AND
PREPARATION FOR MASS SPECTROMETRIC ANALYSIS
2.2.1 Isoelectric focusing

Samples from the concentrated supernatant and water-soluble extraction were dissolve
in 8 M urea, 4% CHAPS, 2 mM TBP, 0.5% carrier ampholytes and 40 mM tris and then

loaded into the tray for re-hydration of IPG gels. The samples from the second and th

extractions were loaded directly into the tray for IPG gel re-hydration. Gel re-hydr
was performed overnight or for a minimum of ten hours.
Following re-hydration, IEF was performed at 20°C in the Multiphor™ IEF unit
(Amersham Pharmacia Biotech, Uppsala, Sweden) using a voltage gradient program.
An example of a daytime gradient program for 13 cm long IPG gels is given in Table
2.1. The gels were focussed for a total of 20 802.5 volt hours for the program shown

Table 2.1. In overnight programs the gels were focussed for a total of 21 571 volt h

with a total run time of 11.35 hours. For the 7 cm long IPG gels, the gels were focus
for 17 755 volt hours for daytime programs. If an overnight program was used, the 7
cm long gels were focussed for 20 213 volt hours.
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Hours

Cumulative
time

Voltage (V)

Volt hours

0

0

0

0

0.2

0.2

150

15

0.5

0.7

500

162.5

0.5

1.2

1000

375

2.0

3.2

3500

4500

4.5

7.7

3500

15750

Table 2.1 Voltage supply program for IEF of 13cm IPG gels with daytime focussing.

2.2.2 SDS-PAGE
Following IEF, those gels that were not immediately equilibrated for the second

dimension were stored at -80°C. The equilibration solution for SDS-PAGE consisted
6 M urea, 2% SDS, 20% glycerol, 5 mM TBP, 2.5 % acrylamide (monomer) and

0.375 M tris. The gels were soaked in this solution for approximately 20 min. The

equilibrated IPG gels were then embedded on the top of polyacrylamide gels with a
solution of 1% agarose that contained a small amount of BPB. If molecular weight

markers were used they were also embedded with 1% agarose in a separate lane. The
precast minigels were supplied with a lane for molecular weight markers. For the
that were cast in-house, a cut drinking straw was used as a marker lane.
The 7 cm IPG gels were embedded on the top of precast Ready Gels™, whilst the

13 cm IPG gels were embedded on the top of 1mm thick 12% polyacrylamide gels that
had been cast in-house. The gels were then run under constant current conditions
a discontinuous buffer system. The anode buffer used was 0.75 M tris with 0.005%

sodium azide, adjusted to pH 8.8. The cathode buffer (which was placed in the upp
portion of the tank) was 192 mM glycine with 0.1% SDS, adjusted to pH 8.3. The
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cathode buffer was made freshly for each run, whereas the anode buffer solution was
used for up to 20 gels. For mini gels, the Ready Gel Cell™ (Bio-Rad Laboratories
Hercules, U.S.A.) was run without cooling at 5 mA constant current per gel for
30 minutes and then 12 mA constant current per gel for 20 min after the bromophenol

blue (BPB) front had run off the gels (usually 2 to 2.5 hours). The larger format gels
cm x 16 cm) were run in the Hoefer™ 600SE unit (Amersham Pharmacia Biotech,
Uppsala, Sweden) at 5 mA constant current per gel for 2 hours, followed by 20 mA
constant current per gel for approximately 30 min after the BPB had left the gel. The
current was often increased to 30-40 mA per gel when the BPB front was approximately

1 cm from the gel bottom. A circulating water cooler maintained the temperature of the
Hoefer™ unit at 4°C.

2.2.3 Silver Staining
Following SDS-PAGE, the gels were removed from the unit and placed in 50%

methanol, 10% acetic acid solution to fix the proteins. The gels were left in fixer fo
30 min or overnight. The gels were then stained with silver, using the protocol from
Garvan Institute of Medical Research, Sydney, Australia (Dr Garry Corthals, personal

communication) with minor modifications. Following fixing, the gels were equilibrated
in 5% methanol for 15 min, washed 3 times for 5 min each in MilliQ™ water, sensitised
with sodium thiosulphate (0.2 g/L) for 2 min then washed 3 times for 1 min each in

MilliQ™ water. Incubation in a solution of 0.2% (w/v) silver nitrate was performed for
25 min followed by three washes with MilliQ™ water for 1 min each. The silver stain
was then developed with a solution containing sodium carbonate (3% w/v),
formaldehyde (0.05% v/v) and sodium thiosulphate (2% of the solution used for
sensitisation). The development was stopped using a 5% solution of acetic acid. The
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gels were then thoroughly washed with MilliQ™ water. Fixed and stained gels were
stored at 4°C in plastic bags or the staining trays prior to in-gel digestion.

2.2.4 In-gel tryptic digestion
Protein spots were cut from the 2DE gels and placed in microcentrifuge tubes.

Acetonitrile was added to completely cover the gel and was left to dehydrate the gel
approximately 10 minutes. The acetonitrile was removed and the gel pieces dried by
vacuum centrifugation. The gel pieces were then covered with 12.5 ng/u,L trypsin in
50 mM ammonium bicarbonate and rehydrated at 4°C for 45 min. If, after rehydration

with the trypsin solution, the gel pieces were no longer covered with solution, 50 m
ammonium bicarbonate was added to cover the gel. The tubes were then placed in a
circulating water bath at 37°C and incubated overnight.
The supernatant from the gel pieces was collected and 20 mM ammonium

bicarbonate was added to cover the gel. The gel pieces were sonicated for 5 min then
left at room temperature for 15 min with occasional mixing. The pieces were

centrifuged, the supernatant collected and added to the first supernatant. Three fu
20 min extractions were performed with 50% acetonitrile, 5% formic acid. The
combined supernatants were concentrated by vacuum centrifugation to less than 10 pL

and desalted using Cig ZipTips™ (Millipore Corporation, Bedford, U.S.A.)(see section
2.4.1).

2.3 PREPARATION OF ANTI-CD4 SAMPLES
2.3.1 Affinity capture of CD4 and co-associating proteins
Preparation of samples by affinity capture of CD4 was performed by either Dr Andrew
Sloane or Mr Oliver Bernhard at the Millennium Institute, Centre for Virus Research
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(University of Sydney, Westmead, Australia). C E M T 4 cells were prepared and applied
to an IgGi column and an anti-CD4 column as previously described (Sloane, 2000;
Lynch et al, 1999). Briefly, the supernatant following cell lysis was passed over a
sepharose column with mouse IgGi coupled to the sepharose. This column was
connected to a similar column with anti-CD4 Q425 antibody coupled to the sepharose
place of IgGi. After column washing, the bound protein was eluted. Samples were
collected from elution of both the columns and also from the IgGi column alone.
Samples from the affinity columns in were reduced in 10 mM dithiothreitol, 6 M
urea and alkylated with 40 mM iodoacetamide. After desalting on an NAP-10 desalting
column, (Amersham Pharmacia Biotech, Uppsala, Sweden) samples were digested
overnight with modified trypsin (Promega Corporation, Madison, U.S.A.).

2.3.2 Anion Exchange Chromatography
Anion exchange chromatography for removal of the remaining detergents from the
digested peptides was also performed by either Dr Andrew Sloane or Mr Oliver

Bernhard at the Millennium Institute, Centre for Virus Research (University of Sydn
Westmead, Australia). The digested samples were loaded on to a MONO-Q™ PC 1.6/5
anion exchange column (Amersham Pharmacia Biotech, Uppsala, Sweden) attached to a
SMART™ micropurification HPLC system (Amersham Pharmacia Biotech, Uppsala,
Sweden). The column was loaded and washed with 20 mM glycine (pH 10.0) and
peptides were eluted with 350 mM NaCl in 20 mM glycine (pH 10.0). The elution of
peptide was monitored by UV absorbance at 280 nm and 214 nm using a SMART™
pPeak monitor (Amersham Pharmacia Biotech, Uppsala, Sweden). The collected
peptides were concentrated in a vacuum centrifuge and desalted using Qg ZipTips®
(Millipore Corporation, Bedford, U.S.A.) (see section 2.4.1).
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2.4 MASS SPECTROMETRY FOR PROTEOMICS APPLICATIONS
2.4.1 Desalting samples for mass spectrometric analysis
An equivalent volume of 10% formic acid was added to the peptides that had been
concentrated by vacuum centrifugation (from in-gel digests or anion exchange

chromatography). If the samples had been completely dried, 10 pL of 5% formic acid
was added and the sample was sonicated. QgZipTips™ (Millipore Corporation,
Bedford, MA, U.S.A.) were wet with 50% aqueous acetonitrile and equilibrated with

5% formic acid. The peptides were bound to the Qg by flushing the solution through
ZipTip™ 10-20 times. The ZipTip™ was then washed with 5% formic acid (10-40 pL).

A small volume of 50% aqueous acetonitrile with 5% formic acid was pipetted into a

separate microcentrifuge tube. The bound, desalted, peptides were eluted into this
volume. The volume used to elute the peptides was varied to obtain appropriate
concentrations of peptides. A maximum of 10 pL was used but typically a volume of
8 uL was used. These solutions were then used directly for MALDI and nanoESI
analyses.
For LC-MS and LC-MS/MS analyses, the desalted sample was carefully

concentrated with nitrogen. Before the solution had been removed completely, 10 uL

1% formic acid solution was added to the tube. This was concentrated again and ano
10 pL of 1% formic acid solution added.

2.4.2 MALDI-MS analysis
For MALDI-MS analyses, 0.5 pL of the desalted sample was mixed with 0.5 pL of a
saturated solution of oc-cyano-4-hydroxycinnamic acid (Sigma-Aldrich, St Louis,
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U.S.A.) in 5 0 % aqueous acetonitrile with 0.01% trifluoroacetic acid (TFA) (SigmaAldrich, St Louis, U.S.A) and spotted on a MALDI target.
MALDI data were acquired with a Bruker Biflex™ MALDI-TOF instrument
(Bruker Daltonics, Bremen, Germany). MALDI analyses were performed using gridless
delayed extraction and a reflector. The accelerating voltage was approximately 19 kV
with 14 kV on the IS2 focusing lens. Laser power was optimised for each sample

preparation. The instrument was calibrated using a linear two-point calibration (with
ACTH 18-39 (human, clip) and angiotensin II (AusPep, Parkville, Australia)).

2.4.3 NanoESI-MS and NanoESI-MS/MS

For nanoscale electrospray ionisation, desalted peptide samples were loaded into met
coated borosilicate capillaries (made in-house or obtained from Micromass U.K.,
Manchester, U.K. or Protana, Odense, Denmark). Nanoscale ESI was performed on a
quadrupole orthogonal acceleration time-of-flight mass spectrometer (Q-Tof™ or QToFM2) (Micromass U.K., Manchester, U.K.) with the Nanoflow-Z™ interface. The
capillary voltage was optimised for each capillary (between 0.7 and 1.2 kV) and the
cone voltage set between 30 and 40 V. Data was acquired in continuum mode with a

2.4 s integration time and a 0.1 s interscan delay. During MS/MS, the resolution on t

quadrupole was set to allow the transmission of all the precursor isotopes. Argon was

used as the collision gas and the collision cell voltage2 was optimised between 20 an
40 V. Spectra were processed using MassLynx™ software (Micromass U.K.,
Manchester, U.K.). The instrument was calibrated using a solution of [Glu1]-

fibrinopeptide B (Sigma-Aldrich, St Louis, U.S.A.) at a concentration of 100 fmol/pL.

The voltage applied to the collision cell is often termed the collision energy. If the ion selected for MS/MS is singly
charged the voltage applied to the collision cell is equal to the laboratory collision energy; for multiply charged
ions the energy is equal to the voltage multiplied by the charge. The term 'collision cell voltage' is used herein.
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M S / M S was performed on the doubly charged molecular ion (m/z 785) with a collision
cell voltage of 32 V. A two point linear calibration using the product ions at m/z
and 1285.5 was applied.

2.4.4 Capillary LC-MS and LC-MS/MS
LC-MS was performed using a Waters CapLC® System with a 0.32 x 150 mm
Symmetry® 100 Ci8, 5 pm column (Waters Corporation, Milford, U.S.A.). A 1 pL

injection was performed using the microlitre pickup mode. A solvent gradient of 3.8

B to 43.8% B in 18 min was used to separate the peptides at a flow rate of 2 pL/min
(Solvent A: 1% aqueous formic acid; Solvent B: 80% aqueous acetonitrile, 1% formic

acid). After 18 min, the percentage B was increased to 75%. A low dead volume union

was used to connect the outlet from the column directly to the Nanoflow-Z™ interfac
which was plumbed with 50 pm internal diameter fused silica.
A solvent delay of approximately 20 min was used to prevent data acquisition

prior to elution of the peptides. Mass spectra were acquired between m/z 500 and 12
An integration time of 1 s was used with a 0.1 s delay.
The threshold for MS to MS/MS switching was set between 3 and 5 ion counts

and precursors with 2, 3 or 4 charges were selected for MS/MS. The switch back to M

mode was set to occur after each component had been subjected to MS/MS for a certai
period of time. For more information on these parameters see Chapter 4.

2.4.5 Database searching

Database searching was performed using either Peptide Search (also known as PepSea)
(http://www.mann.embl-heidelberg.de/GroupPages/PageLink/peptidesearchpage.html;
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http://peptsearch.protana.com) (Mann and Wilm, 1994) or MS-Seq and MS-Pattern
from Protein Prospector (http://prospector.ucsf.edu) (Clauser et al, 1999).

2.5 MASS SPECTROMETRY OF NONCOVALENT COMPLEXES
2.5.1 Preparation of samples for the analysis of complexes formed between
glutathione S-transferase and ligands
Glutathione S-transferase A1(C112S), glutathione S-transferase A1(Y9F) and

glutathione S-transferase PI were the kind gift of Professor Lu-Yun Lian (Biomolecula
Science, UMIST, Manchester, U.K.). Wild-type glutathione S-transferase Al was
purchased from Oxford Biomedical Research (Michigan, U.S.A.). Glutathione (GSH),
S-propylglutathione, S-hexylglutathione and S-decylglutathione were purchased from
Sigma-Aldrich (Dorset, U.K.) and were of the highest purity available.
GST A1(C112S) was provided as a lyophilised powder and did not require

extensive purification prior to mass spectrometry. Stock solutions of the protein wer
prepared with concentrations of between 100 and 500 pmol/pL. A small amount of
BioRad AG-501-X8 mixed bed resin (Bio-Rad Laboratories, Hercules, U.S.A) was
added to the stock solution and mixed for 10-20 minutes to minimise the formation of

salt adducts. Aliquots of these solutions were stored at -20°C and diluted to 5 pmol/
with 10 mM ammonium acetate (NH4CH3COO) prior to analysis. For molecular mass
determination of the denatured protein, a 5 pmol/pL solution in 50% aqueous
acetonitrile with 0.2% formic acid was used.
GST A1(Y9F) and GST PI were supplied in buffered solutions with estimated
concentrations of 1.5 mg/mL and 11 mg/mL respectively. These were desalted using
membrane centrifugation cartridges (Microcon™ concentrators, 10K NMWL, Millipore

Corporation, Bedford, U.S.A). The protein was washed with at least 4 times the initia
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sample volume of MilliQ™ water. The concentrated, desalted protein was then
collected in MilliQ™ water and the approximate concentration calculated from the
estimated load and recovered volume. This stock solution was deionised with Bio-Rad
AG-501-X8 mixed bed resin (Bio-Rad Laboratories, Hercules, U.S.A.) before aliquots
were stored at -20°C. Samples for mass spectrometric analysis were prepared as for
GSTA1(C112S).
Recombinant human GST Al (wildtype) (100 pg determined by Bradford

method) was purchased as a buffered solution and required desalting. Ultrafiltration o
the samples was performed as for GST A1(Y9F) and GST PI and the resulting stock
solution in water was deionised and stored at -20°C. Samples were prepared for mass
spectrometry in the same way as for the other GST samples.
Solutions of GSH, S-propylglutathione, S-hexylglutathione and Sdecylglutathione were prepared in 10 mM ammonium acetate to final concentrations of
between 100 and 500 pmol/pL. S-hexylglutathione and S-decylglutathione required a
small amount of dimethylsulphoxide (DMSO) for solubilisation. S-hexylglutathione
solutions contained between 0.5% and 1% DMSO whereas the S-decylglutathione
solution contained 1.6% DMSO.
An appropriate volume of ligand solution was added to a 2 pL aliquot of GST
protein stock solution and then diluted with 10 mM ammonium acetate to a final protein
concentration of 5 pmol/pL. For the titration of GST A1(C112S) with glutathione,
molar ratios of protein to ligand ranged from 2:1 to 1:80. For the titrations of GST
A1(C112S) with S-hexylglutathione and S-decylglutathione, molar ratios ranged from
20:1 to 1:40.
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2.5.2 M a s s spectrometry for the analysis of complexes of glutathione S-transferase
Data were acquired on a quadrupole time-of-flight mass spectrometer (QTof™ or
QTof™2, Micromass U.K., Manchester, U.K.) with the Nanoflow-Z™ interface and
MassLynx™ software. Borosilicate capillaries were purchased from Micromass U.K.
(Manchester, U.K.) or Protana (Odense, Denmark).
Molecular mass determination

For the molecular mass determination of the glutathione S-transferase proteins, sample
dissolved in 50% aqueous acetonitrile with 0.2% formic acid were loaded into
borosilicate capillaries. The capillary voltage was set to between 700 and 1200 V to
obtain a stable spray and the cone voltage was optimised between 30 and 50 V. The
flow of nitrogen desolvation gas was optimised for each sample and the source

temperature was set to 80°C. Data were acquired with argon gas in the collision cell a
the voltage on the collision cell was 4 V. The integration time used was 2.4 s with a
delay of 0.1 s. Spectra were combined, baseline-subtracted and smoothed with the
MassLynx™ software. For calculation of the molecular mass, the spectra were centred
(at 80% peak height). MassLynx™ was used to calculate the average molecular mass
and the mass error (using 'Component Find').
Noncovalent complex analysis:
Prior to analysis of complexes, the QTof™ (or QTof™2) was set up for high m/z
detection as follows: i) the focus voltage was set to around 150 V to assist in

acceleration of the ions; ii) the pusher time was set to 180 psec3 (rather than automat
mode); iii) the RF voltage on the gas cell and hexapole ion bridge were set to their

The equation (m/z)1/2= 0.595 x T was used to calculate an appropriate pusher time. The time was set to a value
slightly higher than the calculated time for the desired upper m/z limit.
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m a x i m u m (by setting the transfer and collision offsets to 1); iv) the voltage on the
collision cell was set to 10 V; v) the source temperature was set to 50°C.
The optimal conditions for the detection of complexes of glutathione S-transferase
were set using a solution of caesium iodide (Csl) at 2 mg/mL with a cone voltage of
between 90 and 110 V. In the peak window of the MassLynx™ tune page two m/z
windows were viewed, a low m/z range around the 133 peak of Csl and a higher mass
range from approximately m/z 2900 to 3100. Once a Csl peak in the low mass range

was detected, the rotary pump in-line isolation valve was partially closed to increase
pressure between the cone and extraction lens whilst monitoring the peak window. After
approximately 2.5 turns of the in-line isolation valve, higher mass peaks appeared and

the low mass peak decreased in intensity. The valve was then fine-tuned for transfer of
the high mass peaks.
A solution of Csl (2 mg/mL) was used for calibration of the instrument after

optimisation of the conditions. A multipoint, linear calibration was applied to the m/
range of approximately m/z 2500 to m/z 4000. Samples were loaded into borosilicate
capillaries and the capillary voltage was set to between 700 and 1200 V to obtain a
spray, often assisted with a small amount of nitrogen back-pressure. The cone voltage
was optimised between 70 and 90 V, depending on the pressure and capillary voltage
(see section 5.3). For experiments investigating the effects of the cone voltage and

collision cell voltage, these two parameters were adjusted accordingly (see section 5.
Spectra were combined, baseline-subtracted and smoothed using the MassLynx™
software (Micromass U.K., Manchester, U.K.). In some cases, MaxEnt™ was used to
transfer the data from an m/z scale to mass scale.
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CHAPTER THREE: AN EXAMPLE OF CONVENTIONAL
PROTEOMICS
IDENTIFICATION OF PROTEINS RELEASED FROM
MITOCHONDRIA DURING PERMEABILITY TRANSITION

3.1 INTRODUCTION

Apoptosis is a highly regulated form of cell death that is characterised by a number of
morphological changes including cell shrinkage, nuclear condensation, DNA cleavage,
cell surface exposure of phosphatidylserine and blebbing of the cell membrane into
apoptotic bodies (Bossy-Wetzel et al, 1998; Mignotte and Vayssiere, 1998; Thornberry
and Lazebnik, 1998). Apoptosis is critical for embryologic development, T cell
selection in the thymus, and normal tissue homeostasis (Narula et al, 1997; Wang and
Lenardo, 1997; Tsujimoto, 1997). Diseases such as HIV, Alzheimer's disease,
Parkinson's disease, cancers, autoimmune diseases, stroke and rheumatoid arthritis have

been associated either with insufficient activation or with over-activation of apoptoti
mechanisms (Wilson, 1998; Ashkenazi and Dixit, 1998; Gulbins etal, 1996).
The process of apoptosis can be divided into three phases: initiation, execution
and degradation (Figure 3.1) (Kroemer et al, 1997; Wilson, 1998; Susin et al, 1999a).

In the initiation phase, cells receive the stimulus that activates the apoptotic pathwa
Many different changes can act as apoptotic stimuli including heat, irradiation,

depletion of growth factors, cross-linking of death receptors (such as TNFR1 or Fas), o
treatment with pharmacological agents (Ashkenazi and Dixit, 1998; Kroemer et al,
1997; Tsujimoto, 1997; Zamzami et al, 1996). In contrast to the heterogeneity of the
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shows

a regular cellular response

with

characteristic morphological changes such as the cell shrinkage and membrane blebbing
mentioned above. The degradation phase involves the removal of any remainder of the
cell, including phagocytosis of the apoptotic bodies (Mignotte and Vayssiere, 1998).

1. Initiation

•<—cell membrane
nucleus

2. Execution

cell shrinkage,
chromatin
condensation

apoptotic bodies

nuclear fragmentation,
membrane blebbing,
formation of apoptotic
bodies

phagocyte

3. Degradation
phagocytosis of
cellular debris

Figure 3.1 Stages of apoptosis
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The mitochondria (i.e. the energy-producing organelles of cells) are known to be
key regulators of the execution phase of apoptotic cell death and there are a number
mechanisms that may lead to cell death that involve mitochondria. These mechanisms
include disruption of the energy production pathway (electron transport, oxidative
phosphorylation and ATP production) and Ca2+ homeostasis, release of apoptogenic
factors from the mitochondria, alteration of the redox potential and an increase in
production of reactive oxygen species (ROS) (Cai and Jones, 1999; Green and Reed,
1998; Scarlett and Murphy, 1997; Loeffler and Kroemer, 2000; Bernardi et al, 2001).

3.1.1 The role of mitochondria in apoptosis

Mitochondria possess a proton electrochemical gradient across the inner mitochondria

membrane as shown in Figure 3.2 (Petit et al, 1990). The uneven distribution of proto

gives rise to a membrane potential (Aii/mit) and a chemical (pH) gradient both of whi

are crucial for normal mitochondrial function (Petit et al, 1990; Kroemer et al, 1997
Disruption of the A\|/mit often precedes apoptosis and occurs before the exposure of
phosphatidylserine or degradation of DNA (Zamzami et al, 1996; Kroemer et al, 1997;
Zamzami et al, 1997; Mignotte and Vayssiere, 1998). Experiments have indicated that

the loss of A\|/mit results from a process known as permeability transition (PT) (Za
etal, 1997; Kroemer et al, 1997).
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intermembrane space
(excess H+)

nner mitochondrial
membrane
outer mitochondrial
membrane
cristae

Figure 3.2 Structure of the mitochondrion

Permeability Transition
Permeability transition (PT) is the sudden increase in the permeability of the

mitochondrial membrane to solutes < 1 500 Da (Kroemer et al, 1997). It is thought to

result from the formation of pores in the inner membrane at contact sites between th
inner and outer mitochondrial membranes (Green and Reed, 1998; Zamzami et al,

1997; Scarlett and Murphy, 1997). The opening of these pores allows equilibration of
ions between the mitochondrial matrix and the intermembrane space and therefore

dissipates the proton electrochemical gradient (Green and Reed, 1998). The pores als
allow the influx of water (owing to the osmolality of the matrix) resulting in
enlargement of the mitochondria (Green and Reed, 1998). The folded inner membrane

has the capacity to expand but the outer membrane does not possess the large surface
area of the inner membrane (Figure 3.2). The outer membrane eventually ruptures,
releasing the contents of the intermembrane space (Scarlett and Murphy, 1997; Green

and Reed, 1998; Vander Heiden et al, 1997). Despite the loss in integrity of the out
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membrane, the inner membrane m a y continue oxidative phosphorylation and the

production of ATP, which may be necessary for ordered destruction of the cell (Vande

Heiden et al, 1997). The order of these changes in the mitochondria may be dependent

on the cell type and the stimulus that resulted in initiation of apoptosis (Susin e
1999a).
The PT pore can operate in either a low-conductance state (LC-PT), in which the
pore opens and closes rapidly, or an irreversible high-conductance state (HC-PT) in
which the pore remains open (Bossy-Wetzel et al, 1998; Green and Reed, 1998; Pinton
et al, 2001). HC-PT results in a long-term loss of Ay^t whereas LC-PT results in a

transient loss of Ax^e In the LC state, only small molecules and ions are able to pa

through the pore, whilst in the HC state larger molecules pass through and subsequen
the outer mitochondrial membrane may be disrupted (Pinton et al, 2001).
The PTpore
The PT pore is believed to be composed of the adenine nucleotide translocator (ANT,
an inner membrane protein), the voltage-dependent anion channel (VDAC, which is an

outer membrane protein also known as porin or the peripheral benzodiazepine receptor
(PBA)), creatine kinase (an intermembrane protein), cyclophilin D (a mitochondrial

matrix protein) and hexokinase (a cytosolic protein) (Zamzami et al, 1997; Kroemer e
al, 1997; Shimizu et al, 1999; Gottlieb, 2000). Furthermore the ANT has been shown

to interact with Bcl-2 and Bax (Shimizu et al, 1999) (see section 3.1.2) and to poss
the ability to form non-specific pores in response to several inducers of apoptosis
(Loeffler and Kroemer, 2000). These non-specific pores may lead to permeabilisation

the inner membrane, causing swelling and a resulting disruption of the outer membran
(Loeffler and Kroemer, 2000).
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In some examples, certain inhibitors of components of the P T pore did not prevent
permeabilisation of the mitochondrial membrane (Loeffler and Kroemer, 2000). It is,
therefore, possible that a number of mechanisms operate to cause PT.
AIF
Apoptosis-inducing factor (AIF), a flavoprotein of approximately 57 kDa, is released
from the mitochondrial intermembrane space during PT (Susin et al, 1996; Susin et al,
1999b). AIF is able to induce chromatin condensation and fragmentation in isolated
nuclei (Susin et al, 1999b). AIF also affects the function of mitochondrial membranes,
so that AIF released from mitochondria may act on other mitochondria (Susin et al,
1999b). Bcl-2, which is associated with the outer mitochondrial membrane, inhibits PT
and the release of AIF from mitochondria, although the mechanism by which this occurs
remains unknown (Mignotte and Vayssiere, 1998).
Other proteins that are released from the mitochondria of cells undergoing
apoptosis include cytochrome C, procaspase-2, procaspase-9 and a DNAse (Susin et al,
1999a). The release of these proteins is also inhibited by Bcl-2 (Susin et al, 1999a).

3.1.2 The Bcl-2 Family
The Bcl-2 family consists both of inhibitors and of activators of apoptosis. Bcl-2 and
BC1-XL

are inhibitors of apoptosis, whilst Bad, Bax, Bid and Bim promote apoptosis

(Du et al, 2000). The mechanisms by which the Bcl-2 family regulate apoptosis are not
fully understood. It has been shown that competition between Bcl-2 and Bax exists but
each of these proteins is able to independently regulate apoptosis (Mignotte and
Vayssiere, 1998).
Bcl-2 and Bcl-XL are located primarily in the outer mitochondrial membrane,
nuclear envelope and endoplasmic reticulum (Mignotte and Vayssiere, 1998; Kroemer
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et al, 1997). Bcl-2 has been shown to prevent the release of cytochrome C from
mitochondria but does not prevent apoptosis induced by the addition of exogenous
cytochrome C (Kluck et al, 1997). In a similar fashion, Bcl-2 prevents the release of
AIF from mitochondria but does not protect the cell from AIF present in the cytosol
(Susin et al, 1996; Susin et al, 1999b). Bcl-2 has also been shown to protect

mitochondria from a loss of Ai^mu and induction of PT (Susin et al, 1996; Kluck et al
1997). Bcl-XL prevents membrane hyperpolarisation and mitochondrial swelling
apparent prior to cytochrome C release and the loss of Axi/mit (Vander Heiden et al,
1997).
The Bcl-2 family proteins are structurally similar to some pore-forming domains

of bacterial toxins (Vander Heiden et al, 1997; Kluck et al, 1997; Bossy-Wetzel et al
1998; Green and Reed, 1998). Furthermore, Bcl-2, Bcl-XL and Bax have been shown to

form channels in artificial bilayers (Vander Heiden et al, 1997; Green and Reed, 1998

Bossy-Wetzel et al, 1998) and Bax is thought to be part of the PT pore (Antonsson and
Martinou, 2000). Hence, the Bcl-2 family may regulate the flow of small ions (and
maybe larger molecules) across mitochondrial membranes (Vander Heiden et al, 1997;

Bossy-Wetzel et al, 1998; Green and Reed, 1998). Experiments have also indicated that
the Bcl-2 family may regulate the conformation of VDAC in the PT pore (Shimizu et
al, 1999).

3.1.3 Cytochrome C
Cytochrome C resides in the intermembrane space of mitochondria and is an electron
carrier in oxidative phosphorylation (Liu et al, 1996; Bossy-Wetzel et al, 1998).
Cytochrome C is released from mitochondria in cells undergoing apoptosis and is able
to activate downstream caspases and DNA fragmentation (Liu et al, 1996; Bossy-
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Wetzel et al, 1998; Kluck et al, 1997). Cytochrome C binds to Apaf-1 (apoptosis
protease activating factor-1), dATP (deoxyadenosine triphosphate) and procaspase-9,

resulting in the autoactivation of caspase-9, which inturn activates downstream caspa
(caspases 3, 6 and 7) (Du et al, 2000).
The release of cytochrome C has been shown to be an early event in the execution

phase of apoptosis and can occur prior to the loss of A\j/mit and independently of cas

activation (Vander Heiden et al, 1997; Bossy-Wetzel et al, 1998). Inducers of PT have
been shown to cause release of cytochrome C from isolated mitochondria (BossyWetzel et al, 1998) but a decrease in the Ay^t of isolated mitochondria does not
necessarily result in the release of cytochrome C (Kluck et al, 1997).
The mechanism(s) responsible for the release of cytochrome C from the
mitochondrial intermembrane space are unknown (Bossy-Wetzel et al, 1998). It is
possible that the release of cytochrome C occurs through the PT pore and does not

require HC-PT (and is therefore apparent prior to a sustained loss of A\|/mit) (Scarl

Murphy, 1997; Bossy-Wetzel et al, 1998). Another possibility is that upon disruption o
the outer membrane in a small subpopulation of mitochondria, a general disruption of
Axi/mit might not be apparent (Mignotte and Vayssiere, 1998; Scarlett and Murphy,
1997). The Bcl-2 family members may also act as pore-forming proteins and regulate
the release of cytochrome C (Mignotte and Vayssiere, 1998; Bossy-Wetzel et al, 1998;
Gottlieb, 2000). It has been suggested that a channel formed by Bax and VDAC may
allow the passage of cytochrome C out of the mitochondria (Gottlieb, 2000; Antonsson
and Martinou, 2000). It is also of interest that the import of newly translated,

apocytochrome C into the mitochondria does not require an import receptor, proteolyti
processing, high Axjw or ATP (Liu et al, 1996; Bossy-Wetzel et al, 1998; Mignotte
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and Vayssiere, 1998). It is, therefore, possible that the import of cytochrome C is related
to its export.
The release of cytochrome C may have different consequences on different cells
(Green and Reed, 1998). Those cells containing high levels of cytochrome C may be
able to continue ATP production and the induction of apoptosis therefore occurs via
caspase activation. In cells with lower levels of cytochrome C and/or high levels of
caspase inhibitors, apoptosis may occur because of the depletion of ATP and production
of ROS.

3.1.4 Caspases

Caspases are cysteine proteases that cleave substrates on the C-terminal side of aspartic
acid residues (Du et al, 2000). These proteases require recognition of specific
tetrapeptide sequences on the N-terminal side of the aspartic acid (Thornberry and
Lazebnik, 1998). The activation of caspases is one of the key steps in the execution of
apoptosis (Bratton et al, 2000). They are synthesised as inactive enzymes and, in cells
undergoing apoptosis, are converted to the active form by proteolytic cleavage
(Thornberry and Lazebnik, 1998; Bossy-Wetzel et al, 1998). Activated caspases then

activate other caspases ("caspase cascade") and cleave many intracellular substrates tha
would otherwise protect the cell from apoptosis (Thornberry and Lazebnik, 1998; Du et
al, 2000).
Activation of individual caspases can occur by a number of mechanisms and cells
that have been induced to undergo apoptosis through different pathways may activate
distinct caspase cascades (Thornberry and Lazebnik, 1998; Bratton et al, 2000).

Activation of the initial caspase appears to involve cofactors. For example, procaspase-9
activates itself (autoactivation) after binding to a complex of cytochrome C, Apaf-1 and
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d A T P (see also section 3.1.3) (Green and Reed, 1998). Caspase-9 and caspase-3 are
released from mitochondria as proenzymes and become activated during, or
immediately after, their release (Susin et al, 1999a).
Another group of proteins important in the regulation of apoptosis are the
"inhibitors of apoptosis proteins" (IAPs) (Thornberry and Lazebnik, 1998). IAPs are

able to bind to procaspase-9 and prevent its activation (Du et al, 2000). IAPs also bi
and inhibit other activated caspases (Thornberry and Lazebnik, 1998; Du et al, 2000).
The inhibition of IAPs is opposed by another protein called Smac (second
mitochondria-derived activator of caspase) (Du et al, 2000). Smac is a mitochondrial

protein that is released to the cytosol during apoptosis and promotes the activation o
procaspase-9 by bindings IAPs (Du et al, 2000; Gottlieb, 2000).
Activated caspase-3 activates DFF/CAD (DNA fragmentation factor, which
appears to be a complex of caspase-activated deoxyribonuclease and its inhibitor
(Wilson, 1998)), which triggers DNA fragmentation (Susin et al, 1999b). Capase-3 also
cleaves polyADP-ribose polymerase (PARP, a DNA-repairing enzyme), protein kinase
C 5, DNA-dependent protein kinase and other proteins (Bossy-Wetzel et al, 1998).
DNA repair proteins, DNA replication enzymes and factors important for mRNA
splicing are cleaved by caspases (Thornberry and Lazebnik, 1998). Bcl-2-protective
proteins are also inactivated by caspase-catalysed cleavage, which appears to result
pro-apoptotic fragment (Thornberry and Lazebnik, 1998). The pro-apoptotic protein Bid
is also activated by caspases (Pinton et al, 2001). Cellular structure is affected by

caspase cleavage of structural proteins such as lamins (causing destruction of nuclear
lamina) and actin, as well as focal adhesion kinase (FAK), gelsolin and p21-activated

kinase-2, which are proteins that regulate the1 cytoskeletal components (Nicholson and
Thornberry, 1997; Thornberry and Lazebnik, 1998).
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Caspases are also capable of inducing P T pore opening (Green and Reed, 1998).

In cells that show release of cytochrome C prior to the loss of Ati/mit, activation of
caspase cascade by cytochrome C may result in PT (Green and Reed, 1998). This would

cause further caspase activation through an increase in cytosolic cytochrome C and AIF
Caspases have an enormous capacity for destruction of cellular activities. Cell-tocell contact, cytoskeleton and nuclear structure organization, DNA replication and
repair and splicing events are all disrupted by caspase activation (Thornberry and

Lazebnik, 1998). Many of these events are poorly understood and there are likely to be
caspase effects that remain unknown.
An important role exists for many other components in the apoptotic pathway
including Ca2+, serine/threonine protein kinases (such as PKC, MAPK and PKB),
ceramide and calpains (Pinton et al, 2001). Although significant advances in the past
decade have greatly improved our understanding of the components and pathways
involved in apoptosis, the complicated and diverse mechanisms involved in the

execution phase of apoptosis are not clearly understood. For application of inducers o
inhibitors of apoptosis to disease therapies, an improved understanding of the
underlying mechanisms is necessary.

3.1.5 Mitochondria and proteomics
The complexity of mitochondria, their importance in energy production and the central
role they play in the execution phase of apoptosis indicate that establishment of the
proteome of normal functioning mitochondria would be useful. Mitochondria have
recently evoked interest from a proteomics perspective and the development of a
mitochondrial proteome has commenced (Rabilloud et al, 1998). Advances in the
approaches used to establish the mitochondrial proteome have included a sucrose
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density gradient separation of the mitochondrial proteins prior to 2-dimensional

electrophoresis (Hanson et al, 2001) and affinity fractionation using mini-spin columns

to retain calcium-binding proteins, glycoproteins or hydrophobic proteins (Lopez et al,
2000b). An analysis of the proteins released from mitochondria following HC-PT has

also been reported, in which 79 known proteins were identified (Patterson et al, 2000).

Proteomics techniques have significant potential for identifying proteins released fro
the mitochondria during apoptotic processes and changes that occur within the
compartments of the mitochondria. Comparisons of mitochondrial fractions from
normally functioning mitochondria and mitochondria undergoing PT may provide
further insight into proteins that are implicated in apoptosis. Combining the affinity
fractionation reported from Lopez et al. (Lopez et al, 2000b) with control and PT
samples may reveal interesting changes in the proteins retained. Currently there have
been no reports of changes that accompany LC-PT being studied by proteomic
techniques.

3.1.6 Project aims
Prior to the commencement of this project, 2-dimensional electrophoresis had not been
used in our laboratory. The initial part of this work therefore involved setting up
equipment and establishing protocols for 2-dimensional electrophoresis. Application of
the technique to mitochondrial samples was then planned.
The development of a cell-free system for the analysis of PT in mitochondria was
undertaken by Ms Alison Smail and Dr Mark Wilson (Department of Biological
Sciences, University of Wollongong). The aim of this project was to develop a method

for the proteomic analysis of the mitochondria and, in particular, to assess the change
in the protein complement released from mitochondria that had undergone LC-PT.
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3.2 RESULTS
3.2.1 Overview of method
Mitochondria were prepared in collaboration with Dr Mark Wilson and Ms Alison
Smail (Biological Sciences, University of Wollongong). The mitochondria and
supernatant from the mitochondria were stored at -80°C until required.
Figure 3.3 shows an outline of the method for two-dimensional electrophoresis of
the mitochondrial samples. Mitochondria were induced to undergo permeability
transition (PT) with protoporphyrin IX (PPIX) (Alison Smail, Biological Sciences,
University of Wollongong). The intact mitochondria (a sample that was treated with

PPIX and a control sample) were washed with isotonic media to collect the proteins t
were released during PT and the mitochondria were pelleted. Three extractions were
performed on the mitochondria. The first extracted water-soluble components using a
solution of 40 mM Tris buffer. The second and third extractions removed hydrophobic
proteins from the mitochondria. The second extraction used urea and the detergent

CHAPS whilst the third extraction buffer contained urea and CHAPS as well as thioure
and SB3-10 detergent.
The second and third extractions from mitochondria were applied directly to the

IPG gels by retry drating the gels in the extraction solutions. The mitochondrial wa

water-soluble extraction required further preparation before they were applied to th
IPG gels. Some early preparations contained KC1, which was removed prior to IEF
using ultrafiltration devices. The samples were then lyophilised and redissolved in

dimensional electrophoresis buffer (as used for the second extraction solution). The
gels were then rehydrated in these solutions.
After performing 2DE, the gels were fixed and the proteins visualised by silver

staining. It was found that staining with Coomassie Brilliant Blue was not sufficien
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Figure 3.3 Overview of method - Preparation of samples for M S
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sensitive to detect the low concentrations of proteins loaded on the gels. The gels from
the control mitochondrial samples and the samples from mitochondria that had been
induced to undergo PT were then compared to detect protein differences. Protein spots
of interest were excised from the gels and the proteins in the spot were enzymatically
cleaved with trypsin.
Extracted peptides from in-gel digests were desalted using Ci8ZipTips™ and then
analysed by MALDI-MS and/or nanoESI-MS. The information obtained from MS was
used to interrogate databases of protein and translated oligonucleotide sequences using
the programs from Protein Prospector (http://prospector.uscf.edu) (Clauser et al, 1999)
and/or Peptide Search (also known as PepSea) (http://pepsea.protana.com) (Mann and
Wilm, 1994).

3.2.2 Extraction of proteins from mitochondria
Figure 3.4 shows the gels obtained from a sequential extraction of proteins from
mitochondria that had not been treated with PPIX. Figure 3.4A shows the gel from the
extraction of water-soluble proteins. The dark staining in the high mass region suggests
that the gel was overloaded and therefore the proteins in this region could not be
resolved. The lower mass region shows many resolved proteins. The second gel (Figure
3.4B) is from the extraction performed on the pelleted membranes after the first
extraction. The protein concentration appeared to be lower on this gel but the
background in the high mass region was still quite dark. Some of the spots in the first
gel were also apparent in the gel from the second extraction but there was also evidence

of proteins that were not apparent in the first extraction. The gel pictured in Figure 3
was from the final extraction of the same mitochondria, which had been pelleted after
the second extraction. The gel from this extraction did not appear to be overloaded but
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3

Figure 3.4 Sequential extraction of proteins from mitochondria A ) First extraction with
4 0 m M Tris, water soluble proteins, B ) Initial extraction from membranes of
mitochondria, C ) Final extraction from membranes of mitochondria
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there were fewer spots in the low mass region of the gel. Again there were proteins that

were evident in the two previous gels. The majority of detected protein spots were in

basic pi region of the gel. The three gels show the decreasing concentration of prote

through the extractions. The lack of proteins in the low mass and acidic regions of t

gel from the third extraction suggests that although this gel did not reveal the dark
background indicative of overloading, some proteins were not detected as a result of
their low concentration.

3.2.3 Gels from proteins released from mitochondria during LC-PT
Figure 3.5 shows two gels obtained from 2DE of the supernatant from control
mitochondria. These gels were from the same preparation and were obtained under

identical conditions. Small differences in the intensity of the silver stain were ob

in the gels, even though they had been treated using the same experimental conditions

The large number of spots on the gels in Figure 3.5 indicates that many proteins were
soluble in the mitochondrial wash, either from mitochondrial surface proteins or
proteins that were released from the mitochondria even before the induction of PT.
The gels in Figure 3.6 are from the supernatant of mitochondria from a different
mouse liver preparation. The gel from the supernatant of mitochondria that had not

undergone PT (control gel, Figure 3.6A) appears to be significantly different from th

two control gels in Figure 3.5, even though the mitochondria were prepared in the sam
way. Fewer protein spots were apparent on the gel and an intense series of spots was
apparent in the basic-pl/high-mass region. The gels from the supernatant of
mitochondria that had undergone low conductance (LC) PT (Figure 3.6 B-D) also

showed this intense series of proteins. There were, however, a number of different sp
in the LC-PT gels that were not apparent in the control gel.
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Figure 3.5 Silver stained gels from 2-dimensional electrophoresis of the supernatant
from a control mitochondrial preparation. Gels obtained under identical conditions.
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Figure 3.6 Silver stained gels from 2-dimensional electrophoresis of the supernatant
from mitochondrial preparations. A ) Control mitochondria, B ) C ) and D ) Mitochondria
treated with 2 0 p M PPIX.
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LC-PT

mitochondria are shown in Figure 3.7. The control gel from this preparation (Figure

3.7A) appears to be similar to the gels in Figure 3.5 but showed some differences t
control gel in Figure 3.6A. The intense series of spots seen in Figure 3.6 was not

apparent in the gels in Figure 3.7. Of the gels in Figure 3.7, the intensity of the

the control gel (Figure 3.7A) appears to be greater than in the LC-PT gel (Figure 3

The ability to distinguish novel spots in the LC-PT gel is therefore made more diff

by uncertainty in the intensity of the silver stain and the vast difference between
in Figure 3.6 and 3.7.

3.2.4 Examples of the identification of proteins from 2-DE gels
Figure 3.8 shows the MS/MS spectrum obtained from a doubly charged ion of m/z
705.9 that was apparent in the nanoESI mass spectrum of an in-gel digest of spot A

from Figure 3.5. The digest was performed on four equivalent combined spots in orde
to maximise the sample amount. The MS/MS spectrum was used to obtain a sequence

tag for searching the available databases. The ions at m/z 817.4, 916.5, 1013.6, 10
and 1183.6 resulted in the sequence tag (817.4)VPAV(1183.6). This was entered into
the program Peptide Search with the peptide molecular mass, 1409.78 Da. The search

resulted in the identification of the rat mitochondrial matrix protein, electron tr
flavoprotein alpha-subunit (ETFa) (Swiss Prot accession number PI3803, the

equivalent mouse protein was not present in the database). The remainder of the pro
ions in the MS/MS spectrum matched the retrieved sequence (LNVAPVSDIIEIK).

Along with B ion and Y ion series, internal fragments from the preferential cleavag

the N-terminal side of proline were apparent in the spectrum (this is discussed fur
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Figure 3.7 Silver stained gels from 2-dimensional electrophoresis of the supernatant
from mitochondrial preparations. Approximate molecular masses are shown on the
right-hand side of the figure. A) Control mitochondria, B) Mitochondria treated with
20pM PPIX.
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Figure 3.8 M S / M S spectrum of doubly charged precursor ion at m/z 705.9froman
in-gel digest of spot A shown in Figure 3.5. Ionsfromthe identified sequence,
LNVAPVSDIIEIK, are shown
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Figure 3.9 M S / M S spectrum of triply charged precursor ion at m/z 854.1 from an
in-gel digest of spot B shown in Figure 3.5. Ions from the identified sequence,
L V Q D V A N N T N E E A G D G T T T A T V L A R , are shown
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Chapter 4). A number of peptides from ETFcc were sequenced by M S / M S from this
particular digest (data not shown).
Figure 3.9 shows an MS/MS spectrum from an in-gel digest of equivalent spots
combined from two gels (spot B in Figure 3.5). MS/MS of the triply charged precursor

at m/z 854.1 resulted in protein identification through sequence tag searching with t
tag (933.6)GDGA(1233.6). The retrieved sequence from the mitochondrial precursor of
heat shock protein 60 (accession number P19226) closely matched the remaining
MS/MS data and the Y and B ions are labelled in Figure 3.12. A number of other
peptides from the same protein were also identified by MS/MS, which further
confirmed the identity of spot B in Figure 3.5.
An example of a MALDI mass spectrum of an in-gel digest is shown in Figure
3.10. This spectrum was obtained from the tryptic digest of the same spot combined
from three separate gels of mitochondria that had undergone LC-PT. The spot chosen

(spot A, Figure 3.6D) corresponded to a spot from the intense series of spots mentione
above that was not apparent in the gels in Figures 3.5 and 3.7. The list of ions with

over 1000 Da, which were used for a mass fingerprint search, are shown in Figure 3.11.
Using Protein Prospector to search human and mouse entries in the Swiss Prot database

with these masses resulted in 93 matches, the top 10 of which are shown in Figure 3.12
The entry with the highest rank, with 20 out of 41 peptides matched, was mouse
catalase (accession number 24270). The identity of this protein was confirmed by
nanoESI-MS/MS and database searching with sequence tags from the MS/MS data

(data not shown). Also noted in the mass fingerprint search results was a human kerati
with 7 matched peptides, which was apparent in a number of samples.
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Figure 3.10 M A L D I mass spectrum of an in-gel digest of spot A from Figure 3.6

1046.64
1066.31
1119.63
1184.60
1276.65
1307.71
1391.67

1412.78
1475.81
1493.78
1502.84
1631.02
1648.96
1659.02

1687.03
1689.99
1700.95
1707.94
1713.02
1740.99
1818.06

1839.03
1852.07
1941.04
1994.02
2011.06
2119.15
2184.10

2211.26
2234.22
2399.28
2474.38
2501.21
2518.36
2705.49

2811.22
2826.61
3312.12
3325.07
3338.01
3497.40

Figure 3.11 Peak list of ions with m/z > 1000 D a in Figure 3.10 entered into M S Fit for peptide mass fingerprint search of Swiss Prot database.
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MS-Fit Search Results
Sample ID (comment): spot A
Database searched: SwissProt.01September2001
Molecular weight search (1000 -100000 Da) selects 94640 entries.
Full pi range: 100228 entries.
Species search ( H U M A N M O U S E ) selects 11762 entries.
Combined molecular weight, pi and species searches select 10474 entries.
Pre searches select 10474 entries.
MS-Fit search selects 93 entries (results displayed for top 10 matches).
Parameters Used in Search
Considered modifications: | Peptide N-terminal Gin to pyroGlu | Oxidation of M | Protein N-terminus
Acetylated |
Min. # .* Peptide „.. Max. # Cysteines _ ., _ .,
„ .,
Mass
,,r
Digest
,,. ,
' .._ ,
Peptide
Peptides
_ ,
Masses
,
Missed
Modified
»T. •
TT
5, , Tolerance
Used
_,.
,
N terminus
to Match
...
are
Cleavages
by
5 0.300 Da monoisotopic Trypsin 1 acrylamide Hydrogen (H) Free Acid (O H)

Peptide
^. •
C terminus

Result Summary
„ , MOWSE ,» Protein „ . Accession „ . . KT
Rank
„
Masses
, _ „ m .. T Species
„
Protein N a m e
Score
Matched
MW(D.)feI
#
1 3.88e+011 20/41(48%) 59765.8/7.72 MOUSE P24270 CATALASE
2
1.48e+006 10/41 (24%) 59756.7 / 6.90 H U M A N P04040 C A T A L A S E
TYROSINE-PROTEIN KINASE ZAP-70 (70
K D A ZETA-ASSOCIATED PROTEIN)
(SYK-RELATED TYROSINE KINASE)

3

3.24e+003 8/41(19%) 69872.9/7.79 H U M A N

P43403

4

2.33e+003 7/41(17%) 95202.8/8.94 MOUSE

GLUTAMATE RECEPTOR, IONOTROPIC
Q60934 KAINATE 1 PRECURSOR (GLUTAMATE
RECEPTOR 5) (GLUR-5)

5

1.6e+003 7/41(17%) 65865.8/8.07 H U M A N

KERATIN, TYPE IICYTOSKELETAL 2
P35908 EPIDERMAL (CYTOKERATIN 2E) (K2E)
(CK 2E)

6

1.22e+003 6/41(14%) 81278.4/6.10 H U M A N

092503

SEC14-LIKE PROTEIN 1

7 821 5/41(12%) 47773.9/8.37 MOUSE Q^fi^SSSSST
SPLICING FACTOR 3B PROTEIN,
8
601
5/41(12%) 97657.5/5.53 H U M A N

013435

S U B U N I T 2 (SF3B150) (SPLICEOSOME
A S S O C I A T E D PROTEIN 145) (SAP 145)

9 476 5/41(12%) 37206.7/6.67 HUMAN 095154 ^CT^^^T™
rVFAF) ROY PROTFTN ^ Y
10
455
5/41(12%) 73095.1/6.96 H U M A N

Q15523

CHROMOSOMAL

Figure 3.12 Results from peptide fingerprint search from MS-Fit (Protein
Prospector) using the m/z ratios of ions in Figure 3.10.
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Another example of an identification obtained from the gels in Figure 3.6 was the
protein acetyl-CoA C-acyl transferase. This protein (spot B, Figure 3.6D, combined
from three gels) was identified through MS/MS and sequence tag searching (data not
shown). Acetyl-CoA C-acyl transferase is also known as 3-ketoacyl-CoA thiolase and

the rat sequences retrieved from the Swiss Prot database were P21775 and P07871 (no

equivalent mouse entries were found in the Swiss Prot database). Catalase and acety
coA C-acyl transferase are both peroxisomal proteins.

3.2.5 LC-MS of digests from gel-separated proteins
Capillary LC-MS was performed on an in-digest of spot C shown in Figure 3.5. The

digest was performed on identical spots combined from four gels. The total ion curr
(TIC) chromatogram (Figure 3.13F) provided minimal information in regards to the

elution of peptides from the column. The base peak intensity (BPI) chromatogram was
more informative for the elution of components from the column (Figure 3.13E). The
BPI chromatogram and individual mass chromatograms showed that the peptides eluted
between approximately 33 minutes and 41 minutes. Figure 3.13A-D shows four
individual mass chromatograms and the corresponding summed spectra from the peaks

in these chromatograms are shown in Figure 3.14. The first multiply charged compone
that was detected by MS from the capillary column was a doubly charged ion at m/z

566.3 at a retention time of 32.8 minutes. The portion of the spectrum illustrating

isotopic resolution of this ion is in Figure 3.14A. The abundant ions that were als

apparent in the spectrum were from singly charged ions (m/z 571.3, 672.4, 743.4 and
782.4). The mass chromatogram from the doubly charged ion at m/z 639.8 (Figure

3.13B) showed a higher signal-to-noise ratio than the other three mass chromatogram

in Figure 3.13. The summed spectra in Figure 3.14 also reflected the high signal-to
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Figure 3.13 Chromatograms from L C M S of an in-gel digest of spot C shown in Figure
3.5. A ) Mass chromatogram of m/z 566.3, B) Mass chromatogram of m/z 639.8 C )
Mass chromatogram of m/z 581.2, D ) Mass chromatogram of m/z 899.9, E) Base peak
intensity chromatogram, F) Total ion current chromatogram.
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Figure 3.14 Summed spectra from mass chromatograms shown in Figure 3.13. Average
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noise of the ion at m/z 639.8. Ions of lower abundance were also apparent in this
spectrum but the ion at m/z 639.8 dominated the spectrum. In contrast, the summed
spectra from the other chromatograms did not show the most abundant ion to be that
with which the chromatograms were generated. The doubly charged ion at m/z 581.2

eluted at a retention time of 37.5 min along with a number of other multiply charge
ions, including the doubly charged ion at m/z 583.3, which can also be seen in the

enlarged section of Figure 3.14C. The most abundant ion in this spectrum was from a

ion at m/z 652.4. The summed spectra from the peak in the chromatogram of m/z 899.9
showed the ion at m/z 563.5 to be the most abundant. The ion at m/z 899.9 did,

however, have a high signal-to-noise ratio and was clearly doubly charged, as can b
seen in the enlarged section of the spectrum in Figure 3.14D.
Separation of the digest by LC-MS revealed many ions that were not apparent in

the nanoESI mass spectrum of the same sample (Figure 3.15 A). The most abundant ion
in the nanoESI mass spectrum is from a singly charged ion at m/z 672.4. The high

signal to noise ratio of the doubly charged ion at m/z 639.8, which was apparent in
Figure 3.14B, is clear in Figure 3.15. The ions at m/z 581.2 and 583.3, which were

apparent in the LC-MS experiment at a retention time of 37.5 min (Figure 3.14C) wer

however, not visible above the background noise in the nanoESI mass spectrum (Figur
3.15A). The spectrum resulting from summation of the individual spectra from 32.5

minutes to 41.5 minutes of the LC-MS experiment (Figure 3.15B) was quite similar to
the nanoESI mass spectrum of the same sample (Figure 3.15A). Both spectra showed

the same singly charged ion at m/z 672.4, which was apparent at a retention time of
min in the LC-MS experiment (Figure 3.14A). The multiply charged components that
were apparent in the nanoESI mass spectrum were also apparent in the summed LC-MS
spectra but the nanoESI mass spectrum showed higher signal-to-noise ratios for the
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Figure 3.15 ESI mass spectra from the in-gel digest of spot C in Figure 3.5 A )
nanoES-MS B) Summed spectra from LC-MS experiment in Figure 3.13
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majority of these components. It was clear from Figure 3.15B that the spectrum

obtained by summing all the spectra in the LC-MS experiment resulted in lower sign
to-noise ratios than the individual spectra in the LC-MS experiment.

3.2.6 LC-MS/MS
LC-MS/MS experiments can be performed automatically during an LC-MS experiment

when criteria for selection of a suitable precursor are met. Correct settings for
from MS mode to MS/MS mode and then from MS/MS mode back to MS mode are
crucial for obtaining useful data in this type of experiment (known as "function
switching"). This is further discussed with other examples in Chapter 4.
Figure 3.16 shows three MS/MS spectra that were obtained from "function

switching" during an LC-MS experiment. Sequence tags from these spectra resulted i

the identification of three peptides from the mitochondrial matrix protein ornith

carbamoyltransferase (also known as ormthine transcarbamylase or OTcase, Swiss Pro
accession number PI 1725). The Y ion series from the sequence
LS(OxM)TNDPLEAAR (where OxM represents oxidised methionine) is shown in

Figure 3.16A. The doubly charged ion at m/z 639.8 from the peptide with the seque
VLSS(OxM)TDAVLAR was selected for MS/MS. The resulting MS/MS spectrum

(Figure 3.16B) showed a number of Y ions and another short series of ions, which w

64 Da below the corresponding Y ions (m/z 828.4, 915.5 and 1002.5). The loss of 64

is often observed from peptides containing oxidised methionine and corresponds to

loss of HSOCH3 (Kinter and Sherman, 2000). The B2 and A2 ions were also abundant i

Figure 3.16B. The MS/MS spectrum from the doubly charged ion at m/z 715.3 from the
peptide LQAFQGYQVT(OxM)K is shown in Figure 3.16C. The Y ions in this spectrum

resulted in peptide identification and are labelled along with the B2 and B3 ions.
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Figure 3.16 M S / M S spectra from an L C - M S separation of an in-gel digest of spot C in
Figure 3.5. Precursors selected by data-dependent M S to M S / M S switching: A ) m/z
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spectrum also showed the presence of ions that were 64 D a below the Y 4 ", Y 9 " and Yio"
ions.
The MS/MS spectra from function switching during an LC-MS experiment
(Figure 3.16) differ from the spectra acquired from nanoES MS/MS (Figure 3.8 and 3.9)
mainly because of the lower ion counts in the LC-MS/MS spectra. The time constraints
when acquiring data during an LC-MS experiment often mean that only a few spectra

are acquired on a single precursor ion. Therefore series of product ions are often not
complete, as can be seen in Figure 3.16C where the Y5" and Y6" ions are not evident in
the spectrum. Sufficient information for identification may not require extensive
coverage of the possible product ions, however, and a small number of ions may result

in assignment of the peptide sequence with high confidence. This is explained further
Chapter 4.
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3.3 DISCUSSION
3.3.1 Identification of mitochondrial proteins
The identification of mitochondrial proteins from 2DE gels was achieved with both
MALDI mass fingerprinting data and sequence tag data derived from ESI MS/MS. A
number of proteins from the mitochondrial matrix were identified from the supernatant
of mitochondria that had not undergone permeability transition (PT). These proteins

included an electron acceptor for dehydrogenases (the electron transfer flavoprotein), an
enzyme important for arginine biosynthesis (OTCase) and a heat shock protein
(HSP60), which is implicated in mitochondrial import and the folding of imported
proteins. There are a number of reasons that may account for the presence of these
mitochondrial matrix proteins. It is possible that a loss of mitochondrial membrane
integrity may have occurred in a fraction of the mitochondria prior to the addition of
PPIX, resulting in release of matrix proteins to the supernatant. Alternatively, a
mechanism for the controlled release of proteins from normal functioning mitochondria
may be in operation. The appearance of the gels from the mitochondrial supernatant

suggests that a general release of the contents of the matrix had not occurred, as limit

spots were apparent. Further studies are required to establish the reason for the presenc
of matrix proteins in the supernatant.
The spots identified as mitochondrial matrix proteins mentioned above were also
apparent in the gels from the supernatant of mitochondria that had undergone LC-PT.
Hence, the presence of these matrix proteins was apparently not affected by LC-PT. It
was difficult to compare relative intensities between gels so it could not be concluded
to whether the concentrations of these proteins had changed. The LC-PT gels therefore
did not provide further insight into possible reasons for the presence of the
mitochondrial matrix proteins. Furthermore, visually finding protein spots that appeared
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to be different in the control and L C - P T gels proved to be very difficult. The use of a
fluorescent stain such as SYPRO Ruby (see also section 3.3.2) may improve the
staining reproducibility and help to determine whether the concentration of proteins
differed between the supernatant from control mitochondria and the supernatant from
mitochondria that had undergone LC-PT. The process of quantifying spots on a gel is,
however, not very accurate, even with computer-assisted methods. More accurate
methods for protein quantification have been developed using isotope labelling of
peptides prior to mass spectrometry (Mann, 1999; Gygi et al, 1999b). These techniques
have improved the ability to demonstrate concentration differences between specific
proteins from different samples and the peptides can be labelled in the enzymatic
cleavage process. Such methods are discussed further in Chapter 4.

3.3.2 Problems associated with 2-dimensional electrophoresis
A range of difficulties was encountered with initial attempts to separate proteins from
the mitochondrial samples by 2DE. Two-dimensional electrophoresis had not been used
previously in our laboratory, thus this study required the purchase and set-up of
instrumentation. Standard samples were employed to obtain the expertise required for
2DE and the technique was then applied to mitochondrial samples. Optimisation of

suitable samples loads, conditions for separation, equilibration of the IPG strips prior
the second dimension SDS-PAGE and staining techniques was necessary. Notable
problems that were encountered included the presence of KC1 in early preparations, the
presence of BSA in various samples and the use of PPIX to induce PT. KC1, which
interfered with the IEF stage of 2DE, was removed by ultrafiltration and was later
excluded from the sample preparation. BSA, which resulted in a large broad stained
region on the gels, was removed after cell lysis through buffer exchanges (Alison Smail,
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Department of Biological Sciences, University of Wollongong, N.S.W.). Removal of
PPIX proved to be more difficult.
The PPIX used to induce PT in mitochondria caused problems in IEF of the
samples. Varying concentrations of PPIX were used to induce LC-PT. For high
conductance PT (HC-PT), 4 mM PPIX was used in the buffer to induce PT. The

residual PPIX in the supernatant fractions and the water-soluble fractions from the H

PT samples caused a dramatic loss in the resolution of protein spots on the gels (dat
shown). For LC-PT, a concentration of 20 pM PPIX was used. This lower concentration

was less detrimental to the gels but also resulted in lower resolution of proteins. T
resolution was increasingly compromised as the sample load increased. To improve the
resolution of the gels from samples containing PPIX, various attempts were made to
remove the PPIX prior to 2DE (data not shown). The most useful procedure involved

acidification of the sample and extraction with diethyl ether. The major problem with
this method was the significant decrease in the number of gel spots, suggesting that

procedure caused precipitation and loss of proteins. Therefore gels from mitochondria
that had undergone HC-PT could not be analysed further. Gels from mitochondria that
had undergone LC-PT were useful even though the PPIX affected the resolution.

Increasing the sample load resulted in a decrease in the resolution of the spots in t

gels from the supernatant and first extraction of mitochondria that had undergone LCPT. This was presumably a consequence of an increase in the concentration of PPIX.

Therefore, to increase the concentration of peptides in the digests, multiple gels we
obtained and equivalent spots were combined from a number of gels.
PPIX was not completely soluble and the presence of insoluble PPIX presumably
resulted in the diminished resolution. IEF is affected by even low concentrations of
insoluble material or particulates (Janson and Ryden, 1989). Centrifugation did not
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successfully remove the P P I X and, since the extractions were found to cause protein
loss, it was difficult to resolve this issue to achieve more definitive results.

3.3.3 Visualisation of proteins on gels
Coomassie Brilliant Blue staining of the proteins in the gels was not sufficiently
sensitive and as a result silver staining was used. The intensity of the stain and the
darkness of the background were affected by small differences in the time of each step
in the staining process. Hence, obtaining similar staining of equivalent samples run
under identical conditions was very difficult.
Silver staining is reported to be up to 100 times more sensitive than Coomassie
staining (Lauber et al, 2001). The detection limit of silver staining lies between 1 and
10 ng, compared to 100 ng for Coomassie staining (Shevchenko et al, 1996c). The
reproducibility of silver staining is, however, affected by temperature and the complex

staining procedures may result in up to 20% variation in intensity (Patton, 2000). Silver
stains have also been shown to result in lower sequence coverage than Coomassie stains
(Patton, 2000). The sequence coverage of proteins from MALDI-MS analyses of in-gel
digests may be improved by destaining of the gel pieces with potassium ferricyanide
and sodium thiosulphate prior to digestion (Gharahdaghi et al, 1999). Another problem

with silver staining is that the stain is not quantitative because the intensity is depe
upon individual protein sequence and post-translational modifications (Lauber et al,
2001; Herberts al, 1997).
Comparisons between gels were complicated by differences in the intensity of

staining, and recovery of peptides from in-gel digests of the spots was also problematic.
To obtain peptides for detection by mass spectrometry, it was found that gel spots from
a number of equivalent gels had to be combined. The combining of gel spots was
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complicated by gel-to-gel staining variations since the same spot had to be carefully

chosen from gels that had different intensities of silver stain. With protein spots of l
intensity, some gels did not show the spots and therefore could not be used to pool
equivalent proteins.
Fluorescent staining has become the method of choice for detection of proteins on
two-dimensional gels (Lauber et al, 2001; Malone et al, 2001; Patton, 2000).
Fluorescent stains, such as SYPRO Ruby, are MS compatible and have low limits of
detection (Malone et al, 2001). A further advantage is the large dynamic range and an
improvement in recovery of peptides from in-gel digests (Lopez et al, 2000a). For
small laboratories, however, the expense of these commercial stains may restrict menuse, particularly when re-use of the stain is not recommended.

3.3.4 Identification of peroxisomal proteins in mitochondrial preparations
Another problem that was encountered with the identification of proteins from
mitochondria was the discovery of peroxisomal proteins. The identification of these
proteins suggested that the preparation of mitochondria was contaminated with
peroxisomes. The contamination of other cellular components in the subfractionation of
organelles is a common problem associated with the analysis of organelle proteomes
(Rabilloud et al, 1998). Organelles of similar densities may cause contamination of
mitochondrial fractions, regardless of the methods used (Lopez et al, 2000b). The
separation of mitochondria from other components and organelles may also be limited
because of interactions between organelles (such as the mitochondria and the
endoplasmic reticulum) (Hanson et al, 2001; Lopez et al, 2000b). Catalase, which was

identified in this work, is a highly concentrated protein that is found within peroxisom
and catalyses the reduction of hydrogen peroxide to water and oxygen (Mathews and
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van Holde, 1990). Lopez et al. also identified catalase in an affinity preparation of
mitochondria (Lopez et al, 2000b). The other peroxisomal protein that was identified in
this work was acetyl-CoA C-acyl transferase. The presence of these proteins suggests
that the contents of the contaminating peroxisomes were released into the supernatant of
the mitochondrial preparation.

3.3.5 MALDI mass fingerprint and nanoES-MS/MS sequence tag searches
Identification of proteins from 2-dimensional electrophoresis using mass spectrometry
and database searching has focussed on two main approaches: i) MALDI mass
fingerprinting and ii) sequence tag searching with ESI MS/MS data. Factors that have
resulted in preferential use of one technique over the other have included access to
instrumentation, sample preparation, sample consumption, time required for data

acquisition and analysis, quality of the results obtained, the ability to analyse mixtur
of different proteins and the use of automated procedures.
MALDI-TOF mass spectrometers have generally been more accessible to
proteomic laboratories owing to their lower cost and ease of operation. Other reasons
for the preferred use of MALDI mass fingerprinting include lower sample consumption,
less time required for analysis, and the potential for automation. Prior to the
introduction of nanoESI techniques, the small sample volumes required for MALDI
compared to ESI analyses resulted in the wide application of MALDI analysis for
identification of proteins from gels. With current technologies, both MALDI and
nanoESI require only small volumes and subpicomole levels (usually hundreds of
femtomoles) are all that is required for identification of gel-separated proteins
(Blackstock and Weir, 1999). The time required for sample analysis is typically greater
for MS/MS analyses, particularly given automated procedures exist for in-gel digests,
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sample clean-up and M A L D I target spotting. Automated sample handling m a y also be
implemented for MS/MS analyses, particularly with LC-MS applications (further
discussed in Chapter 4), but this is limited when off-line nanoESI from borosilicate
capillaries is used.
The data obtained from MS/MS analyses is often more useful than the
information from MALDI analyses. Mass fingerprinting data is limited when more than
one protein is digested in the same sample as there is no way of distinguishing which
peptides belong to a particular protein. Protein spots from 2DE may contain more than

one protein, particularly in regions of the gel that are highly populated and tend to ha
overlapping proteins. MS/MS data requires only a single peptide for identification and
is therefore highly suited to the analysis of complex mixtures (as demonstrated in
Chapter 4). Mass fingerprinting data is also not suitable for searching the database of
expressed sequence tags (ESTs). The ESTs only cover a portion of a gene sequence and
may not represent sufficient peptides for identification through peptide mass
fingerprinting (Aebersold and Goodlett, 2001). Sequence tag data therefore allows
access to a vast amount of information that peptide mass fingerprinting does not cover.
An added advantage with MS/MS data is the potential to assign large stretches of
sequence in many cases. The sequence can be used to search databases without any
mass information in a "sequence only" search. This type of search may be useful for the
identification of proteins from modified peptides and unexpected enzymatic cleavages.
Examples of the application of "sequence only" searches are presented in Chapter 4.

3.3.6 Capillary LC-MS
Capillary LC-MS has enhanced the sensitivity of protein identification by MS based
methods and improved the identification of peptides in complex mixtures.
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Technological advances in miniaturisation of H P L C columns and solvent delivery
systems have resulted in the capability for interfacing HPLC systems to low-flow ESI
sources, with or without flow splitting. The CapLC™ system used in this work is
capable of delivering flow rates as low as lpL/min for gradient separations and
200 nL/min for isocratic separations.
Capillary LC-MS has a number of advantages for proteomic applications. The
separation of components in a mixture results in improved sequence coverage, and in

the case of complex mixtures, identification of proteins that might otherwise be missed.
Background contamination, which is often a significant problem in the identification of
gel-separated proteins, may interfere with detection of peptide ions. The improvement

in sensitivity in LC-MS results in a lower limit of detection and may facilitate protein
identification that might not be achieved with off-line nanoESI-MS/MS.
LC-MS and LC-MS/MS have a greater potential for automation than do off-line
nanoESI-MS and nanoESI-MS/MS. The ability to automatically load samples and
acquire data results in higher throughput of samples. This is crucial in conventional
proteomics applications when many in-gel digests are generated and there is a demand
for analysis of a large number of samples. With MS detection, resolution of individual
peptides is not necessary as multiple components may be detected and subjected to
MS/MS simultaneously. Therefore fast gradient analyses may be used, increasing
sample throughput (Tomer, 2001).

3.3.7 Automated procedures for conventional proteomics
The need for methods to increase the throughput of samples for proteomic analysis is
evident from the significant amount of time required for sample preparation, 2DE, gel

staining, analysis of the gels for novel spots and subsequent excision and processing of
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samples for M S analysis. Other important advantages of automated procedures are that
gel-to-gel variations are minimised and the chance of introducing contaminants through
human handling (such as keratin) is reduced. Large-scale proteomics laboratories are
able to ran numerous gels in batches to reduce gel-to-gel variations. The use of

densitometers and computer software in the identification of novel spots assists with g
comparisons. The software also enables protein assignments and labelling for excision
by gel-cutting robots. Robots also perform in-gel digests and the resulting extracted
peptides are automatically loaded on to MALDI targets, or on to microtitre plates for
LC-MS.
Small laboratories that do not have access to equipment for automation require
significantly more time to produce gels and may suffer from increased gel-to-gel
variation and contamination. In our laboratory, up to twelve IPG gels could be run
simultaneously and four second-dimension gels could be run simultaneously (in two
tanks connected with the same power supply and cooling system). For mini-gels, only
two second-dimension gels could be run simultaneously. Gel-to-gel variations were also
introduced in the casting of gels for the second dimension. A maximum of four gels
could be cast at one time with the available equipment. Precast mini-gels minimised
variations but were costly and have insufficient capacity for identification of in-gel
digested peptides by MS. As mentioned above, the complicated steps in silver staining
produced significant gel-to-gel variations, which further complicated the comparison of
gels from different samples.

3.3.8 Summary
Conventional proteomics has relied upon 2DE to separate proteins in a complex sample
prior to analysis by MS. The ability of 2DE to provide an image of the protein
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complement of an organism, tissue or organelle has enabled comparisons of normal and
diseased or treated samples. The ability to distinguish differences between a control

sample and a diseased sample, and to subsequently identify the proteins of interest has
resulted in the identification of many interesting proteins.
The establishment of proteomes of organisms and subcellular fractions from

tissues is continuing to increase the information available for rapid identification of
proteins. The identification of peroxisomal proteins in the gels from mitochondria in
this study, however, shows one of the potential problems with the analysis of

subcellular fractions. Careful separation of the organelles is required to minimise the
contamination by other organelles and cellular components.
The application of 2DE to the analysis of mitochondrial samples was

accomplished in this work after some initial difficulties with particular components in
the samples such as BSA, KC1 and PPIX. The complexity of the mitochondrial samples
was clear from the number of proteins that were resolved following differential

solubilisation of the mitochondria. The supernatant from the mitochondrial samples also
showed a large number of resolved proteins, some of which were known mitochondrial
matrix proteins. The variation between gels and difficulty in recognising proteins of
interest, however, complicated identification of changes that occurred in the
mitochondrial supernatant following LC-PT. The ability to detect differences in the

concentration of a particular protein between gels was also found to be a limiting fact
Two-dimensional electrophoresis is a time-consuming and labour-intensive

technique. In addition, the information obtained usually does not provide any detail on
the function of the protein or possible protein-protein interactions that may be
important. The results from 2DE and MS analysis of the proteins in small scale
laboratories is expected to be surpassed by analyses in large scale laboratories owing

Chapter 3: Conventional Proteomics

89

greater access to automated procedures. Development of alternative techniques for the
separation of proteins is of interest to many research groups. Techniques that not only
provide separation but also give some indication of protein function, i.e. functional
proteomics projects, are increasingly being developed. Long-term goals may include the
removal of 2DE from many laboratories but current methodologies have not found a
replacement that allows the visualisation provided by 2DE.

CHAPTER FOUR: ISOLATION AND IDENTIFICATION OF
CD4 AND CO-ASSOCIATING PROTEINS
4.1 INTRODUCTION
CD4 is a type I transmembrane glycoprotein from the immunoglobulin superfamily (IgSF)

of proteins. CD4 is expressed on the surface of T cells and also, to a lesser extent on
Langerhan's cells, dendritic cells, macrophages and monocytes (Bour et al, 1995). CD4
has four immunoglobulin-like domains, DI, D2, D3, and D4, a transmembrane region and a

cytoplasmic tail of 38 amino acids (Bour et al, 1995). The most widely known function of
CD4 is amplification of T lymphocyte activation. CD4 has been implicated in autoimmune
disorders and transplantation reactions and is known to be the major cellular receptor
the human immunodeficiency virus (HIV) (Huang et al, 1997).

4.1.1 CD4 in T-cell activation
The immune system can be divided into the humoral (or antibody) response and cellmediated immune responses (Alberts et al, 1994; Kuby, 1997). The two main cell types
involved are the B lymphocytes and the T lymphocytes (B and T cells). B cells are

antibody-producing cells, which are recognised as the major effector cells of the humor
response. T cells are crucial in the cell-mediated response in which specialised cells

recognise foreign antigens displayed on the surface of other cells. T cells can be divi

into two groups, cytotoxic T cells and T helper cells (Kuby, 1997). Both these groups ar

important in cell-mediated immunity and T helper cells are also crucial for assisting B
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in humoral immune responses. Another important aspect of the immune system is its ability
to respond very quickly and with more intensity towards an antigen that has been
recognised previously. The initial encounter with an antigen elicits a primary immune

response (Alberts et al, 1994; Kuby, 1997). The primary immune response results in clona

expansion of cells that are able to recognise the antigen. Some of these cells are memor
cells, which can live for long periods of time (possibly years) and are able to produce
secondary response if the same antigen is encountered at a later stage (Alberts et al,
Kuby, 1997).
T cells recognise an antigen only once it has been processed within, and displayed

upon, an antigen-presenting cell (APC) (Jensen, 1997; Vignali et al, 1993; Krummel et al
2000). The antigen is bound to a major histocompatibility complex (MHC) molecule on the

surface of an APC as shown in Figure 4.1. There are two types of these heterodimeric MHC
proteins, MHC class I and MHC class II. The T cell receptor (TCR), in association with
another protein complex called CD3, binds to the complex of peptide antigen and MHC

molecule. The TCR is also a heterodimer and is always found associated with CD3. T cells
do not contain a cytoplasmic domain so CD3 serves as the signal transduction component
of the T cell receptor complex (Krummel et al, 2000). The affinity of the TCR for a
peptide-MHC complex is quite low (KD >100pM) (Huang et al, 1997; Krummel et al,
2000), however, there are numerous other molecules involved in binding of the TCR/CD3
complex to peptide-MHC and/or subsequent T cell activation and these are outlined in
Table 4.1.
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Figure 4.1 T-cell receptor recognition of antigen bound to an M H C Class II molecule .

The T-cell receptor along with CD3 is expressed on the surface of a T helper (TH) cel

CD4 is also expressed on the TH cell and its cytoplasmic domain is associated with th

protein tyrosine kinase, p56lck. The MHC class II molecule is expressed on the surface
of an antigen-presenting cell (APC). See text for further details.

1

Artist St John Skilton
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Name

Cell type

Binds to

Function

T cell receptor
(TCR)

Tcell

Peptide-MHC

Recognition of
antigen on A P C ,
T cell activation

CD3

Tcell

TCR, Peptide-MHC

Signal
transduction of
T C R engagement

M H C class I

APC

TCR/CD3, C D 8

Antigen
presentation

M H C class II

APC

TCR/CD3, C D 4

Antigen
presentation

CD4

T cell (usually
helper T cell)

TCR/CD3/peptideM H C class II

Enhance T cell
activation,
recruitment of
p56lck

CD8

T cell (usually
cytotoxic T cell)

TCR/CD3/peptideM H C class I

Enhance T cell
activation,
recruitment of
p56Ick

LFA-1

Tcell

ICAM-l(onAPC)

Enhance T cell
activation

CD2 (LFA-2)

Tcell

LFA-3 (on A P C )

Enhance T cell
activation
Enhance or
suppress T cell
activation

CD28

Tcell

B7.1,B7.2(onAPC)

CD45

Tcell

p561ck, CD4, CD45AP

Regulate p561ck
activity
'

Table 4.1 Molecules involved in T cell activation, their location, binding partners
and functions.

C D 4 and C D 8 are co-receptors involved in T cell recognition (Jensen, 1997;
Krummel et al, 2000). T cells that express C D 4 on their surface (CD4 positive cells, CD4 + )
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recognise complexes of peptide antigen with M H C class II molecules on A P C s , whilst T
cells expressing CD8 (CD8+ cells) bind to peptide-MHC class I. MHC class I molecules are
found on most cells of the body whereas MHC class II molecules are specifically found on
APCs such as macrophages, dendritic cells and B lymphocytes (Jensen, 1997). The MHC
class I molecules display peptides that have been synthesised and degraded within a cell
and may be derived either from foreign proteins (such as those a virus would cause to be
produced) or self-proteins. T cells able to recognise self-antigen are destroyed in the
process of T cell development that occurs in the thymus (see below), therefore MHC class

molecules in a complex with self-peptide antigens are not recognised by mature T cells. I
CD8+ cytotoxic T cell recognises peptide antigen in a complex with an MHC class I

molecule, the antigen will usually have derived from viral infection and the cell display

the antigen is destroyed (Jensen, 1997). The peptides displayed by MHC class II molecules
are vastly different to those displayed by class I (Jensen, 1997). MHC class II molecules
able to bind much longer polypeptides than class I and the peptides may be derived from
internalised proteins that are from exogenous sources (Lederman and Suciu-Foca, 1999).
Most CD4+ T cells are T helper cells and play an important role in the regulation of
immune responses such as antibody production and cytotoxic T cell function. Although
CD4+ cells are usually of the helper phenotype and the majority of CD8+ are cytotoxic or
suppressor T cells, there is some crossover (Bour et al, 1995; Lederman and Suciu-Foca,
1999). The distinction between CD4 and CD8 expression is therefore closely associated
with MHC class specificity rather than the T cell type.
The binding of CD4 to the recognition machinery amplifies T-cell activation by a
factor of 10-100 (Krummel et al, 2000). CD4 binds weakly to the peptide-MHC class II
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complex through domains D I and D 2 . The T C R / C D 3 complex associates with C D 4 via the
extracellular portion of CD4, most probably through domain D3 (Vignali and Vignali,
1999) and is also connected via a protein tyrosine kinase (p56Ick) associated with the
cytoplasmic tail of CD4 (Sweet et al, 1991; Vignali et al, 1993). The association of
TCR/CD3, peptide-MHC class II and CD4 at the cell surface result results in optimal

activation of the T cell (Figure 4.1) (Li et al, 1998b; Bour et al, 1995; Vignali and Vi
1999). There is mounting evidence that suggests the active form of CD4 is dimeric or
oligomeric (Huang et al, 1997; Li et al, 1998b; Gratton et al, 2000) and studies have
shown that T cell activation requires co-aggregation between CD4/p56lck and the TCR
(Gratton etal, 2000).
CD4 and CD8 are both associated with p56lck, an src-related tyrosine kinase (Veillette
et al, 1988). The association occurs via two cysteine residues of CD4 and two cysteine
residues in the N-terminal portion of p56lck via Zn2+ (Turner et al, 1990; Gratton et al,
2000). The activation of p56lck is required for initiation of the tyrosine kinase cascade
occurs intracellularly following TCR engagement (Zamoyska, 1998). An increase in the
phosphotyrosyl content of a number of proteins occurs just prior to T cell activation
(Gratton et al, 2000). Another tyrosine kinase, ZAP-70, is also required for T cell

activation and is thought to be activated by p56lck (Gratton et al, 2000; Bosselut et al,
1999). The TCR/CD3/peptide-MHC association with CD4 brings p56lck in close proximity
to the TCR/CD3 complex and improves phosphorylation of sites on CD3 and ZAP-70
(Sweet et al, 1991; Bosselut et al, 1999). ZAP-70 inturn phosphorylates LAT (linker for
activation of T cells), which is also associated with CD4 (Bosselut et al, 1999). P59fyn
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another src-family tyrosine kinase that m a y be activated upon T C R / C D 3 engagement with
peptide-MHC (Bosselut et al, 1999).
Following the association of CD4 with the TCR/CD3 complex, CD4 is

phosphorylated, it dissociates from p56lck and is removed from the surface of the T c

(Vignali et al, 1993). The dissociation of p56lck from CD4 has been proposed to resul
phosphorylation of CD4 by protein kinase C (PKC) (Sweet et al, 1991; Vignali et al,
1993).
There are many other molecules that are known to be important in the adhesion and
activation of T cells. LFA-1, a member of the integrin family on the surface of a T
recognises ICAM-1 on an APC once the TCR has engaged with peptide-MHC (Krummel et

al, 2000). Two molecules on the T cell surface, CD28 and CTLA-4, bind to the molecul
B7.1 (CD80) and B7.2 (CD86) on other cells (Krummel et al, 2000). Binding of B7.1
enhances the T cell activation whilst binding to B7.2 suppresses T cell activation.

important in amplification of activated T cell responses and is often required for n

cell responses (Krummel et al, 2000), i.e. in the primary immune response of T cells
The ability of CD45 to regulate p56Ick is crucial in T cell activation (Veillette et

1999; Bonnard et al, 1997). CD45 has been shown to associate with CD4 in resting T c

and has also been shown to modulate T cell activation through this association (Bonn
al, 1997; Gratton et al, 2000). A transmembrane protein known as CD45 associating
phosphoprotein (CD45-AP) and CD45 form part of the large multiprotein complex for

optimal T cell activation that includes the TCR, CD4 and p56lck (Veillette et al, 199

isoform of CD45 that is expressed on memory T cells remains permanently associated w
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C D 4 and m a y play an important role in the activation of m e m o r y T cells (Bour et al,
1995).

Interleukin 16 (IL-16) is another ligand for CD4. The binding site of IL-16 is distinct
from the MHC site (Center et al, 2000). The binding of IL-16 to CD4 causes crosslinking
of CD4. If this binding occurs in the absence of antigen, CD4 no longer interacts with
TCR and the cell enters a state of anergy. In this way, CD4 can act to either activate
cell by interacting with TCR/MHC when antigen is presented by the correct MHC

molecule, or, to inhibit T cell activation via IL-16 but still produce inflammatory sig

(Center et al, 2000). The state of unresponsiveness of the IL-16 T cells is reversible af

sufficient time has elapsed and the T cell is then able to be activated upon binding an
antigen-MHC class II complex. IL-16 may therefore play a role in the accumulation of T

cells for future antigen recognition or in preventing prolonged activation of T cells (
etal, 2000).

4.1.2 CD4 in thymocyte differentiation

T cells develop from thymocytes in the thymus. It is important that the T cells are abl

recognise foreign antigens presented by self-MHC molecules but that they are not reacti

to self-antigen (Finkel et al, 1991). In a process termed 'positive selection', the T ce
express TCRs which recognise self-MHC molecules survive, but those that express TCRs

not specific for self-MHC molecules are destroyed because they would not be useful to t
cell (Alberts et al, 1994). A second process, termed 'negative selection', ensures any T

cells that form high-affinity complexes with self-antigen bound to MHC molecules are al

destroyed in the thymus (Finkel et al, 1991; Alberts et al, 1994). The thymocytes begin a
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double negative ( D N ) cells that express neither C D 4 nor C D 8 . These cells then begin to
express both CD4 and CD8 and are termed double positive (DP) thymocytes, as they are

both CD4+ and CD8+. The DP cells then undergo a process so that they express either CD
or CD8 but not both. DP cells expressing TCRs that recognise MHC class I molecules

mature into CD8+ cells, whilst DP cells with TCRs that recognise MHC class II molecule
become CD4+. The co-receptors CD4 and CD8 are crucial in both positive and negative

selection but the mechanism by which a fully functional single positive T cell is pro
is not completely understood (Finkel et al, 1991). Two models have been proposed to
explain the change in expression of CD4 and CD8 from a double positive to a single

positive T cell (Sweet et al, 1991; Killeen et al, 1993; Hernandez-Hoyos et al, 2000)

instructional model proposes that the association of CD4 and a TCR/MHC class II compl

causes the expression of CD8 to be stopped. Likewise, an instructional signal produce
upon the association of CD8 with a TCR/MHC class I complex informs the cell to cease

expression of CD4. The second model, known as the stochastic model, proposes that the

co-receptor selection occurs independently of the TCR specificity (Hernandez-Hoyos et

2000). In this model the expression of one of the co-receptors is stopped independent
TCR association with peptide-MHC. Since recognition of peptide-MHC is dependent on

expression of the appropriate co-receptor, CD8+ T cells expressing TCRs that recognise

MHC class II molecules do not mature, whilst CD8+ cells expressing TCRs that recognise

MHC class I molecules are able to be activated. Correspondingly, CD4+ cells expressing

TCRs that recognise MHC class I molecules do not mature, whilst the CD4+ cells with th
correct TCR specificity are able to mature into fully activated T cells.
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Recently a role of p 5 6 c in the determination of co-receptor lineage has also been
proposed (Hernandez-Hoyos et al, 2000) that supports the instructional model of coreceptor commitment. Hernandez-Hoyos et al. found that the activity of p56lck during

positive selection of self-MHC molecules has an effect on the selection of either CD4 o
CD8. The thymocytes are able to determine quantitative differences between the p56lck
signals and thereby control the expression of only one of the co-receptors. P56lck is

associated with CD4 or CD8 and its activity (phosphorylation of CD3) is dependent on th

association of a co-receptor with a TCR. The co-receptor itself therefore has the abil
influence the commitment to CD4+ or CD8+.

4.1.3 The role of CD4 in HIV entry
Human immunodeficiency virus

It is now widely established that the retrovirus HIV is the causative agent of acquired
immunodeficiency syndrome (AIDS). It is estimated that there are 36.1 million people

worldwide who are living with HIV and in the two decades since the virus was identified
21.8 million people have died owing to implications directly resulting from AIDS
(UNAIDS, 2000). The development of more effective preventative measures and
therapeutic treatments are crucial in the fight against this epidemic.
The discovery of HIV in 1986 revealed two different variants, which were called
HIV-1 and HIV-2 (Kuby, 1997). HIV-1 is much more widespread than HIV-2 and appears
to be much more virulent (Kuby, 1997).
The genome in retroviruses is encoded by RNA and is reverse-transcribed to DNA in
the host cell (Turner and Summers, 1999). The genome of HIV encodes 2 envelope
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proteins, 3 structural proteins, 3 enzymes and 6 accessory proteins (Turner and Summers,
1999). A simplified schematic of the HIV life-cycle is shown in Figure 4.2. The initial

event of infection involves fusion with the cell membrane. Once the virus is within th

cytosol of the host protein, reverse transcription occurs and the viral DNA produced i

transported to the cell nucleus. The viral DNA is then integrated into the genome of t
host. Messenger RNA (mRNA) is synthesised from the DNA, as in a healthy, uninfected

cell, and the mRNA is transported out of the nucleus. Translation of the mRNA into the

viral proteins occurs and the proteins, along with unspliced RNA, form new viral parti

that bud off from the cell membrane. (Turner and Summers, 1999; Kuby, 1997; Bour et al
1995; Weiss, 2001; Bour et al, 1994; Alberts et al, 1994)
Initial infection with HIV causes a dramatic increase in the viral load and a lack of

helper cell response to the virus (Altfeld and Rosenberg, 2000). Activated T cells are

susceptible to HIV and T cell activation greatly enhances the replication of HIV-1 (B

al, 1995; Picker and Maino, 2000). Following the initial production of virus, the virus

decreases to a steady low level but there is still a lack of T helper cell response (

Rosenberg, 2000). Cytotoxic T cell responsiveness is apparent through the rise and fal

viral load and these cells are critical in the immune response to HIV (Picker and Main

2000). The loss of CD4+ T cells occurs well after the loss of T helper cell function (Altfe

and Rosenberg, 2000). A marked increase in the viral load and a decrease in the cytoto
cell function lead to progression of the disease (Altfeld and Rosenberg, 2000).
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Figure 4.2 The lifecycle of HTV 1 . Binding of the H T V surface glycoprotein, gpl20, to
CD4 and recruitment of a chemokine receptor results in fusion of the HTV membrane
with the cell membrane. The RNA of HTV is reverse transcribed into viral DNA, which

enters the nucleus of the cell and is integrated into the genome of the host. Viral
produced through the cells own machinery and proteins are translated from the viral
RNA. A new virion is assembled and buds off from the cell membrane. A mature HIV
particle is thus produced.

1

Artist St John Skilton
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HIV fusion with the cell membrane

The surface of HIV particles is coated with glycoproteins. A surface (SU) glycoprotein
gpl20 is anchored to the membrane by another transmembrane (TM) glycoprotein, gp41

(Sweet et al, 1991; Turner and Summers, 1999). Each of these glycoproteins are generate
from the cleavage of the gpl60 envelope glycoprotein precursor (Sweet et al, 1991;
Sattentau and Moore, 1993; Bour et al, 1995). The binding of an HIV particle to a cell
mediated through interactions between DI of CD4 and gpl20 (Sweet et al, 1991). In
addition, although they are separate, there is some overlap between the gpl20 binding

and the MHC class II binding site of CD4 (Bour et al, 1995). The binding of gpl20 to CD
induces a conformational change in both gpl20 and CD4 (Yachou and Sekaly, 1999) but

alone is not sufficient for HIV entry (Moore et al, 1997). After initial binding to CD
chemokine receptor is recruited and binds to the gpl20/CD4 complex (Fauci, 1996). The

association with the chemokine receptor is critical for viral entry. It is thought th

of gpl20 to the chemokine receptor induces further conformational changes in gpl20 th
culminate in fusion (Kwong et al, 1998; Turner and Summers, 1999; Horuk, 1999). These

conformational changes in gpl20 cause it to dissociate from gp41, which possibly indu
conformational changes in gp41, exposing sites on gp41 that are necessary for fusion
et al, 1995; Yachou and Sekaly, 1999; Turner and Summers, 1999). A hydrophobic fusion

peptide of gp41 is inserted into the cell membrane, which is followed by fusion of the
cell membrane with the viral membrane (Wyatt and Sodroski, 1998; Kwong et al, 1998).

HIV-1 varies in its ability to infect particular cells. Immediately after infection, t

virus usually infects and replicates within monocytes and macrophages that express CD
The virus is said to be M-tropic, even though there is some ability to replicate in T
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(Moore et al, 1997). M-tropic strains are responsible for initial H I V infection (Fauci,

1996). A virus that preferentially infects T cells is termed T-tropic and usually domina
with the progression of the infection (Fauci, 1996; Choe et al, 1998; Horuk, 1999). T-

tropic strains are involved in laboratory cell lines and in vivo forms often have the a
infect T cells and macrophages (dual tropic) (Choe et al, 1998). The dual tropic forms

appear to dominate later in the course of infection (Choe et al, 1998; Wyatt and Sodros

1998) and are thought to be intermediate in the change from M-tropic to T-tropic strain
(Berson and Doms, 1998). The T-tropic and M-tropic strains of HIV-1 use different

chemokine receptors as co-receptors for fusion with the host cell. T-tropic virus utili
CXCR4 whilst CCR5 is the co-receptor for M-tropic strains (Deng et al, 1996; Dragic et
al, 1996; Moore et al, 1997; Fauci, 1996; Horuk, 1999). CCR5 is the most commonly
used co-receptor through most of the infection (Choe et al, 1998; Wyatt and Sodroski,
1998).
Gpl20 is also able to interact with CD4 independently of gp41. Gpl20 antibodies in
complex with gpl20, free gpl20, and multimeric gpl20 are able to bind to CD4 at the

surface of uninfected cells. This binding may induce T cell cytolysis, anergy or apopto
(Bour etal, 1995).
Down-regulation ofCD4from the cell membrane

The reduction in circulating CD4+ cells has been used as a marker for the progression of
HIV to AIDS (Richman, 2001; McCune, 2001). The killing of infected CD4+ cells is not
the only mechanism that results in the reduction in CD4+ cells. HIV invokes the down-

regulation of CD4 from the surface of infected cells. There are a number of ways in whi

this down-regulation of CD4 may be achieved (Bour et al, 1995). A reduction in the level
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of C D 4 m R N A in H I V infected cells has been reported and m a y be the result of the
inhibition of CD4 transcription or of a decrease in the stability of the CD4 mRNA (Bour

al, 1994). CD4 has also been shown to bind to gpl60 (the precursor to gpl20 and gp41) in
the endoplasmic reticulum (Bour et al, 1994). Such intracellular complexes impair the
expression of CD4 on the cell surface. A protein encoded by the HIV genome called Vpu
also binds to CD4 in the endoplasmic reticulum and promotes CD4 degradation (Bour et
al, 1994). The trapping of CD4 by gpl60 enhances CD4 degradation by Vpu (Bour et al,
1995). Another protein produced by the HIV genome is the Nef protein. Nef has the
capability of binding to the cytoplasmic tail of CD4 and to p56lck (Turner and Summers,

1999; Bour et al, 1995) and is known to down-regulate cell-surface CD4, independently of

the transcription and translation of CD4 (Bour et al, 1995). It acts at the surface to c
internalisation and degradation of CD4 in lysosomes (Turner and Summers, 1999).
Anti-HIV therapies

The drugs that are currently available for the treatment of HIV target two enzymes in th

virus life-cycle: reverse transcriptase and the protease enzyme. The available drugs are
usually used in combinations to improve the efficacy of attack on HIV (Turner and
Summers, 1999).
The first drugs developed for HIV were nucleosides and targeted the enzyme reverse
transcriptase (Figure 4.2) (Richman, 2001). Non-nucleoside inhibitors of reverse

transcriptase have also been developed. Reverse transcriptase inhibitors are still cruci

anti-HIV therapy but cause undesirable side effects such as liver toxicity. The virus ha

shown the ability to develop resistance to reverse transcriptase inhibitors, particularl

administered alone. There are currently 6 nucleoside reverse transcriptase inhibitors an
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non-nucleoside reverse transcriptase inhibitors on the market (World Health Organization,
2000; HIV/AIDS treatment information service, 2001).
The other available antiviral drugs target the protease enzyme that is required for

processing of the viral proteins produced by the host cell. There are 5 currently available
protease inhibitors (World Health Organization, 2000; HIV/AIDS treatment information
service, 2001). Side effects from protease inhibitors have including insulin intolerance,
increased cholesterol levels and redistribution of body fat (Richman, 2001). Resistance to
protease inhibitors also develops (Turner and Summers, 1999). Combination therapies have
been shown to more effective in HIV control and protease inhibitors are usually used in
combination with reverse transcriptase inhibitors.
The third enzyme in the HIV life cycle, integrase, is involved in the integration of
viral DNA into the host genome and has also been targeted for HIV therapy. There are,

however, no integrase inhibitors currently available for anti-HIV treatment. Preventing th

infection by vaccination has been shown to be very difficult (Landau, 1999). Other possible

targets that are currently being developed include inhibitors of gpl20, gp41, the chemokine
receptors CCR5 and CXCR5, Tat (important for replication of HIV), Nef and Rev (crucial
for transport of viral DNA). Many inhibitors of these targets have been found to be
inefficient or produce toxic side effects. Further understanding of the life cycle of HIV
assist in the development of therapies and identify new targets for anti-HIV drugs.

4.1.4 Aims

The use of a functional proteomics approach may provide insight into proteins that have not
previously been found to associate with CD4. The identification of such proteins could
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expand our understanding of the m a n y roles that C D 4 plays and m a y reveal potential

targets for the prevention of HIV entry and treatment of immune disorders. The aim of thi
project was to develop a method for the isolation and identification of proteins that
associate with CD4.
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4.2 R E S U L T S

4.2.1 Overview of method and method development

Figure 4.3 shows a summary of the method developed for the isolation and characterisation
of proteins that co-elute with CD4 from an affinity column. The first four steps, CEMT4
cell preparation and lysis, IgGi and anti-CD4 separation and the anion exchange
chromatography were performed at the Millennium Institute, Centre for Virus Research
(University of Sydney, Westmead, Australia) by Mr Oliver Bernhard, Dr Andrew Sloane or
Dr Tim Hochgrebe.
Ion Exchange Chromatography
A portion of a typical ion exchange chromatography profile in which the peptides of
interest eluted is shown in Figure 4.4. Figure 4.4B shows the profile obtained from the

digest of IgGi column eluate. The profile in 4.4A is from the digest of eluate that passed
through both the IgGi column and the anti-CD4 column (hereafter referred to as 'anti-CD4
column'). The bound peptides were eluted using a step gradient of 350 mM NaCl (35%

buffer B), which was introduced at 62 minutes, and fractions were collected from this poin
Twelve fractions were collected over the elution period (62 to 68 minutes) and these are

labelled on the elution profiles. The highest absorbance was recorded in fractions 4 and 5
for digests from both the IgGi and the anti-CD4 columns. The percentage buffer B was
increased to 60% after 68 minutes to completely flush the column of bound species.

Cell preparation and lysis

Igd control column for non"^
specific binding capture

JI

Anti-CD4 affinity column
Method
development
for obtaining
viable
fractions

Anion exchange chromatography

Figure 4.4

Desalt fractions (C18 ZipTips™)
fl

MALDI-MS
• Screen for sample viability
• Any significant difference between
control and anti-CD4 fractions?

Figure 4.5
Figure 4.6
Figure 4.7

ft

NanoESI-MS
• Multiply charged ions apparent
over background?
• Any significant difference between
control and anti-CD4 fractions?

Figure 4.8
Figure 4.9

LC-MS (Section 4.2.4)
• Multiply charged ions
apparent?
• Determine threshold for
LC-MS/MS

NanoESI-MS/MS
(Section 4.2.3 for
examples)

V
Database searching
• 'Sequence tag'
• 'Sequence only'
(Section 4.2.3 and 4.2.5
for examples, advantages
and limitations)

ft

< = ^

LC-MS/MS with data dependent
M S to M S / M S switching
(Section 4.2.5)

Figure 4.3 Overview of method
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Figure 4.4 Ion exchange chromatography profile from 60-70 minutes of the
tryptic digests from A ) anti-CD4 (Q425) affinity column, and B) IgGi control
column. The U V absorbance at 280nm (blue line) is shown on the left hand
axis (arbitrary units). The right hand axis shows the percentage of Buffer B
(1M NaCl, 2 0 m M glycine) used for the elution. The buffer used to elute the
peptides was 3 5 0 m M NaCl in 2 0 m M glycine (35% buffer B), shown on the
graph by the red line over the elution profile. Salts and detergent eluted over
the first 30 minutes and were detected as a large broad absorbance at 280nm
(data not shown).
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Fractions were tested for C D 4 antigen by spotting 2 u L of each fraction on to a
nitrocellulose membrane and analysing with a CD4 polyclonal antibody (poly T4-5) (data
not shown). Fractions 4, 5 and 6 from the anti-CD4 column digest contained CD4. The
same test on the fractions from the IgG] column did not indicate the presence of CD4.

MALDI-MS
MALDI-MS was used to check for the presence of peptides in the collected fractions. It

was necessary to desalt the samples prior to MALDI analysis. Fractions 4-6 from the anti
CD4 preparation and the IgGi control preparation were desalted using QgZipTips™
(Millipore Corporation, Bedford, MA, U.S.A.). In the initial experiments, when MALDIMS spectra of the samples from an ion exchange chromatography experiment did not show
peptide ions, or there was no apparent difference between the control and anti-CD4
samples, the method was further developed to obtain clearer spectra. Developments

included: an increase in the number of cells grown, modifications in the elution of pep
from the IgGi control column and the anti-CD4 column (Oliver Bernhard, personal
communication) and changes in the solutions used to elute the peptides from the ionexchange chromatography column (Sloane, 2000).
Figure 4.5 shows MALDI-MS spectra of fraction 5 from an early preparation of the
anti-CD4 and control IgGi samples. The spectrum from fraction 5 of the anti-CD4 digest
(Figure 4.5A) contained many components that were also present in the spectrum of the

corresponding fraction from the IgGi control digest (Figure 4.5B). The large peak at m/z

1533.4 in the spectrum from the anti-CD4 preparation was not present in the spectrum fro
the IgGi preparation.
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Figure 4.5 M A L D I - M S spectra of fraction 5 from an early ion-exchange
chromatography separation of the column eluates after cleavage with trypsin
A ) digest of eluate from anti C D 4 column, B ) digest of eluate from IgG control column
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Figures 4.6 and 4.7 show M A L D I - M S spectra from fractions 4-6 of the anti-CD4 and
control IgGi preparation after increasing the number of cells used, exclusion of
iodoacetamide from the cell lysis solution and elution from the affinity column with a

solution containing glycine rather than EDTA (as in Figure 4.5). Each of the fractions from
the anti-CD4 preparation resulted in significantly different MALDI spectra (Figure 4.6AC), which indicated that further analysis of each of these fractions was warranted.
Comparing the spectra from Figure 4.6 to those in Figure 4.7 revealed that there were also
significant differences between the anti-CD4 preparation and the IgGi preparation. The
MALDI-MS spectra also showed components that were present in both the anti-CD4
preparation and the IgGi preparation, such as the components of approximate m/z values of
1516 and m/z 3312 in fraction 5 from both preparations (Figure 4.6B and Figure 4.7B).
NanoESI-MS
Following desalting and MALDI analysis, the samples were analysed by nanoESI-MS.
Representative ESI-MS spectra of fractions 4, 5 and 6 from ion exchange chromatography
of the digest from the anti-CD4 column are shown in Figure 4.8. As seen in the MALDI-

MS spectra (Figure 4.6), there are noticeable differences between the fractions. Singly a

multiply charges ions can be readily distinguished in the ESI mass spectra because the high
resolution of the quadrupole-ToF instrument enabled the separation of individual isotopes
of each species. The spectra show significant background ions and many singly charged
ions were apparent. Fraction 6 from this particular preparation (Figure 4.8C) contained
abundant singly charged ions, such as m/z 683.6, 711.6, 739.7, 1041.9, 1069.9 and 1098.0
that dominated the spectrum. Even with the extensive background and singly charged ions,

Figure 4.6 M A L D I - M S of fractions from ion-exchange chromatography of
the eluate from the anti-CD4 affinity column after cleavage with trypsin.
A ) Fraction 4, B ) Fraction 5, C ) Fraction 6
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multiply charged components were also apparent in the spectra. For example, a doubly
charged ion was apparent at m/z 862.5 in the spectrum from fraction 6 (Figure 4.8C).
ESI-MS spectra of the corresponding fractions from the IgGi control column samples
are shown in Figure 4.9. The background is also apparent in these spectra and the majority
of ions below m/z 600 in these spectra are from singly charged ions. Comparison of the
ESI-MS spectra from the anti-CD4 preparation and the IgGi preparation showed that some
multiply charged ions were present in fractions from both columns, such as m/z 1105 in
fraction 5. Close investigation, however, revealed many multiply charged ions in the
spectra from the anti-CD4 fractions that were not present in the spectra from the IgGi
fractions, such as the doubly charged ions at m/z 612.5 and 615.5 (Figure 4.8B). These two
abundant components with high signal-to-noise ratios were easily seen above the
background but many others were distinguishable from the singly charged background only
by the spacing between their isotopes (1 m/z between isotopes of a singly charged ion, 0.5
m/z for a doubly charged ion and 0.33 m/z for a triply charged ion).
Following nanoESI-MS, the fractions containing peptides were then used for
nanoESI-MS/MS analyses and LC-MS experiments. LC-MS/MS data was obtained from
samples once an initial LC-MS experiment provided sufficient information to set up the
LC-MS/MS experiment. MS/MS spectra then provided sequence information, which was
entered into various search programs for interrogation of protein and translated
oligonucleotide databases. Examples of nanoESI-MS/MS spectra and a search protocol are
given in section 4.2.3. Sections 4.2.4 and 4.2.5 show examples from LC-MS and LCMS/MS, respectively.
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Figure 4.8 ESI-MS of fractions from ion-exchange chromatography of the eluate from
the anti-CD4 affinity column after cleavage with trypsin.
A ) Fraction 4, B ) Fraction 5, C ) Fraction 6, magnified by 6 from m/z 750
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4.2.2 S u m m a r y of proteins identified
Table 4.2 shows a list of the precursors selected for MS/MS from the anti-CD4 samples

that resulted in identification of the peptide sequence. The table does not include peptide
that were also found in the IgGi control samples or peptides identified from trypsin
autolysis or known contaminants such as human keratins. Identifications that were
uncertain are also excluded from Table 4.2.
Examination of the sequences of the peptides in Table 4.2 shows that all of the

peptides contained at least one acidic amino acid (glutamic acid or aspartic acid) and all
two of the peptides contained two or more acidic residues. The two peptides that contained

only one acidic amino acid were the peptide from the B cell receptor-associated protein an
the peptide of mass 1353.1 Da from p56lck.
The myosin regulatory light chain peptide NAFACamFDEEATGTIQEDYLR was
sequenced from four different precursors. Two of these precursor ions, which are listed in
Table 4.2, were of the expected peptide mass of 2349.0 Da. The other two ions were
consistent with the loss of ammonia from the triply charged peptide and the addition of a
sodium ion to the protonated peptide. Another precursor that was from the same tryptic
peptide was a doubly charged ion at m/z 547.3. This corresponded to a fragment of the
tryptic peptide with the sequence GTIQEDYLR, which indicated that the peptide bond
between threonine and glycine had cleaved. This peptide is not included in Table 4.2.
Of the peptides sequenced from the anti-CD4 samples, a total of 10 proteins were

identified. These proteins and their Swiss Prot accession numbers (A.N.) are listed in Tab
4.3. The T cell surface glycoprotein, CD4, and the protein tyrosine kinase, p56lck, were
identified. Three different myosin proteins were identified, two from various light chains.
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T w o ribosomal proteins were identified, a 40S subunit and a 60S subunit, but only one
peptide from each was sequenced. Alpha tubulin was identified from three separate
peptides and each of these peptides matched a h u m a n alpha tubulin in Swiss Prot that was
brain specific (P04687). Three mouse tubulin proteins also contained each of the peptides
and they were from alpha chains 1, 2 and 6 (P02551, P05213 and P05216). Translated
oligonucleotide sequences from various human tissues also contained each of the three
peptides and all of these translated sequences were from alpha 1 tubulin (such as
A A C 3 1 9 5 9 and A A H 0 6 4 6 8 ) . A single peptide from an actin protein and a single peptide
from the B cell receptor-associated protein were also sequenced.

Swiss Prot A.N.

Protein identification

peptides

Actin (a or y)

1

P02570 or P02571

BCR-associating protein

1

Q99623

CD4

2

P01730

Myosin heavy chain type A

3

P35579

Myosin light chain alkali

4

P16475

Myosin regulatory light chain

2

P19105

7

P06239

40S Ribosomal protein

1

P25112

60S Acidic Ribosomal protein P2

1

P05387

Tubulin alpha-1 chain

3

P04687

P 56

lck

Table 4.3 S u m m a r y of identified proteins with the total number of peptides sequenced
from each of the proteins. The Swiss Prot accession number (A.N.) is listed in the final
column.
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A number of M S / M S spectra (either from nanoESI-MS/MS or L C - M S / M S ) from
precursor ions that were apparent in the anti-CD4 samples but not in the IgGi control

samples did not enable identification of a peptide that could be assigned to a known pro

A summary of these unidentified precursor ions is given in Table 4.4. Some of these spect
(e.g. the peptide of molecular mass 1764.8 Da) showed clear fragmentation but the
information entered for database searching did not result in any retrieved sequences. In

other cases (e.g. the peptide of mass 1828.9 Da) sequences were retrieved from the search

but they did not match the full MS/MS spectrum. Finally, a number of spectra, particularl
those from LC-MS/MS, either did not contain sufficient product ions to establish
information with which to search the databases, or alternatively, the MS/MS spectra was
sufficient to generate a tag but when a search retrieved a sequence (e.g. peptide of

molecular mass 1365.6 Da), confirmation of the sequence was difficult, if not impossible.
One curious result was for MS/MS of the doubly charged ion at m/z 877.1, which resulted
in a very informative spectrum but database searching did not reveal a sequence that
matched the data (Table 4.4). De novo sequencing of the peptide was attempted but there

were a number of combinations of residues leading to ambiguity of the full sequence. Thes
are denoted by the square brackets in Table 4.4. In the first set of brackets either two
glycine residues or one asparagine residue agreed with the MS/MS spectrum. The second
set of brackets shows that either combination of aspartic acid and valine (in any order)
leucine/isoleucine and threonine (in any order) was possible. "Sequence-only" searching
with any of these combinations did not result in identification of the protein.
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Other difficulties in assignment of the M S / M S spectra arose w h e n the charge on the
ion could not be established. With ions that had low signal-to-noise ratios the isotopic
resolution was often obscured by the background noise. The overlap of two species also

complicated determination of the charge and, if both species were subjected to MS/MS, the
spectrum contained product ions from both precursors.
Examples of identifications from Table 4.2 are presented in the following sections

and illustrate the applicability of different search techniques for protein identificatio
example of an unidentified peptide is also included and illustrates the limitations of
database searching for the identification of some proteins.

4.2.3 MS/MS and database searching
Multiply charged ions that were apparent in the spectra of fractions from the anti-CD4

preparation but not in the spectra of fractions from the IgGi preparation were selected f
further analysis by MS/MS. Figure 4.10 shows the MS/MS spectrum obtained from
fragmentation of a doubly charged ion at m/z 1004.5. The region above the precursor,

which is the base peak in the spectrum, shows a series of singly charged product ions. An

example of a possible sequence tag is indicated by the arrows and labelled amino acids in

Figure 4.10. The four ions selected form a tag that could be used to search protein datab

in a number of ways. One possibility is to enter the four product ion masses along with t
mass of the precursor into a search program such as Protein Prospector
(http://prospector.uscf.edu, (Clauser et al, 1999)). Alternatively, the mass of the ions
either end of the sequence with the amino acid sequence and the precursor mass can be
entered into the search program Peptide Search (also known as PepSea) (Mann and Wilm,
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1994) (http://pepsea.protana.com/). The example in Figure 4.10 generated the sequence tag

(1044.6)NFS(1393.8) and the mass of the precursor was 2000.98 Da. Figure 4.11 shows the
parameters in Peptide Search that are entered for searching the Swiss Prot database

(http://au.expasy.org/sprot) (as explained in Chapter 3). Sequence tags were searched a

both Y ion series and B ion series and missed cleavages by trypsin were also allowed. A

2 Da error tolerance in the peptide mass was typically used but was decreased in search
that retrieved large numbers of proteins.
A portion of the results from the search parameters displayed in Figure 4.11 is shown
in Figure 4.12. Only 13 of the 34 matches retrieved are displayed but the remaining

matches also corresponded to the peptide sequence shown in the left hand column of Figu
4.12. When this sequence was compared to the MS/MS spectrum from which the sequence

tag was obtained, a clear Y ion series was apparent, as well as other sequence ions fro
retrieved sequence. Figure 4.13 shows the MS/MS spectrum with the Y ion series of the
retrieved sequence labelled. The sequence matched the MS/MS data very well and alpha

tubulin was therefore identified in the sample. Of the alpha tubulin proteins retrieved
Peptide Search from the Swiss Prot database that were not translated oligonucleotide
sequences, only one corresponded to a human alpha tubulin (accession number P04687).
This protein was described as human tubulin alpha-1 chain but was brain specific. The

T cells used were from a human cell line and were not from brain tissue. The translated
nucleotide sequences identified tubulin alpha 1 (accession numbers AAH06468,
AAC31959, AAH00431, AAH06481 and AAH08330) and alpha 6 (accession number
Q9BQE3) from various different tissues for example muscle, bone marrow, and skin.
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Figure 4.10 E S I - M S / M S spectrum of the precursor ion at m/z 1004.5 from preparation
from the anti-CD4 column. The peptide sequence tag (1044.6)NFS(1393.8) was
obtained from the labelled peaks.

Search parameters
Sequence tag

(1044.6)NFS(1393.8)

Protein mass range

0-300 k D a

Cleavage agent

Trypsin

Peptide mass accuracy

2 Da

Methionine is

Native

Cysteine is

CarbamidomethylCys

Peptide mass

2006.98

Match regions

1 and 2 and 3

Search by

Y-type sequence ions

Allowed number of
errors

0

N terminal specific

Yes
Yes

C terminal specific

Figure 4.11 Search parameters obtained from M S / M S of the precursor at m/z 1004.5
(Figure 4.10) entered into Peptide Search (http://pepsea.protana.com/)
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Search result
34 matches were found.
Peptide Sequence matched/
Peptide found
i^sort

Mass
[kDa;

Database accession

psort

sort

Protein N a m e
Digest1
sort j
i

i

TIGGGDDSFNTFFSETGAGK 50.891 SDtrembl: 094978

Q94978 A L P H A - 2
TUBULIN.//:tremb

im ii

TIGGGDDSFNTFFSETGAGK 50.809 SDtrembl.094985

Q94985 A L P H A - 1
TUBULIN.//:tremb

C: :

TIGGGDDSFNTFFSETGAGK 50.692 sptrembl:026595

Q26595 A L P H A TUBULIN.//:trembl|

c

TIGGGDDSFNTFFSETGAGK 50.893 sptremblnew:AAG15319 AAG15319 A L P H A
TUBULIN.//:

'c

1
j

AAG15365 ALPHA = *».
TIGGGDDSFNTFFSETGAGK 50.685 sptremblnew:AAG15365!
TUBULIN.//:
HSTUBAK_1
C .•TIGGGDDSFNTFFSETGAGK 50.837 trembl:K00558
human alpha!
tubulin m R N
XLTUBAG_1
*«U i
TIGGGDDSFNTFFSETGAGK 50.564 trembl:X07045
product: "alphatubulin

TIGGGDDSFNTFFSETGAGK 50.780 pironlv:C24903

C24903 tubulin
alpha-3 chain - C

c

TIGGGDDSFNTFFSETGAGK 43.388 Dironlv:S33517

S33517 tubulin
alpha chain - mar

-m

TIGGGDDSFNTFFSETGAGK 50.843 swissnew:P04687

TIGGGDDSFNTFFSETGAGK 50.590 swissnew:P52273

TIGGGDDSFNTFFSETGAGK 50.837 swissprot:P05209

TIGGGDDSFNTFFSETGAGK 50.821 swissprot:P02551
j

,

TBA1_HUMAN
iWGKi
TUBULIN
ALPHA-1 CHAI
TBA_BOMMO
C
TUBULIN ALPHA
CHAIN./
TBA1_CRIGR
c
TUBULIN
ALPHA-1 CHAIN./
TBA1_M0USE
c
TUBULIN
ALPHA-1 CHAIN./

..
Figure 4.12 Search results from input of the sequence tag (1044.6)NFS(1393.8) into
Peptide Search (http://pepsea.protana.com/)
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Figure 4.13 M S / M S spectrum of the precursor ion at m/z 1004.5 from preparation from
the anti-CD4 column (as in Figure 4.10). The region above the precursor is enlarged by
5. The y ion series from the sequence T I G G G D D S F N T F F S E T G A G K is labelled.

precursor

100

980.6

B5
543.3

Y8"
904.6

426.2

Y3" 525.3
Y4"
Y2"

476.3

B6
Y5"{ Y6"
672.4/

276.2
316^
258.1

147.1

B7

Y10"
Y n " Y12"
y "1138.7 1285.8 1414.9
9
1415.9
1051.7 1139.7
1286.8
Y13"

819.4
1416

375.2
.' i . l , :

lUllHijiiLlUHl
400

200

UvW
600

» inlllilljllli^iitll'iii i l
1000
800

1200

1400

m/z

Figure 4.14 M S / M S spectrum of ion at m/z 979.0 from anti-CD4 preparation. The main
singly charged Y and B ions of the sequence E G E Q V E F S F P L A F T V E K ( C D 4 T29) are
shown.
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T w o further examples of M S / M S spectra that enabled unambiguous assignment of
the peptide sequence from peptide sequence tags are shown in Figures 4.14 and 4.15.
Figure 4.14 shows the MS/MS spectrum obtained from a doubly charged precursor at m/z

979.0. The clear series above the precursor enabled a sequence tag to be generated (i.e
(1051.7)SFE(1414.9)) and the retrieved sequence EGEQVEFSFPLAFTVEK closely
matched the MS/MS data. This peptide corresponded to a tryptic peptide from the T-cell
surface glycoprotein CD4. Figure 4.15 shows an MS/MS spectrum of a doubly charged
precursor of m/z 612.4. The matching sequence LIEDNEYTAR was found in a number of
protein tyrosine kinases, including p56lck.
Figure 4.16 shows a more complicated MS/MS spectrum, which was from the

precursor at m/z 766.85. MS/MS of the same precursor from an earlier sample had shown a
much simpler spectrum (data not shown) and the sequence was identified as
LTGSGELWWQAER from the T-cell surface glycoprotein CD4. The Y ion series of this
sequence is labelled in Figure 4.16 (red labels). With this prior information and the
evident product ions that did not belong to the CD4 peptide, a second partial peptide
sequence was established. The sequence between the ions at m/z 595.32 to 1331.6,

QDETFD, was searched without any mass information, i.e. a "sequence-only" search. If th
series was assumed to be Y ions (i.e. using the sequence DFTEDQ) 11 matches resulted
from the Swiss Prot database being searched with the Peptide Search "sequence-only"

option. All of the matches corresponded to myosin light chain alkali and the N-terminal
tryptic peptide CamDFTEDQTAEFK (where Cam represents a carboxyamidomethylated
cysteine) matched the MS/MS data. The peptide mass (1531.7 Da) did not, however match
the theoretical mass of the tryptic peptide sequence, which would be expected to have
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Figure 4.15 M S / M S spectrum of the precursor ion at m/z 612.4 from the anti-CD4
preparation. Thefragmentions labelled arefromthe sequence LIEDNE YTAR.
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Figure 4.16 M S / M S spectrum of ion at m/z 766.85fromfraction5 of anti-CD4
preparation. Two sequences apparent: Red CD4: L T G S G E L W W Q A E R , Blue Myosin:
CamDFTEDQTAEFK
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a molecular mass of 1489.6 D a (with the modified cysteine). The difference (42 D a ) can be

attributed to acetylation of the N-terminal residue. The Swiss Prot entry for this prote
confirmed that the protein was N-terminally acetylated (accession number PI6475). To
check that the same product ions from the MS/MS spectrum in Figure 4.16 could not be

attributed to B ions, the sequence stretch was entered into the search program in the re
order (QDETFD). No matches were returned for this search. Using a sequence tag search

did not identify this myosin peptide, as the peptide mass calculated for the sequence is
1489.6 Da. With a mass of 1531.7 Da, no matches for myosin were retrieved with the
sequence tag (838.5)ET(1068.8). With the peptide mass set to 1489.6 Da the myosin
sequence was retrieved with the same tag. This example demonstrates an advantage of
using "sequence-only" searching.
Figure 4.17 shows an MS/MS spectrum from the precursor ion at m/z 862.5. A

sequence tag from the ions above the precursor in this spectrum was used to identify the
sequence of this peptide and the resulting match, IPWFQYPIIYDIR, corresponded to a
tryptic peptide from a B cell receptor-associated protein (Swiss Prot accession number
Q99623). The Y ion series from this peptide was apparent in the MS/MS spectrum and the

ions are labelled in Figure 4.17A. Many of the abundant product ions below the precursor

did not, however, correspond to the Y or B ion series, but can be attributed to the form

of internal fragment ions from cleavage at the proline residue and a second peptide bond
the backbone chain (see Section 4.3.4). An enlarged portion of the spectrum is shown in

Figure 4.17B and the internal fragments are labelled with the amino acid sequence in the
fragments (PW, PWF, PWFQ, PIIYD, PIIYDI and PWFQY). The identification of these

product ions further confirmed the peptide sequence but its presence in a T cell prepara
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Figure 4.17 M S / M S spectrum of the precursor ion at m/z 862.5 from fraction 6 of an
anti-CD4 preparation. The Y and B ions labelled are from the sequence
IPWFQYPIIYDIR. A ) Full m/z range (50-1600) B ) Enlarged region from m/z 77-750
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was unexpected. The B cell receptor-associated protein sequence was submitted for B L A S T
searching to retrieve any homologous proteins that may have not specifically associated
with the B cell receptor. The proteins retrieved that contained the tryptic sequence from
Figure 4.17 were all from various forms of the B cell receptor-associated protein, (also
known as prohibitin) (data not shown). A "sequence-only" search (using MS Pattern, from
Protein Prospector) of the non-redundant database of human ESTs (updated 01.08.01)
retrieved 295 matches when the sequence was searched with unknown specificity of
leucine/isoleucine residues. The same search with the Genpept database (updated 01.08.01)
showed four translated proteins that were B cell receptor-associated proteins and one that
was a repressor of estrogen activity (accession number AF150962). There were no other
peptides sequenced from the B cell receptor-associated protein.
4.2.4 LC-MS
Separation of the peptides within each of the three fractions was performed using capillary
' LC-MS. Figure 4.18 shows the LC-MS profile of fraction 5 from an anti-CD4 preparation.
The total ion current (TIC) chromatogram (Figure 4.18A) did not provide detailed
information on the elution of peptides from the column. The base peak intensity (BPI)
chromatogram (Figure 4.18B) indicated that elution of components from the column
became apparent after approximately 27 minutes in this separation. Investigation of the
spectra from this separation showed that elution of the multiply charged components was
complete by approximately 40 minutes. From the data obtained in the LC-MS experiment,
mass chromatograms for particular masses or mass ranges can be generated. Figure 4.18C
shows the mass chromatogram for m/z 612.4, which was previously identified as a tryptic
peptide from the protein tyrosine kinase, p56lck. A well-defined peak at a retention time of
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chromatogram of m/z 766.9.
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29.4 minutes was apparent in the chromatogram. The mass chromatogram of m/z 615.3

(Figure 4.18D) also shows a well-defined peak, with a retention time of 32.1 minutes. Th
chromatogram in Figure 4.18E is that of m/z 766.9. The chromatogram of m/z 766.9
revealed two separate peaks at retention times of 34.6 minutes and 36.1 minutes. The
signal-to-noise ratio of the peaks in the chromatogram of m/z 766.9 was lower than the
chromatogram of m/z 615.3 and the total ion count from the chromatogram of m/z 766.9
was significantly lower than that of m/z 615.3 (102 counts versus 685 counts).
The summed mass spectra from the mass chromatograms in Figure 4.18C-E are
shown in Figure 4.19. The spectra summed from retention times indicated by the
chromatograms of each of m/z 612.4 and m/z 615.3 (Figure 4.19A and B) showed the base
peak in each spectrum corresponded to the m/z from which the chromatogram was

generated. Both these ions were doubly charged, as was clear from their isotopic resolu
(insets Figure 4.19A and B). The two separate peaks in the mass chromatogram of m/z
766.9 were summed and the resulting spectra are shown in Figure 4.21C and D. At a
retention time of 34.6 minutes (Figure 4.21C), the spectrum showed the base peak was a

doubly charged ion at m/z 679.3 which did not appear to be present in the LC-MS data for
fraction 5 from the IgGi preparation (data not shown). The ion at m/z 766.9 was also

clearly evident in the spectrum and the isotopic resolution revealed the ion to be doubl

charged (inset Figure 4.21C). The spectrum at a retention time of 36.1 minutes showed th

base peak to be a doubly charged ion at m/z 971.1, which again was not apparent in the L

MS acquisition of the equivalent IgGi control sample. This peptide was later identified

be a fragment from the trypsin used in the digest (data not shown). The ion at m/z 766.9

had a low signal-to-noise ratio but was still discernible and was clearly doubly charged
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Figures 4.20, 4.21 and 4.22 show the mass chromatograms of m/z 615.3 (A) and m/z
766.9 (B) from LC-MS of fractions 4, 5 and 6 of an anti-CD4 preparation. The

chromatograms of m/z 615.3 from each of the three fractions showed a well-defined peak.

The summed spectra from this peak in each of the different fractions showed that the io
m/z 615.3 was doubly charged (data not shown for fractions 4 and 6, Figure 4.19B for

fraction 5). In contrast, the chromatograms of m/z 766.9 (Figures 4.20B, 4.21B and 4.2

showed less well-defined peaks. As seen in Figure 4.18E, two peaks were apparent in the
mass chromatogram of m/z 766.9 from LC-MS of fraction 5 and the summed spectra for

each of these peaks showed the ions at m/z 766.9 to be doubly charged (Figure 4.19 C-D)

The chromatogram of m/z 766.9 in fraction 4 showed a single peak at a retention time of
approximately 37.7 minutes (Figure 4.20B). The summed spectra from the elution of m/z

766.9 resulted in a spectrum in which the base peak was a singly charged ion at m/z 819

(data not shown). This spectrum showed that the ion at m/z 766.9 was singly charged, an

therefore unlikely to be a tryptic peptide. Similarly, the chromatogram of m/z 766.9 fr

fraction 6 revealed only one peak at a retention time of approximately 34.2 minutes. Th
summed spectra from the chromatogram peak showed the ion at m/z 766.9 was not very
abundant but was clearly doubly charged (data not shown). Many other components were

present in the LC-MS data of fractions 4, 5 and 6 from the anti-CD4 preparation that we
not apparent in the equivalent LC-MS data from the IgGi preparation. LC-MS/MS was
therefore performed to obtain more information, particularly on peptides that were not
observed in the nanoESI experiments.
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Figure 4.20 Mass chromatograms of A) m/z 615.3 and B) m/z 766.9 from
L C - M S of fraction 4 from an anti-CD4 preparation
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Figure 4.21 Mass chromatograms of A) m/z 615.3 and B ) m/z 766.9 from
L C - M S of fraction 5 from an anti-CD4 preparation

Figure 4.22 Mass chromatograms of A) m/z 615.3 and B ) m/z 766.9 from
L C - M S of fraction 6 from an anti-CD4 preparation
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4.2.5 L C - M S M S and function switching
To obtain MS/MS information from peptides as they eluted from the RP-HPLC column, the
mass spectrometer was set to automatically detect potential precursors in MS mode and
switch to MS/MS when particular criteria were met. After acquisition of MS/MS data for a
specified time, the mass spectrometer switched back to MS mode to check for newly
eluting components. The ability to perform this data-dependent switching during an LC-MS
experiment allows a large amount of information to be generated from one experiment. The
data obtained from the MS/MS spectra are highly dependent on the switch criteria and on
the parameters used for acquisition of the MS/MS data. Prior knowledge of the samples
from previous LC-MS runs without function switching is helpful for establishing ideal

parameters for a function switching experiment. The ion counts from single spectra in the
initial LC-MS experiments were used as an indicator of ideal thresholds for detection of
suitable precursors. Thresholds between 3 and 5 ion counts were used for the LC-MS/MS
acquisitions in this work.
Figure 4.23 shows the MS/MS spectrum of a precursor ion at m/z 766.9, which was
acquired by data-dependent switching during an LC-MS separation of fraction 5 from an

anti-CD4 preparation. The spectrum in Figure 4.23 is summed from 8 separate spectra, each
of which was acquired for 1 s. The data-dependent switching software also enables MS/MS
acquisitions on multiple components that elute from the column at the same time. In
between the acquisition of each of the 8 spectra of the precursor at m/z 766.9, a second
precursor at m/z 679.4 was selected and subjected to MS/MS. The instrument alternated
between MS/MS of m/z 766.9 and m/z 679.4. A previous LC-MS experiment had shown
that these two components eluted together (Figure 4.19C). The MS/MS spectrum from the
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precursor at m/z 679.4 (data not shown) enabled this component to be identified as a tryptic

peptide of human keratin. The MS/MS spectrum of the doubly charged ion at 766.9 (Figure

4.23) is very different to the spectrum acquired using nanoESI MS/MS, owing to its much

lower ion count. Comparing this spectrum to that in Figure 4.16, however, revealed tha

ion series above the precursor matched some of the ions in Figure 4.16. The ions at m/z

838.5, 967.4, 1068.6 and 1331.7 corresponded to Y ions of the myosin light chain alkali
terminal tryptic peptide CamDFTEDQTAEFK. The ions from the CD4 tryptic peptide were
not present in the spectrum shown in Figure 4.23 as the CD4 peptide had a different

retention time and therefore the MS/MS spectrum of the myosin light chain alkali pept
was much less complicated.
Figure 4.24 shows the MS/MS spectrum from a precursor ion at m/z 851.5 acquired
during an LC-MS experiment of fraction 4 from an anti-CD4 preparation. The spectrum
was generated from 8 separate scans and the retention time was approximately 40.4
minutes. The sequence tag (928.6)ELDV(1384.9) produced 49 matches from Swiss Prot
(when the ions were assumed to be Y ions) and all of the matches were for the same
sequence from alpha tubulin (AVFVDLEPTVIDEVR). The sequence closely matched the

MS/MS data. This peptide had not been identified from the sample without prior separa
of peptides by LC-MS.
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Figure 4.23 M S / M S spectrum of a precursor ion at m/z 767 acquired during L C - M S
experiment of fraction 5 from anti-CD4 preparation.
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Figure 4.24 M S / M S spectrum of a precursor ion at m/z 851.5 acquired during L C - M S
experiment of fraction 4 from anti-CD4 preparation.
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The M S / M S spectrum of a precursor ion at m/z 719.9 is shown in Figure 4.25 and
is the result of the sum of 9 separate spectra, each with an integration time of 1 s. The
precursor was selected by data-dependent function switching during an LC-MS
experiment of fraction 5 from an anti-CD4 preparation. The doubly charged ion eluted at
a retention time of approximately 31.2 minutes and the measured peptide mass was
1437.8 Da. This peptide had not been identified previously by MS/MS of the
unseparated sample. The sequence tags generated from the MS/MS data in Figure 4.25
did not retrieve any sequences from the protein databases that matched the MS/MS data.
The product ions in the spectrum enabled the assignment of stretches of sequence but
"sequence-only" searches did not result in identification of the peptide. De novo
sequencing of the peptide resulted in two possible sequences but could not distinguish
between leucine and isoleucine. These sequences were FDGE[IL]VD[IL]NFDR and
FNGE[IL]VD[IL]NFDR. The difference between the two likely sequences was the
possibility of either an asparagine or an aspartic acid at position 2. The peptide mass
matched the former sequence very well, whilst the latter sequence differed from the
measured peptide mass by approximately 1 Da (i.e. the difference between D and N).
Further searching with these proposed sequences, allowing for the possibility of

incorrect residues, did not result in the identification of a tryptic peptide that mat
MS/MS data.
Figure 4.26 shows an MS/MS spectrum acquired during LC-MS of fraction 5 from
an anti-CD4 preparation. The precursor selected was m/z 896.46, but closer examination
of the MS spectrum revealed that the ion selected for MS/MS was the doubly charged
peptide ion containing one ,3C atom. The peptide ion containing only 12C atoms (i.e. the
monoisotopic ion) was the ion at m/z 895.9. The monoisotopic ion gave a measured
peptide mass of 1789.8 Da. The spectrum did not show a clear series of ions above the

precursor but there was sufficient information for sequence tag searching. An importan
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feature of the spectrum was the intense A 2 and B 2 ion pair at m/z 223.1 and 251.1,

respectively. There are a number of possible amino acid combinations that result in a B2 i
of m/z 251. These combinations are SY, YS, CF, FC, LH, HL, IH and HI. If the cysteine
residues are modified, as in these samples, the combinations CF and FC no longer give a B2
ion of 251 and are therefore excluded. The two N-terminal residues were therefore either

serine and tyrosine or histidine with leucine or isoleucine, but the order of the residue
unknown from the ion pair. The ion at m/z 380.2 differs from the B2 ion at m/z 251.1 by
129, which corresponds to glutamic acid (E). The difference between 493.3 and 380.2

corresponds to leucine or isoleucine (L/I). Searching the Swiss Prot database using MS-Seq
of Protein Prospector with the three ions at m/z 251.1, 380.2 and 493.3 resulted in 132

retrieved proteins, all of which were different entries of the protein actin. The single p
sequence from these proteins was SYELPDGQVITIGNER. Other ions from the spectrum
in Figure 4.26 matched the retrieved sequence. The ion at m/z 1299.8 corresponds to the

second isotope (i.e. the isotope containing one 13C atom) of the Yi2" ion. The monoisotopic
peak of the Yn" ion was also visible at m/z 1298.7. The ion at m/z 1087.7 corresponded to
the second isotope of the Yio" ion. The presence of the second isotope rather than the
monoisotopic ion is attributed to the selection of the precursor. As mentioned above, the
second isotope of the precursor was chosen for MS/MS, rather than the monoisotopic ion.
The rermining two abundant ions, m/z 650.4 and 690.4 are also Y ions. The ion at 650.4 is
actually doubly charged, which can be seen from the smaller monoisotopic ion at m/z
649.8. This corresponds to the doubly charged Y12" ion. The ion at m/z 690.4 corresponds

to Y6". Hence, even with what appears to be very little information, peptide identificatio
can be achieved and confirmed with high confidence using this technique.
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Figure 4.25 M S / M S spectrum of a precursor ion at m/z 719.9 from an L C - M S
separation of fraction 5 from an anti-CD4 preparation.
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4.2.6 Preliminary results with a different anti-CD4 column
The development of a second anti-CD4 column and its use in the search for CD4associating proteins has commenced. The antibody, OKT4, unlike Q425 used for previous

preparations, does not require calcium for binding to CD4. Initial elutions from the OKT

column used guanidine rather than the EDTA or glycine buffers used to elute proteins fro
the Q425 anti-CD4 column. As for previous samples, after enzymatic cleavage of the

proteins in the eluates, the peptides were subjected to anion exchange chromatography (i
this case performed by Oliver Bernhard, Millennium Institute, Westmead). Fractions 4-6
from the ion exchange chromatography of the eluate from the anti-CD4 column indicated

the presence of CD4 (data not shown). After desalting the fractions with Ci8ZipTips™, th
samples were analysed by nanoESI-MS. Figure 4.27 shows the ESI-MS spectra of fraction
4 from the IgGi control digest and the OKT4 anti-CD4 digest. A number of multiply
charged ions were present in both the spectra, and most of the ions in the anti-CD4
preparation (Figure 4.27A) were also present in the IgGi control preparation (Figure
4.27B). The insets in Figure 4.27 show an enlarged region from m/z 750-755, which would
be expected to contain a doubly charged CD4 peptide ion at m/z 766.9. The spectrum from
the anti-CD4 preparation did not show any obvious doubly charged ion at m/z 766.9. To
investigate whether a CD4 peptide could be detected by MS/MS, m/z 766.9 was selected
for MS/MS from both the anti-CD4 sample and the IgGi control sample. The resulting
MS/MS spectra are shown in Figure 4.28. MS/MS of m/z 766.9 from the anti-CD4 sample

showed clear fragmentation characteristic of the presence of a peptide (Figure 4.28A). T
MS/MS data matched the sequence of the CD4 peptide of mass 1531.7
(LTSGELWWQAER) and the Y ion series is labelled in Figure 4.28A. The MS/MS
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Figure 4.28 M S / M S spectra of ion-exchange column fraction 4 from digests of elutions
from the anti-CD4 column (new antibody, O K T 4 ) and the IgG control column. The
quadrupole was set to transmit m/z 766.9. The region m/z 50-760 is magnified by 4 and
the region m/z 770-1450 is magnified by 8.
A ) Digest from anti-CD4 (OKT4) column, The Y ion series from the peptide
L T G S G E L W W Q A E R is labelled. B) Digest from IgG control column
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spectrum of the same precursor from the IgGi control sample (Figure 4.28B) did not show
the peptide from CD4.
Fractions 5 and 6 from ion exchange chromatography of both the IgGi control digest
and the anti-CD4 digest were also analysed by ESI-MS (data not shown). A large number
of multiply charged species were apparent in the spectra but it was very difficult to
establish differences between the spectra. Further development with the elution protocol
from this column is therefore necessary.

4.2.7 Importance of acidic residues

As mentioned in section 4.2.2, each of the identified peptides contained at least one aci
residue (Table 4.2). Anion exchange chromatography retains negatively charged
components and it was therefore crucial for these analyses that the proteins contained

peptides with acidic amino acids. To evaluate further the potential of the method and the

risk of removing peptides without acidic residues, the sequences of the identified protei
were compared.

Figure 4.29 shows the sequence of the cell surface glycoprotein, CD4. The tryptic peptide
in the sequence are labelled from Tl through T63. The acidic amino acids are shown in
boxes and the two peptides that were identified by MS/MS are in bold (T29 and T30). T29
has four acidic amino acids and T30 has two acidic amino acids. The sequence of the
protein tyrosine kinase, p56lck, is shown in Figure 4.30. The seven peptides that were
identified, T6, T8, T13, T17, T37, T46 and T47, are shown in bold. Only one of these
peptides did not contain two or more acidic residues. T17 has only one acidic residue,
aspartic acid at position 3.
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Table 4.5 shows a summary of the acidic residues in C D 4 tryptic peptides of masses
greater than 1 kDa. Singly charged species in a tryptic digest tend to be from background
contamination and spectra were acquired from m/z 500 to avoid the contamination that is
often dominant below this m/z value. The possibility of identifying peptides below 1 kDa

is therefore unlikely. The first peptide listed in Table 4.5 is part of a signal peptide a
would therefore not be detected from mature CD4 on a cell membrane. Of the 16 peptides
over lkDa, only 3 have no acidic amino acids and 6 have a single acidic residue. The
remaining 7 peptides have two or more acidic amino acids. Therefore of the peptides with
masses that are likely to be distinguished from the ESI background, 44% have two or more
acidic residues and therefore have a high chance of being retained by the ion exchange
column. These 7 peptides correspond to a total of 152 amino acids out of the total chain
length of 458 amino acids, i.e. 33% of the protein. Therefore the maximum possible
sequence coverage that could be achieved for CD4 with this method is 33% (Table 4.6).
Table 4.6 shows a summary of the potential sequence coverage from the identified

proteins (see section 4.2.2). The number of peptides below, and above, 1 kDa are listed in
separate columns, with the number of amino acids in each of the peptides included in
brackets. The column listing the peptides with two or more acidic residues includes only
those peptides that have masses over 1 kDa. The potential sequence coverage is calculated
from the number of amino acids in peptides over 1 kDa that contain two or more acidic

residues out of the total number of amino acids in the protein chain (as for the CD4 prote
mentioned above).
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Acidic
Peptide Sequence

Mass

residues

HLLLVLQLALLPAATQGK

1898.2

0

GDTVELTCTASQK

1408.7

ID IE

ILGNQGSFLTK

1176.7

0

SLWDQGNFPLIIK

1529.8

ID

IEDSDTYICEVEDQK

1842.8

3D3E

EEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCR 4408.2

1D3E

TLSVSQLELQDSGTWTCTVLQNQK

2735.3

ID IE

IDrVVLAFQK

1144.7

ID

EGEQVEFSFPLAFTVEK
LTGSGELWWQAER

1956.0

4E

1531.7

2E

SWITFDLK

1008.5

ID

LPLHLTLPQALPQYAGSGNLTLALEAK

2828.6

IE

LHQEVNLVVMR

1336.7

IE

NLTCEVWGPTSPK

1487.7

IE

AVWVLNPEAGMWQCLLSDSGQVLLESNIK

3256.6

1D2E

VLPTWSTPVQPMALIVLGGVAGLLLFIGLGIFFCVR

3854.2
1

0

Table 4.5 The sequences of C D 4 tryptic peptides of mass >1 k D a with their monoisotopic
mass and the number of aspartic acid (D) and glutamic acid (E) residues in the sequence.

O f the 11 proteins identified, the B cell receptor-associated protein has the lowest
potential sequence coverage. Tubulin has 12 peptides with 2 or more acidic residues and a
potential sequence coverage of 6 0 % . Regulatory light chain myosin has a 7 0 % potential
sequence coverage based on amino acids. This light chain myosin, however, has only 9
peptides over 1000 D a and 8 of these contain two or more acidic residues. The anion
exchange column m a y therefore retain 8 9 % of the detectable peptides. Heavy chain myosin
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is m u c h larger than the other proteins and has m a n y peptides below 1 kDa. This lowers the
potential sequence coverage (43%). Of the heavy chain myosin peptides over 1 kDa, 76%
have two or more acidic amino acids, which is a much more promising figure. The protein

tyrosine kinase, p56lck, has a potential coverage of 58%, significantly higher than for CD
These percentages illustrate that acidic residues appear to be quite widespread in these
proteins and are encouraging examples that demonstrate the suitability of anion exchange
for this type of analysis.

Chapter 4: Identification of C D 4 and co-associating proteins

Protein

154

Potential

Chain

Peptides

Peptides

2+ acidic

length

<1000Da

>1000Da

residues

sequence
coverage

47
CD4

16

7

458

p56lck

33%
(159)

(299)

(152)

23

24

16

58%

508
(97)

(411)

(295)

20

20

12

(71)

(380)

(271)

14

9

8

(41)

(131)

(121)

7

8

6

(38)

(112)

(88)

253

74

56

(890)

(1070)

(844)

375

20
(75)

17
(300)

10
(194)

52%

299

29
(140)

12
(159)

5
(77)

26%

69

11
(37)

3
(32)

2
(21)

30%

115

8
(22)

5
(93)

4
(74)

64%

60%

451

Tubulin (alpha)
Myosinregulatory light

70%

172

chain
Myosin- light

59%

150
chain alkali
Myosin heavy

43%

1960
chain (type A )
Actin - beta
B cell receptorassociated
protein
40S ribosomal
protein
60S acidic
ribosomal
protein P2

Table 4.6 S u m m a r y of the potential sequence coverage of the tryptic peptides from
the identified proteins.
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4.3 DISCUSSION
4.3.1 Method development
The method shown in Figure 4.3 was developed through collaboration with Dr Andrew
Sloane, Mr Oliver Bernhard, Dr Tim Hochgrebe and Dr Garry Lynch.
The IgGi column served two purposes: to remove components that bound nonspecifically to the column packing material, and to provide control samples. By passing
lysate over the IgGi column prior to the anti-CD4 column, the majority of non-specific

binding proteins bound to the IgGi column and therefore non-specific binding to the anti
CD4 column was minimised. Components that were apparent in the mass spectra of
samples from the IgGi column were considered to be from non-specific binding and were
not selected for MS/MS when they were also detected in the anti-CD4 samples.
The anti-CD4 affinity column that contained the immobilised monoclonal antibody
Q425 was used for all experiments except those presented in Section 4.2.6. The Q425
antibody requires Ca2+ to bind CD4 and therefore the initial elution protocols used EDTA

(a divalent cation chelator) to elute the bound complexes from the column (Sloane, 2000).

The EDTA elution protocol minimised elution of proteins that were bound non-specifically

to the columns. After further development, glycine was used to elute the components from
the column (Oliver Bernhard, Centre for Virus Research, Westmead Millennium Institute,

personal communication) and this resulted in the identification of peptides that were no
apparent in the samples eluted with EDTA. The mass spectra of samples from glycine
elutions also showed more components in the IgGi samples, as would be expected since

glycine is more likely to disrupt non-specific interactions. Despite the elution of more
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specific binding proteins, there were m a n y components in the anti-CD4 column eluate that
were not in the IgGi column eluate (Figure 4.8 and 4.9).
Preliminary work with a different antibody, OKT4, has commenced. This antibody
does not require Ca2+ for CD4 binding and therefore elution with EDTA was not
applicable. The first attempts of elution from this column used a buffer containing
guanidine (Oliver Bernhard, personal communication). The ESI-MS spectra of samples

from this elution showed many multiply charged ions that were present in the IgGi samples
and the anti-CD4 samples. The presence of the same peptides in samples from both
columns suggested that the elution protocol caused a large number of non-specifically-

bound proteins to be eluted from the columns. The high concentration of peptides from the
non-specific binding proteins masked the less abundant peptides from CD4-binding
proteins. The elution protocol for the OKT4 column therefore requires additional

development for future identification of CD4-associating proteins. It was interesting tha
CD4 peptide was identified in a sample from the OKT4 column but not from the IgGi

column (Figure 4.28). This identification relied upon previous results and would not have

been possible without prior knowledge. The identification of the CD4 peptide did, however
demonstrate that with further development, the OKT4 anti-CD4 column should also

provide interesting results, which may complement the results obtained from the Q425 anti
CD4 column.
The vast majority of mass spectrometry publications have involved water-soluble
proteins (Schaller, 2000). The poor solubility and low abundance of hydrophobic proteins
has impeded their analysis. The development of methods to enable recovery and detection
of hydrophobic proteins from their native environment will help identify protein binding
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partners and elucidate possible protein functions. A further challenge in the analysis of
membrane or hydrophobic proteins is introduced when protein complexes need to be
maintained for analysis. In this work detergents were required to solubilize the hydrophobic
proteins and to maintain higher order structures that were crucial for protein interactions.
The deleterious effect of detergents on ESI mass spectra is well known (Loo et al, 1996)
and removal of the detergent is crucial for MS analysis. The non-ionic detergents used in
the sample preparation were removed by anion exchange chromatography. A consequence
of the anion exchange chromatography, however, was that the peptides detected by MS
were predominantly those containing acidic amino acids.
Initial preparations used iodoacetamide in the cell lysis buffer and the resulting
samples did not show any evidence of the protein tyrosine kinase, p56lck. When
iodoacetamide was excluded from the cell lysis buffer, numerous p56lck peptides were
detected. Similar results were obtained by 1-dimensional gel electrophoresis and MALDI
analysis of the digested gel bands (Sloane, 2000). P56lck is known to associate with CD4
through two cysteine residues on each protein and a Zn2+ ion (Turner et al, 1990; Gratton
et al, 2000). Iodoacetamide disrupts the non-covalent association between these two
molecules. Therefore the use of iodoacetamide in the lysis buffer can be used to investigate
whether co-elution of particular proteins is dependent on the association of p56lck and CD4.
The high background observed in the ESI mass spectra and the presence of abundant
singly charged ions often made detection of multiply charged peptide ions difficult. To
assist in detection of multiply charged ions, reducing the voltage applied to the MCP
detector of the quadrupole-ToF instrument was found to be an advantage. Lower voltages
on the MCP detector discriminate against ions of lower charge because of differences in the
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m o m e n t u m of ions with the same m/z but different masses (Loo and Orgorzalek Loo,
1995). For MS/MS acquisitions the MCP was increased for maximum detection of the
product ions.
Numerous peptides from human keratins and trypsin were identified in the samples.
The contamination of samples with keratins from human skin and hair has often been
observed in conventional proteomics applications (as in Chapter 3). Peptides from the
autolysis of trypsin are also frequently detected in tryptic digests of proteins.
The cell lysis and preparation in the method presented in Figure 4.3 was designed to
capture any CD4 that may be present. This may include mature CD4 on the cell membrane

as well as CD4 that is still within the cell. Future refinement may include steps to isol
membrane CD4 associations. Application of the method to the analysis of monocytes and
macrophages has commenced (Stephen Watt, Honours student, University of Wollongong,
Wollongong). Other future directions include application of the technique to investigate
interactions with CD4 in activated T cells, and T cells that have been exposed to gpl20.
The inclusion of a second affinity column following the anti-CD4 column would also be of
interest. An anti-p56lck or anti-gpl20 column may provide further information and verify
associations between co-eluting proteins. The development of a control preparation with
CD4-negative T cells is also being considered (Oliver Bernhard, personal communication).

4.3.2 Significance of identified proteins
CD4 andp56lck
The identification of CD4 in the samples from the anti-CD4 column but not from the IgGi
control column provided initial confidence in the use of the affinity chromatography
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method for the identification of potential CD4-associated proteins. The two sequenced C D 4
peptides were observed in the early stages of method development and in following
preparations were sought as indicators of useful samples. Both the CD4 peptides that were
sequenced were from the extracellular domain of CD4.
Following the adaptation of the method to exclude iodoacetamide from the cell lysis
buffer, p56lck peptides were observed in the samples. The detection of the CD4-associating
protein, p56lck, provided further evidence that the method was applicable to the

identification of proteins that associated with CD4. Importantly, p56lck was not apparent in

the samples from the IgGi column, indicating that its identification was not a result of no
specific binding to the column packing material.
Tubulin, actin and myosin
The tubulin peptide, TIGGGDDSFNTFFSETGAGK (residues 41-60), was first identified
in samples that had been prepared with iodoacetamide-containing cell lysis buffer. The

same peptide and two additional tubulin peptides were later identified in samples that had
been prepared from cell lysis buffer that did not contain iodoacetamide. The detection of

tubulin in samples from lysis buffer containing iodoacetamide suggested that co-elution of
CD4 and tubulin does not depend on the association between p56lck and CD4.

Immunoprecipitation studies from cell lysates and Western blotting of the eluates from the
IgGi and anti-CD4 columns confirmed that tubulin associated with CD4 (Sloane, 2000).
Furthermore, immunopreciptation studies were also performed in the presence of
iodoacetamide, confirming that the CD4-tubulin association was not dependent on the
association of p56lck and CD4 (Sloane, 2000).
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Myosin peptides were identified in samples both from cells that were lysed in buffer
containing iodoacetamide, and from those lysed in the absence of iodoacetamide. As was
the case for tubulin, this suggests that co-elution of myosin was not dependent on the
association of p56lck and CD4. Many different forms of light and heavy chain myosins have
been characterised. Non-muscle myosin is known as myosin-I and is often membranebound (Alberts et al, 1994). The myosin molecule consists of two heavy chains, two alkali
light chains and two regulatory light chains (Swiss Prot Entry P35579,
http://au.expasy.org/sprot,) each of which was identified in the samples from the anti-CD4
column.
Tubulin and actin both form important components of the cytoskeleton. Tubulin
forms microtubules and actin forms microfilaments (or actin filaments) (Alberts et al,
1994). Myosin (a motor protein) binds to actin filaments and this complex is important for
cell movement (Alberts et al, 1994). Only a single actin peptide was identified in the
samples from the anti-CD4 column, but its presence can be rationalised because it is known
to associate with myosin.
Other proteins
The significance of the two ribosomal proteins that were identified from the anti-CD4
preparations is not clear. The identification of only a single peptide from two different
ribosomal proteins does not provide confident identification. Non-specific binding of
ribosomal proteins to the column would not be surprising considering the high abundance
of ribosomes in cells (Alberts et al, 1994). The identified peptides were not, however,
apparent in the control samples. It is possible that immature CD4, which was still
associated with ribosomes, was isolated by the affinity purification method. As mentioned

Chapter 4: Identification of C D 4 and co-associating proteins

161

above, the cell preparation method is not specific for membrane-bound C D 4 . T o test this
hypothesis, a method that allowed the specific isolation of membrane-associated CD4
would be required.
Identification of the B cell receptor-associated protein is also difficult to explain. The
B cell receptor-associated protein is also known as D-prohibitin. A sequence from a
different prohibitin protein was also retrieved from a database search but the sequence was
unable to be confirmed from the MS/MS data (Table 4.4, precursor at m/z 722.5 with
doubly and triply charged ions). Further work is required to establish whether the
identification the B cell receptor-associated protein is significant.

4.3.3 Database searching
A variety of different databases and programs for searching the databases are available to

the public directly via the Internet or using email based queries. Table 1.2 (Chapter 1) giv
a summary of the databases available and the information they contain. The programs that
are available to search these databases are shown in Table 1.3. As discussed in Chapter 3,
the databases used in this work were searched using Peptide Search programs
(http://pepsea.protana.com/) and/or Protein Prospector programs
(http://prospector.uscf.edu). Peptide Search programs use the combined entries from the
Swiss Prot and Trembl databases and do not have an option for searching other databases.
Protein Prospector programs allow searching of Swiss Prot, OWL, Genpept, NCBInr,
Ludwignr and dbEST. The programs available in Protein Prospector have more options for

the input of additional search information. The option to restrict the search to a particula
species is very useful because retrieved sequences from unrelated organisms can be

Chapter 4: Identification of C D 4 and co-associating proteins

162

excluded. The ability to enter additional information is crucial w h e n the sequence tag (or
stretch of sequence) entered has many possible matches. By specifying the origin of the
sample, many extraneous matches can be avoided. Conversely, by introducing constraints,

a true identification can be missed altogether. The possibility of a high degree of sequenc
homology between proteins from different species should also not be ignored. If a sequence

is not retrieved when species and/or other constraints are imposed, it is important to atte
the same search with less specific parameters.
The ability to access the vast number of protein and translated oligonucleotide

sequences that are available is crucial for proteomic applications. Rapid identifications a
possible from proteins that have previously been sequenced and related proteins can be

retrieved from these databases. There is significant potential for automation (section 4.3
and many laboratories use automated search procedures. With the vast amount of

information available, often very little sequence information is required for identificatio

a protein. There are, however, limitations associated with database searching, particularly
with the use of search programs that are available on the Internet. Furthermore, some
MS/MS spectra do not lead to protein identification, even when the product ion spectrum is
highly informative (such as some of the examples in Table 4.4). These problems are
addressed in the following sections.

4.3.4 Peptide fragmentation
The fragmentation of peptides in an MS/MS experiment has been well documented
(Papayannopoulos, 1995) and many trends have been observed as outlined in Chapter 1

(Section 1.1.5). Some of these trends were apparent in the mass spectra of peptides in this
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work. These characteristic fragment ions are helpful for obtaining information from
MS/MS spectra when only a small number of product ions are apparent.
Characteristic product ions from tryptic peptides

Tryptic peptides, unless they are the C-terminal peptide of the protein, have an arginin

lysine residue at their C-terminus. The Yi" ion of a tryptic peptide with a C-terminal l
has an m/z of 147 and the Yi" ion of a peptide with a C-terminal arginine has an m/z of

175. These characteristic ions are often helpful in determination of the C-terminal amino
acid. The peptide EGEQVEFSFPLAFTVEK (Figure 4.14) is an example where the Yi" ion
from lysine is clear, whilst the peptide LIEDNEYTAR (Figure 4.15) has a C-terminal
arginine. When an MS/MS spectrum is derived from more than one peptide of the same
nominal mass, there may be evidence of both an arginine and lysine Yi" ion, as in the
example shown in Figure 4.16 for the two peptides LTGSGELWWQAER and
CamDFTEDQTAEFK. Assignment of the Yi" ion may also assist in assignment of the Bn.i
ion if present.
The presence of the C-terminal basic residues has a substantial effect on the MS/MS
spectra of peptides (Hunt et al, 1986; Tang et al, 1993). The fragmentation typically
results in charge retention on the C-terminus and the predominance of Y-type sequence

ions. This same trend was clearly observed here for the peptides presented in Figures 4.1
through 4.17.
A2/B2 product ions
The Bi ion is rarely observed in MS/MS spectra but the B2 ion is usually present and is
generally observed with the corresponding A2 ion (Kinter and Sherman, 2000). The B2/A2

product ions can be useful tools for identification of the N-terminus. The possible amino
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acids in the B 2 ion can be calculated from their residue masses. The complementary Yn_2"
ion may be present in the MS/MS spectrum. If the Yn-i" ion is also present, the identity of
the N-terminus can be confirmed. The peptide LIEDNEYTAR (Figure 4.15) provided an
example where these ions enabled confirmation of the N-terminus. The B2 ion was apparent
at m/z 227.2, its identity confirmed by the A2 ion 28 Da below the B2 ion. This B2 ion could
have arisen from a combination of proline and glutamic acid, or from 2 leucine/isoleucine
residues. The molecular ion mass was 1224.8 Da (612.4 x 2) and the corresponding Y ion
at 1224.8-227.2 = 997.6 was clearly present. The Yn-i" ion was also apparent, at an m/z 113
higher than the Yn-2" ion. The Y ions confirmed that the two N-terminal amino acids were
isoleucine or leucine residues (since these two amino acids are indistinguishable by low
energy CAD).
Although the B2 and A2 product ions were clearly evident for the peptide
LIEDNEYTAR (Figure 4.15) and provided information on the peptide sequence, their

presence was not essential for the identification of the peptide in this case. In contra
peptide SYELPDGQVITIGNER (Figure 4.26) was an example where the B2 and A2 ions
were critical for identification of the peptide sequence. Recognising that the ion at m/z
251.2 was a B ion lead to the generation of a sequence tag from the B ions in the low m/z
range and subsequent identification of a peptide from actin.
Fragmentation at proline

Preferential fragmentation at the N-terminal side of proline residues (the "proline eff
has been extensively documented (Hunt et al, 1986; Barinaga et al, 1989; Tang et al,
1993). Owing to the preferential cleavage on the N-terminal side of proline, cleavage on

C-terminal side is far less frequent and consequently ions from cleavage on the C-termi
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side of proline are often of low abundance or not present. Examples of this effect were
apparent for the peptides EGEQVEFSFPLAFTVEK (Figure 4.14) and IPWFQYPIIYDIR
(Figure 4.17). For EGEQVEFSFPLAFTVEK the Y8" ion, which results from cleavage N-

terminal to the proline residue, was of high abundance. The Y7" ion from cleavage on the

C-terminal side of proline was not apparent in the spectrum. A similar observation was
for the peptide IPWFQYPIIYDIR where the Y7" ion (PIIYDIR) was of high abundance and
the Y6n ion (IIYDIR) was of low abundance.
A second observation with proline-containing peptides is the dominance of product

ions that result from internal fragments. Following cleavage at the proline amide bond,

producing a typical Y-type ion, a second cleavage of the type that would normally prod

a B ion can occur (Hunt et al, 1986). An example of abundant internal fragments resulti
from cleavage adjacent to proline was apparent from the peptide IPWFQYPIIYDIR (Figure
4.17).
Other fragmentation observed in this study

Product ions resulting from cleavage at a glycine residue are typically lower in abund
than other product ions, particularly if the cleavage is between GG or AG (Staudenmann
and James, 2001). This trend was apparent in a number of the spectra in this work. An
example was in the spectrum from the peptide TIGGGDDSFNTFFSETGAGK (Figure

4.13) where cleavage between isoleucine (I) and glycine (G) to give Yi8" produced a more
abundant ion than the Yn" ion produced from cleavage between two glycine residues. The
Yi5" and Yi6" ions were also of lower abundance owing to cleavage at glycine. The Yi4"
ion, produced by cleavage between two aspartic acid residues, was significantly more
abundant than either Y15" or Yi6".
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The loss of characteristic neutral fragments from product ions can also assist in
assignment of amino acids. Loss of ammonia (17 Da) typically occurs from peptides that

contain asparagine, glutamine, lysine or arginine but may also occur from the N-terminus
(Kinter and Sherman, 2000). The loss of water (18 Da) often occurs from peptides that

contain serine or threonine but may also occur from peptides that contain the acidic ami
acids, glutamic acid and aspartic acid (Kinter and Sherman, 2000). When the N-terminal
amino acid is glutamic acid, the loss of 18 Da is observed owing to the formation of
pyroglutamic acid. The peptide EGEQVEFSFPLAFTVEK (Figure 4.14) provided an
example of a peptide with an N-terminal glutamic acid. The loss of 18 from the B5 ion

resulted in the ion at m/z 525.3. Likewise, loss of 18 from the B4 ion resulted in the io
m/z 426.2.
Another point to note, which is not a direct observation of a fragmentation pattern but
has important implications on the appearance of the MS/MS spectra, is the charge on the

peptide ions. The vast majority of the multiply charged ions in the MS spectra of the d

were doubly charged. Tryptic peptides have at least two basic sites for proton attachme
the C-terminal lysine or arginine and the N-terminus. The location of the charge on

peptides in MS/MS experiments controls the fragmentation of the peptide (see Chapter 1).
The dominance of multiply charged peptides and the characteristic spectra produced from
MS/MS of tryptic peptides has resulted in the prevalent use of trypsin for enzymatic

cleavage prior to MS/MS. Of the peptides that resulted in protein identification (Table

only three were not doubly charged. The peptide consisting of residues 588-608 from heav
chain myosin (DFSALESQLQDTQELLQEENR), the peptide from residues 63-78 of
myosin light chain alkali (VLDFEHFLPMLQTVAK), and the peptide from residues 478-
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490 of p56lclc ( E R P E D R P T F D Y L R ) were identified from triply charged ions. The sequence
from the heavy chain myosin peptide did not contain any additional basic sites that would
result in an additional proton to those expected on the C-terminal arginine and the Nterminus. The doubly charged ion of the same peptide was also apparent, suggesting that
the triply charged ion was not necessarily the predominant ion in the spectrum. The
sequence of the myosin light chain alkali peptide contained a histidine residue, which has
significant gas phase basicity and might also be expected to be protonated. The three

protons would therefore most likely reside on the C-terminal lysine, the N-terminus and the
histidine residue. The sequence of the triply charged peptide from p56lck has two internal

arginine residues as well as a C-terminal arginine. The internal arginine residues each ar

from the presence of a proline residue C-terminal side to the arginine. Trypsin is unable t
cleave the peptide bond between a lysine or arginine and a proline residue (Kinter and

Sherman, 2000). The presence of the internal arginine residues gave rise to a triply charge
peptide ion.
The location of protons, and the ability of the protons to mobilise and locate at other
peptide bonds, is a fundamental aspect of peptide fragmentation (Wysocki et al, 2000).

The presence of basic amino acids in the peptide, such as the arginine residues in the p56lc
peptide and the histidine in the myosin light chain alkali peptide, may have significant

effects on the MS/MS spectra. The localisation of protons on basic residues can result in a
decrease in the abundance of other ions, impeding sequencing of the full peptide. These

effects may be of importance in the interpretation of some of the peptides that did not res
in protein identification (Table 4.4). The analysis of peptide fragmentation is, however,
beyond the scope of this thesis and will not be expanded further here.
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Options for database searching
As mentioned in Chapter 3, the Protein Prospector programs enable more information to be
entered for database searching compared to Peptide Search. Searching Swiss Prot with
Peptide Search has advantages because less time is required to enter the information. For

MS/MS spectra with clear product ion series (usually Y ions) Peptide Search is very easy t

use and the Swiss Prot/Trembl database is often sufficient for protein identification. For
spectra that do not have clear ion series, but do contain significant information, the
programs in Protein Prospector may be more useful. An example of this can be drawn from
the spectrum of the peptide SYELPDGQVITIGNER from actin (Figure 4.26). The B ions

at m/z 251.1, 380.2 and 493.3 gave a sequence tag that resulted in the identification of a
using either Peptide Search or the program MS-Seq in Protein Prospector. Alternatively,
MS-Seq searching of the same database with only the two Y ions above the precursor, m/z
1087.7 and 1298.7, resulted in the same matches as for the B ion search with only two

additional proteins (134 matches, 132 of which were actin, the correct match). To enter the
same Y ion information into Peptide Search is much more difficult. The mass difference
between m/z 1087.7 and 1298.7 is 211 Da, which could correspond to either the
combinations GGP (in any order) or NP (or PN). Furthermore, the Y ion of m/z 1087.7 was

actually the second isotope (i.e. contained one 13C atom). Hence, the true mass difference i

212 Da, which could correspond to DP or VL (VI) (in any order). If all of the possibilities

were taken into account, a number of tags would have to be separately entered into Peptide
Search. Hence, MS-Seq provided a more convenient search tool for this example.
With increased understanding of peptide fragmentation and improved ability to

control the fragmentation through derivatisation, there is a need for more versatile searc
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programs. M a n y research groups working in thefieldof proteomics have in-house software
programs to cope with individual requirements. With highly specific fragmentation and

programs that are able to utilise the information to its full potential, a relatively small

amount of information is required for identification of a protein that is already present i
database.

4.3.5 Unidentified peptides
Table 4.4 outlined the large number of precursor ions that were selected for MS/MS but did

not result in identification of the parent protein. There were a number of reasons that may
explain why these peptides remain unidentified. One possibility is that the protein from
which the peptide originated is not in the database that was searched. A more likely
explanation, however, is that there is some inconsistency between the information entered
into the search program and the information contained in the database. Molecular mass
changes in a peptide may arise from post-translational modifications or modifications
introduced through sample handling. An example of the effect of changes in the peptide
mass was observed with the peptide from residues 103-122 of regulatory light chain

myosin. As stated in section 4.2.2, this peptide was observed with three different molecula
masses. The two peptides that did not correspond to the correct molecular masses were
from a sodiated peptide ion and a peptide ion that had lost ammonia. The extensive
sequence information from the MS/MS spectra enabled the identification of each of these
peptides through "sequence-only" searches. If a sequence tag had been used rather than
"sequence-only" searching, the incorrect peptide mass would have prevented identification
of these peptides. The use of "sequence-only" searching to avoid any mass discrepancies is
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advantageous but there is not always sufficient information in the M S / M S spectrum to

obtain a stretch of amino acids of an ideal length for this type of search (i.e. approxi
5 or more amino acids).
Other problems encountered with identification of peptides from database searching
arose when minimal fragmentation was apparent in the MS/MS spectrum, which prevented
confirmation or exclusion of sequences that were retrieved. Erroneous sequence tags may
also account for some of the unidentified peptides.

4.3.6 Capillary LC-MS
The development of capillary LC-MS has vastly improved the analysis of complex
mixtures by mass spectrometry. The capability of detecting numerous components eluting
at the same time removes the need to fully resolve the components in a mixture by other
means. Even with short chromatography gradients and minimal separation, there is a
noticeable improvement in the detection of peptides in mixtures such as the anti-CD4
samples in this work.
The CapLC™ used for this work is capable of delivering low flow rates without flow
splitting. A flow rate of 2 uL/min with a 0.32 mm column was used for the experiments
presented in section 4.2.4. Lower flow rates and smaller columns could also be used with
this system to further improve the sensitivity. Although the TIC chromatogram did not

clearly show the elution of peptides, the BPI chromatogram often provided an indication o

the retention time at which the peptides began to elute from the column. The most valuabl
information was obtained from the individual chromatograms of particular m/z ratios.
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The most notable advantages in the use of L C - M S were an increase in the signal-to-

noise ratios of individual peptides, and a corresponding increase in sensitivity. Componen
that were not apparent in the spectra from nanoESI-MS were apparent in the spectra from
LC-MS. The separation of different peptides with the same m/z was also beneficial,

simplifying interpretation of MS/MS spectra and improving the ability to assign the charge
on the precursor ions that otherwise overlapped.
A further aspect of LC-MS is the capability of automated sample handling and data
processing (see section 4.3.8).

4.3.7 Data dependent MS to MS/MS switching
The option for "function switching" during an LC-MS experiment allowed MS/MS data to
be acquired when suitable precursor ions were detected by MS. The data generated from
these experiments was highly dependent on the precursor selection parameters and the data

acquisition parameters. For this type of analysis, time is a crucial factor that must be t
into account as components that elute while the mass spectrometer is still in MS/MS mode
rather than MS mode will remain undetected.
The selection of an ideal precursor involves a number of important user-defined

parameters. The first of these is the threshold, which is the minimum ion count at which t
instrument will switch into MS/MS mode, providing other criteria are also met. The
threshold is set to avoid MS/MS acquisitions on background noise. As noted in section
4.2.5, the threshold in this work was set to between 3 and 5 ion counts. Other optional
parameters can also be used to improve the selection of peptide ions and avoid

contaminants. These parameters include: charge recognition, lists of excluded and included
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masses, a time w i n d o w for selection of the same precursor and a mass w i n d o w for
precursor selection. In the current work, only precursors with 2, 3 or 4 charges were
selected for MS/MS. A list of masses to include was not used but masses of previously
identified precursors and known contaminating peptides were entered into exclude lists in
some experiments. The time window offers the option to exclude a precursor that has been
selected once in the LC-MS acquisition from further selection in the remainder of the
experiment. The same precursor can be excluded for the whole experiment or for a
specified period of time. In this work, selected precursors were excluded for only a short
time, merely to prevent repeated selection of the same precursor in an eluting peak.

Importantly, if the same m/z eluted with a different retention time it was likely to be fr
different peptide and was able to be selected for MS/MS. The mass selection window
prevents the selection of more than one isotope of the same ion. Various detection windows
were used for different acquisitions and these ranged from m/z 0.6 to 1.5.
It was found that the crucial parameters for obtaining clear product ions in the
MS/MS spectra were the length of time each precursor was acquired and the voltage on the
collision cell. The nanoES-MS/MS data acquired previously provided very useful
information for ideal collision cell voltages. There are a number of available options for
setting the collision cell voltage in a "function switching" experiment: i) charge

recognition, which calculates an ideal collision cell voltage dependent on the charge of th

ion selected for MS/MS; ii) an option for setting the collision cell voltage manually on the

tuning page of the standard MS software or iii) a "collision energy profile", which is set b

the user. The "collision energy profile" selects the collision cell voltage based on the m/
the precursor and a list of voltages. The profile can contain a number of collision cell
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voltages for particular m/z ranges. For example, if the m/z range 500-700 had three

different voltages, 28 V, 29 V and 30 V, a precursor in this m/z range would be subjected to
MS/MS at each of these voltages, time permitting. Each voltage requires the acquisition of

at least one spectrum; therefore with a 1 s integration time and a 0.1 s delay, acquisiti
a spectrum at each collision cell voltage would take 1.1 s. To obtain a single spectrum at
each voltage would take 3.3 s. The consideration of time factors is therefore crucial to
obtain sufficient data.
The switch from MS/MS back to MS can also be set in a number of ways. For this
work the instrument was set to return to MS after a specified time in MS/MS. Importantly,
the time set was dependent upon the number of precursors that were selected for MS/MS
from a particular mass spectrum. As noted in section 4.2.5, MS/MS data can be acquired on
up to eight components simultaneously but in most experiments this was limited to four
components. If a time of 3.3 s was set and four components were selected for MS/MS the
instrument would not return to MS mode for a total of 13.2 s. If only a single component
was selected, the switch would occur after only 3.3 s. A balance between improved data
quality (by increasing the number of spectra acquired in MS/MS) and the chance of missing
newly-eluting precursors must be achieved. Various times were used in different
experiments to explore the possibilities for these particular mixtures of peptides.
Acquisitions with longer MS/MS times resulted in superior spectra but often missed
suitable precursors. Shorter MS/MS acquisition times resulted in the selection of many
precursors but some MS/MS spectra did not have sufficient data to produce sequence tag
information.
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Another important point to make about the selection of precursors is that as
components elute from the column and are detected by MS, the instrument will switch into
MS/MS as soon as the threshold is reached for a single or multiple components. At that
point in time, MS/MS is performed on whichever precursor(s) reached the threshold. There

is a possibility that at any particular retention time range, more suitable precursors el
immediately after those selected for MS/MS and these could be missed entirely. This means
that even the most abundant peptides may be missed in a particular LC-MS/MS
experiment. A number of LC-MS/MS experiments on the same sample, with small changes
in MS/MS acquisition time or LC elution gradients may dramatically influence the
acquisition of data and should be included as standard protocol in these types of
experiments.

4.3.8 Potential for automated sample handling and data processing
The requirement for high throughput analyses in proteomic applications has increased the

need for at least partial automation in the analysis of peptides and proteins. As discuss
Chapter 3, the processing of spots from gels often uses robotic gel cutters and sampling
handling robots. Large laboratories may have automated sample handling, data acquisition
and data processing. With small laboratories, available resources limit even partial

automation of procedures. The potential for automation in the procedure outlined in Figure

4.3 in our laboratory is in the LC-MS acquisitions and the processing of data from nanoESMS/MS and LC-MS/MS.
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Automation of LC-MS acquisitions
The instrumentation used for LC-MS (CapLC™ and QTof™2 with MassLynx™ software)
enables processing of large numbers of samples with automatic injection and acquisition
samples. The CapLC™ can also be used for addition of reagents in protocols such as
enzymatic cleavages. In this project, minimal automated sample handling was used for a

number of reasons. First, the small number of samples did not necessitate automatic sampl
handling. Secondly, the LC-MS procedures were not well established and changes were

made to each experiment to investigate the most suitable settings for particular samples.
Furthermore, the option for automatic injection and LC-MS of samples requires that the

instrument always be prepared for data acquisition. A significant amount of time is requ
for column conditioning and data need not be acquired in the initial part of an LC-MS
experiment (prior to the elution of peptides). This results in a large wastage of gas. A

change in the automated control to include a switch for the nebuliser and desolvation ga
all that is required for inclusion of gas control in the automated acquisition.
Automation of data processing
The software used for the acquisition of MS data, MassLynx™, includes data processing

and database searching software. With the large amount of data generated from a "function
switching" experiment, data processing can be very time consuming. The ProteinLynx™

software enables automatic summing of spectra from the same precursor and the option for
performing a background subtract and data smoothing. The peak profiles are converted to

single points corresponding to the peak centre and a peak list is generated. The peak li

then be entered into a search program for database searching. It was found that the succ
of this automatic processing was highly dependent on the quality of the data. Although
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manual processing was time consuming, more useful information was obtained through

visual examination of summed spectra of each precursor and critical assessment of the dat
Software to assist in the assignment of stretches of sequence in an MS/MS spectrum was
useful, but was again dependent upon the quality of the data. For confidence in the
assignment of any peptide sequence to a particular MS/MS spectrum, manual assessment
was deemed necessary. The potential for automation in small-scale projects may be
weighed up against the possibility of compromising the accuracy of outputs. For high

throughput projects, manual processing of the large amounts of information is not practic

4.3.9 Conclusions: Summary and future directions
The development of a method for the isolation of proteins that co-elute with CD4 has
resulted in the identification of proteins that may associate with CD4. The method has
proved to be a rapid and sensitive way of identifying proteins for further immunological

investigations. Further studies with one of the identified proteins, alpha tubulin, showe
immunoprecipitation of CD4 and tubulin (Sloane, 2000). Additional investigations of the

significance of other identified proteins are yet to be undertaken. Application of the sa
method to the study of monocytes and macrophages is currently underway (Stephen Watt,
Honours project, University of Wollongong) and future directions for this work include

application of the method to identify proteins that co-elute with CD4 in activated T cell
and in T cells that have been exposed to the HIV-1 envelope glycoprotein, gpl20.
The method used here also provides an example of the use of proteomics for
identifying possible binding partners, which inturn suggests potential functions of the
identified proteins. Examples of functional proteomics approaches are increasing in the
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literature and are of significant value in understanding protein function. Developments in
biological mass spectrometry have led to widespread improvements in the field of
proteomics. The use of LC-MS has enabled the analysis of complex mixtures of peptides
with low limits of detection. Procedures for automation have also advanced many highthroughput applications and are likely to increase in importance, even in small-scale
laboratories. The combination of different chromatography methods and advancements in
the field of chromatography may result in less dependence on the time-consuming and
labour-intensive methods of two-dimensional gel electrophoresis.

CHAPTER FIVE: NONCOVALENT COMPLEXES OF
GLUTATHIONE S-TRANSFERASE
5.1 INTRODUCTION
5.1.1 Noncovalent Interactions
Noncovalent interactions are critical for the maintenance of the secondary, tertiary and
quaternary structure of proteins. The four main types of interactions important in
protein-protein and protein-ligand complexes are electrostatic interactions, hydrogen
bonding, van der Waals forces and hydrophobic effects.
Early methods that were used to obtain information on protein size and the
components present in a protein-protein or protein-ligand complex included
electrophoresis, size exclusion chromatography, and ultracentrifugation. Analytical
ultracentrifugation is still a powerful tool for investigating stoichiometry and
equilibrium constants (Loo, 1997). The ultraviolet (UV) absorption of a mixture of a
protein and ligand is measured as the sample is centrifuged. The higher molecular
weight complex settles faster and is apparent from the change in absorbance through the
centrifugation process (Fersht, 1999). Electrophoresis and size exclusion
chromatography as techniques for molecular weight determination do not provide mass
accuracy comparable to that provided by modern mass spectrometry. Equilibrium gel
filtration, however, is useful for determination of equilibrium constants (Fersht, 1999).
In this method a size exclusion column is equilibrated with buffer containing the ligand
of interest. The protein is then applied to the column in the equilibrating buffer. Free
ligand is able to penetrate the beads and is therefore retained longer by the column. The
beads do not retain ligand that is bound to the protein and the complex travels through
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the column more quickly. The resulting peak areas of the free ligand and the complex
with the protein are used to calculate the binding properties of the system (Fersht,
1999).
Spectroscopic methods such as circular dichroism (CD), UV and fluorescence are

not able to provide high resolution structural information but are useful for monitorin

protein folding or denaturation and also to observe changes in structure upon binding o

ligands. Tryptophan, and to a lesser extent tyrosine, absorb light at around 275-295 nm
and re-emit at around 330-340nm (Fersht, 1999). The environment around these amino
acids impacts the intensity of their fluorescence (Mathews and van Holde, 1990).
Tryptophan only fluoresces weakly in an aqueous environment but when folded into a
hydrophobic core it fluoresces more strongly (Fersht, 1999). Quenching or enhancement
of fluorescence may be observed when a protein undergoes conformational changes
owing to ligand binding or denaturation.
The peptide backbone of proteins absorbs UV light in the 180-220 nm region,
whilst the aromatic side chains absorb in the 275-295 nm region (Fersht, 1999; Mathews
and van Holde, 1990). Changes in the conformation of proteins also affect the UV
absorption spectra of proteins.
CD examines the difference in absorption of left and right circularly polarised
light by optically active molecules (Fersht, 1999; Pelton and McLean, 2000). The
peptide backbone of a protein is optically active and the secondary structure produces

different characteristic absorbances. CD can be used to estimate the amount of a-helice
and p-sheets within a protein (Mathews and van Holde, 1990). It is important to
remember that when used alone, this technique does not provide detailed structural
information. It is most useful when comparing two different structures, such as the
change in protein conformation upon binding of a ligand to a protein.
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Surface plasmon resonance (SPR) is a relatively n e w technique for examining the
binding of ligands to an immobilised protein. This technique measures the change in
refractive index as a ligand in solution is passed across an immobilised protein and a
complex forms between the protein and ligand (Loo, 1997). A problem with this

technique is the possibility that the binding properties of the protein are altered whe

is immobilised on the surface. There is also a limit to the molecular weight of the liga
that can be used since small differences in the molecular mass are not easily detected.
Differential scanning calorimetry (DSC) and isothermal titration calorimetry
(ITC) are the two most widely used forms of calorimetry (Larive et al, 1999). DSC
measures the heat absorbed by a protein as it undergoes denaturation (Fersht, 1999).
The denaturation of a protein is highly endothermic and therefore a high uptake of
energy occurs during this process (Fersht, 1999). The reversible binding of ligands can
be monitored by the change in the heat absorption curve caused by the presence of

ligands. ITC determines the heat of binding by measuring the electrical current required
to maintain a constant temperature whilst ligand is added to the protein (Darby and
Creighton, 1993; Fersht, 1999). The information obtained from this type of experiment
is dependent on how close the concentration is to the dissociation constant. There are
three possible measurements that may be obtained. These are: the stoichiometry of the
complex; the enthalpy of binding; and the dissociation constant. The enthalpy of
binding can be measured regardless of the size of the difference between the
dissociation constant and the protein concentration. The dissociation constant can only

be calculated when the concentration is less than or equal to the dissociation constant.
The stoichiometry can be obtained when the concentration greater than or equal to the
dissociation constant. (Fersht, 1999). Calorimetry techniques are important for
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measurement of the overall binding enthalpies but they do not distinguish binding to
potentially different quaternary structures (van Dongen and Heck, 2000).
Nuclear magnetic resonance (NMR) and X-ray crystallography are the two
techniques that are able to provide high-resolution structures of biomolecules and
biomolecular complexes. Multi-dimensional NMR, where the sample is irradiated with

two RF fields, can be used predict secondary and even tertiary structure of a protein
through the generation of a series of possible structures (Fersht, 1999; Pelton and
McLean, 2000). These experiments usually involve measurement of proteins that have
been labelled with 13C or 15N (Darby and Creighton, 1993) and knowledge of the
primary sequence of the protein is required. Relatively large sample amounts are

required for NMR and the high concentrations of protein necessary may result in prote
precipitation (Loo, 1997). Another drawback with NMR is that it is generally limited
masses below 30 kDa (Fersht, 1999; Pelton and McLean, 2000).
X-ray crystallography can determine structures in crystals to a resolution of
approximately lA and the technique has provided unsurpassed information on the
structure of biomolecules. The biggest obstacle with X-ray crystallography, however,

lies in the production of suitable crystals. This requires a large amount of very pur
protein and crystals of some proteins may be unattainable.
Mass spectrometry has enormous potential for the analysis of noncovalent

complexes. The introduction of electrospray ionisation has enabled the transfer of in

complexes into the gas phase. The speed and sensitivity of MS analyses is an advantag
for protein analyses. In addition, the high mass accuracy achieved with MS enables
clear assignment of the stoichiometry of complexes. There is also mounting evidence
that demonstrates agreement between binding constants calculated from MS data and
constants acquired from condensed phase techniques such as calorimetry (see section
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5.1.2 below). These data must be carefully interpreted, though, as some systems do not
show such agreement.

5.1.2 Mass spectrometry of noncovalent complexes
The analysis of noncovalent complexes by mass spectrometry has been an area of
interest for over a decade. Research has been directed to the understanding of the
processes occurring in the gas phase as well as to answering specific questions on

protein structure. Many examples of protein structural investigations are now availa
in the literature. These include DNA/protein interactions (Veenstra, 1999),
protein/carbohydrate complexes (van Dongen and Heck, 2000), large protein/protein

complexes (van Berkel et al, 2000; Benjamin et al, 1998) and protein interactions wit
ligands (Robinson et al, 1996; Wu et al, 1997). Complexes involving a vast array of
different proteins that have been explored by MS include: HIV proteins (Loo et al,
1998b; Sannes-Lowery et al, 1997), ribosomes (Benjamin et al, 1998), enzymes (van
Berkel et al, 2000; Wu et al, 1997; Chung et al, 1999), carrier proteins such as

transthyretin and retinol-binding protein (Rostom et al, 1998; Nettleton et al, 1998)
and hemoglobins (Green et al, 1999; Lippincott et al, 2000). There have been a

number of reviews on the application of mass spectrometry for the study of noncovalen

complexes, which provide more details on these studies (Przybylski and Glocker, 1996;
Loo, 1997; Smith and Light-Wahl, 1993; Smith and Zhang, 1994).
Instrumentation
It has been well documented that analyses under non-denaturing conditions result in

series of lower charge than those seen under standard denaturing conditions (Loo, 19
Przybylski and Glocker, 1996; Smith and Light-Wahl, 1993). The lower charges and
higher molecular weights of noncovalent complexes require a higher m/z range for
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detection. Most available mass analysers have also been used for the detection of
noncovalent complexes (Loo, 1997; Smith and Light-Wahl, 1993) but with complexes
of very high molecular weights, the m/z range of these complexes may be outside the
limit of detection (Murayama et al, 1997). Orthogonal ToF analysers can routinely
detect m/z up to 20 000, whilst conventional quadrupoles are usually limited to ca. m/z
4000 and for this reason ToF analysers are increasingly being used for these
applications. There are examples of quadrupole mass filters that have been modified to
increase this limit to over m/z 10 000 specifically for these applications (Loo and
Sannes-Lowry, 1998). Further advantages of ToF analysers are the high resolution and
sensitivity. The hybrid quadrupole-ToF instrument is therefore an ideal instrument for
the analysis of noncovalent complexes. The quadrupole provides a first stage mass
analyser, which offers the option for MS/MS. In the work presented here both the
Micromass QTof and QTof2 were used.
The transfer of noncovalent complexes to the gas phase requires careful
optimisation of a range of instrumental parameters (Smith and Light-Wahl, 1993;
Przybylski and Glocker, 1996; Loo, 1997; Loo and Sannes-Lowry, 1998). These include
the solution containing the analyte and the parameters of the electrospray interface.
Standard ESI-MS analysis of proteins and peptides generally uses a solution of the
analyte in aqueous organic phase (usually 50% acetonitrile or methanol). The presence
of the organic solvent improves the stability of ion signal and also affords increased
sensitivity (Loo, 1997). A weak acid such as 0.1-0.2% formic acid or acetic acid is also
included in the solution. The organic solvent and reduced pH disrupt noncovalent
interactions and causes protein unfolding. These conditions are obviously unsuitable for
analysis of noncovalent complexes by ESI-MS. To maintain the complexes most
analyses are performed in an aqueous buffer system at a pH close to physiological
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conditions. E S I - M S is sensitive to salts and there are a limited number of buffers that
can be used. Ammonium acetate and ammonium bicarbonate are useful buffers that are
tolerated by ESI-MS at low concentrations (millimolar range). Alternatively the analyte
can be dissolved in unbuffered water but this generally provides less reproducible

results. These solutions do not disrupt the noncovalent interactions that are crucial for
higher order structures in proteins. The ease with which a stable spray is achieved is
reduced compared to conventional ESI solutions but most samples can still be analysed
from these aqueous systems at suitable temperatures and source conditions.
Nanoscale ESI, or nanoESI (Wilm and Mann, 1996), has similar properties to
standard ESI but the droplets produced are much smaller (see Chapter 1). NanoESI
therefore requires less desolvation and does not use nebuliser gas. The possibility of
collision-activated dissociation (CAD) occurring in the nanoESI source is therefore
reduced compared to the standard ESI source. Furthermore, the capillary voltage is
much lower on the nanoESI source. For these reasons nanoESI is thought to provide
much more gentle conditions for the transfer of noncovalent complexes to the gas phase
(Fligge et al, 2000; Chung et al, 1999; Rostom et al, 1998; Nettleton et al, 1998).
There are a number of source parameters that are critical for the transfer of
noncovalent complexes to the gas phase. The source temperature, capillary voltage,

desolvation gas, cone voltage, collision gas, capillary position and pressure in the sou
region all have pronounced effects on the abundance of noncovalent complexes seen in
the gas phase. Changing one parameter often has an effect on the other parameters. This
is particularly noticeable for the optimisation of pressure and voltage (Tahallah et al,
2001). If conventional ESI is used, the nebuliser gas also requires optimisation. If

nanoscale ESI is used, the capillary may need special attention to achieve a stable spray
This involves a balance between capillary voltage, back-pressure on the capillary and
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size of the capillary orifice. T h e retention of noncovalent complexes in the gas phase

requires gentle conditions that still achieve effective desolvation. Using more string
settings for one parameter may allow milder conditions in another region (Smith and
Light-Wahl, 1993).
Behaviour of complexes in the gas phase
The question at the forefront of the analysis of noncovalent complexes by mass
spectrometry is whether this gas phase analysis can be correlated with the condensed
phase behaviour of molecules. A number of observations have raised specific issues in

this area. An issue of particular relevance to the complexes of GSTs in this study is t
observation of non-specific complexes in the gas-phase. These have been observed for a
number of systems and have also been documented under conventional electrospray
conditions, particularly the formation of complexes from charge-carrying components
present in the solution (Smith and Light-Wahl, 1993). The reasons for these nonspecific complexes are not always clear but it is possible that they reflect both
condensed phase complexes and complexes that are introduced by the electrospray
process (Smith and Light-Wahl, 1993; Przybylski and Glocker, 1996). Decreasing the

concentration of the analytes may reduce the occurrence of these non-specific gas phase

aggregates (Loo, 1997). To ensure that a complex seen in the gas phase is from specific
interactions, a number of simple investigations should be undertaken. First, the
spectrum obtained of the components in denaturing solution should be compared to the
spectrum obtained under non-denaturing conditions. This reveals associations that are

disrupted with organic solvent and acidic conditions and thereby identifies any covalen

modifications that may be present. Even slight changes in pH or organic solvent content

of the solution may reveal that the complex is sensitive to the solution conditions and
that covalent modification has not occurred.
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Once the possibility of any covalent adduct formation has been ruled out,
investigations to assist in the assignment of the complex as either specific or non-

specific can be pursued. The stoichiometry of the complex is an important feature of t
spectrum. The dominance of particular complexes in spectra may indicate specific
binding interactions. Conversely, a large number of complexes from the components in
varying combinations, with little variation in abundance, may suggest non-specific
aggregation rather than specific interactions. To further investigate the binding
stoichiometry, the concentrations of individual components in the solution can be

varied. Experiments involving changes in the source parameters (such as temperature or

voltage) may also provide information on the stability and specificity of a particular
complex. Competition experiments can also be useful to support the specificity of a
complex (Przybylski and Glocker, 1996). The use of site-directed mutants is also a

valuable tool for investigating the specificity of a binding interaction, particularl
competition experiments between mutants and the native protein (Sannes-Lowery et al,
1997). Increasing the cone voltage causes an increase in the acceleration of the ions
through the intermediate pressure region of the source and thereby promotes CAD with
gas molecules in this region (Loo et al, 1998b; Green et al, 1999; van Dongen and
Heck, 2000). Gentle CAD conditions may dissociate non-specific interactions more
readily than specific interactions but it must be considered that weak noncovalent
interactions may also be disrupted this way.
The majority of evidence suggests that ESI-MS does have the ability to detect

specific noncovalent complexes that are also present in the condensed phase. It appear

that even complexes of relative low affinity are amenable to analysis by this techniqu
(Baczynskyj et al, 1994). Careful consideration of complexes observed and their
behaviour under the changes mentioned above provides a powerful tool for discovery of
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the preferred stoichiometry of components that form complexes under non-denaturing

conditions. Further questions are posed beyond the simple task of observing the speci
complexes. First, does the behaviour of these complexes reflect their condensed phase
binding properties? Secondly, does the gas phase complex retain some or all of the
condensed phase structure?
Electrostatic interactions are thought to be strong in the gas phase whilst
hydrophobic effects are not expected to be maintained with the loss of solvent
molecules (Robinson et al, 1996; Loo, 1997; Wu et al, 1997; Loo and Sannes-Lowry,
1998; Last and Robinson, 1999; Chung et al, 1999). A study of acyl CoA binding
protein (ACBP) and various acyl CoA derivatives of different hydrophobic chain length

illustrated this effect. The increasing chain length did not appear to affect the pro
of complexes in the gas phase, even though the condensed phase dissociation constants

are significantly different (Robinson et al, 1996). In a study of HIV protein complexe
Loo and colleagues reported that complexes relying on electrostatic interactions were
more stable in the gas phase than complexes held together by hydrophobic interactions
(Loo et al, 1998b). Importantly, however, the condensed phase behaviour of the

complexes that did contain hydrophobic interactions was reflected in the MS data, even
though the complexes were more sensitive to elevated source voltages and temperatures
(Loo et al, 1998b). Another study of inhibitors of carbonic anhydrase found that,
although hydrophobic interactions were critical in solution, the gas-phase complexes
relied upon polar interactions from electrostatic groups and hydrogen bonding (Wu et

al, 1997). In contrast, interactions between two dimeric structures were retained in t
gas-phase when the interaction was known to be largely hydrophobic (Nettleton et al,
1998). Other studies have shown a close correlation between the behaviour of
complexes in solution and their gas phase behaviour (Smith and Light-Wahl, 1993; Loo,
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1997). Przybylski and co-workers found a correlation between solution stability and
gas-phase stability of oligomeric tail domains of the p24 family of transmembrane

proteins (Fligge et al, 2000). The gas phase behaviour of HIV-1 Tat peptide binding to
TAR RNA also reflected condensed phase interactions (Sannes-Lowery et al, 1997).

The interactions between Tat and TAR are primarily electrostatic and were unable to be

dissociated by CAD. This exemplified that electrostatic interactions may be stronger i
the gas phase owing to the absence of solvent-mediated interactions (Sannes-Lowery et

al, 1997). These observations emphasize the importance of careful consideration of the

results obtained by mass spectrometry and their relation to the behaviour of complexes
in the condensed phase. Continuing studies on different systems will further our
understanding of the behaviour of complexes in the gas phase.
The observation of a lower number of charges and a smaller range of charges in
mass spectra that are acquired under non-denaturing conditions suggests that there is
difference in the structure of a protein from denaturing conditions to non-denaturing
conditions (Smith and Zhang, 1994; Loo, 1997; Benjamin et al, 1998). The extent to
which the complex retains condensed phase structure is unknown. The observation of

protein multimers in the gas phase also supports the retention of at least some second

and tertiary structure that is required for quaternary structure (Smith and Light-Wahl
1993; Przybylski and Glocker, 1996). This observation, however, does not provide

evidence that the condensed phase structure is maintained in the gas phase ions. There

also the possibility that the structures able to form in the gas phase are more divers

than in solution. The importance of solvent molecules in the condensed phase structure

of biomolecules is well established and the effect of desolvation is yet to be clarifi
Kaltashov and Fenselau examined the stability of the a helical conformation of a

protein in the gas phase and the results suggested that the hydrogen bonds of the heli
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enabled the structure to be maintained (Kaltashov and Fenselau, 1997). Further studies

with |3-pleated sheets indicated that multistrand P-sheets retained a structure somewha

like the native structure but single P-strands collapsed in the absence of solvent (Li e
al, 1998a). Loo et al. used H/D exchange and CAD to probe the structures of a small

native peptide and its synthetic counterpart (Loo et al, 1998a). They reported retention
of the unique higher order structure of each of the peptides. Although these peptides
were quite small (16 amino acids in length) and possibly displayed exceptionally stable

structures, the results showed the potential of these techniques for the investigations
higher order structures.
In summary, there remains conflicting data and opinions as to whether ESI-MS
results are useful for the interpretation of condensed phase structure and mechanisms.

is clear, however, that ESI-MS has an important role in structural protein chemistry and
the knowledge gained from the behaviour of molecules in the gas phase is valuable,
regardless of whether it precisely reflects condensed phase behaviour. The continued
analysis of model protein systems will assist in the understanding of mechanisms that

operate in the gas phase. The establishment of a library of information on the behaviour
of different types of complexes under ESI-MS versus solution conditions would also be
beneficial. This information could assist in the interpretation of ESI-MS data from
systems for which there is little structural information from condensed phase studies.

5.1.3 Glutathione S-Transferases
Discovery and nomenclature
The purification of an enzyme from rat liver that catalysed the conjugation of
glutathione with various compounds was reported in 1961 (Booth et al, 1961). It was
previously recognised that this type of conjugation was critical for the excretion of
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xenobiotics through urine. These discoveries lead to many years of research on, what
were later named the glutathione S-transferases or GSTs.
GSTs have been found in both cytosolic and microsomal (membrane-bound)

forms but the cytosolic forms have been characterised more extensively. At least s

different classes of cytosolic GST exist, based upon gene structure, sequence homol

and substrate specificity. These classes are named alpha (A), pi (P), theta (T), s

mu (M), kappa (K) and zeta (Z) (Oakley et al, 1999; Gustafsson et al, 1999; Nieslan
and Atkins, 2000). Different isoenzymes also exist within a class of GST and these
designated by Arabic numerals.
The active structure of the cytosolic enzymes is dimeric and the monomeric units

may be identical or from proteins within the same class (Armstrong, 1997; Cameron e

al, 1995). Nomenclature for denoting the identification of a particular dimer has b
developed (Armstrong, 1997). A dimer formed between isoenzyme type 1 and

isoenzyme type 2 from the pi class is denoted by Pl-2. A homodimer is denoted in th

same way. For example, a homodimer of isoenzyme 1 from the alpha class is designate

Al-1. Four different GST sequences were used in this work. Two native proteins were
used, Al and PI. The remaining two proteins were the result of single amino acid

substitutions in the sequence of the isoenzyme Al. The first of these substitution

cysteine to serine at position 112 (C112S). The second was a tyrosine to phenylalan

substitution at position 9 (Y9F). These proteins would normally be denoted A1(C112S
and A1(Y9F). For simplicity GST Al will be denoted Al, GST A1(C112S) will be
denoted as Alcs and GST A1(Y9F) will be denoted Al^. The Alcs protein was used

owing to its improved stability against oxidation. This substitution has no apparen

effect on the properties of the enzyme (Professor Lu-Yun Lian, Biomolecular Science
Department, UMIST, Manchester, U.K. personal communication). The kl™ modified
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protein has reduced catalytic capabilities and has been widely used to probe the
importance of the tyrosine residue at position 9 (see below).
Function of GSTs
Early work with GSTs recognised their importance in the production of mercapturic
acids in the excretion of unwanted compounds from the body (Booth et al, 1961; Al-

Kassab et al, 1963; Boyland and Williams, 1965; Habig et al, 1974). In this reaction,

shown in Scheme 5.1, the conjugation of glutathione (y-glutamyleysteinylglycine; GSH
to an electrophile is catalysed by GST. The glutamyl and glycyl portions are then
enzymatically cleaved and acetylation by acetyl-CoA produces a mercapturic acid
(Mathews and van Holde, 1990). Mercapturic acids are much more soluble, and in some
circumstances less toxic, than the initial electrophiles (Cameron et al, 1995).
Scheme 5.1
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In addition to the conjugation of glutathione to xenobiotic substrates, GST has

other functions. For example, GST is able to catalyse the release of glutathione from

glutathione conjugate (Dietze et al, 1998). Examples of these types of reactions are,
however, limited.
It is also known that GST binds to non-substrate lipophilic molecules such as

bilirubin, steroids, fatty acids and drugs (Oakley et al, 1999; Dirr and Wallace, 199
The binding of proteins to these types of anionic compounds was first recognised in
proteins named ligandins. It was later noted that GSTs and ligandins were identical
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(Meister and Anderson, 1983). This ligandin function is believed to be important for

storage and transport of these molecules (Sinning et al, 1993; Cameron et al, 1995).
The GSTs also form covalent bonds with a variety of other reactive species but this
covalent modification destroys the catalytic ability of the protein (Meister and
Anderson, 1983).
Structure of cytosolic GSTs
Each monomer in a GST dimer has a molecular mass of between 23 and 28 kDa

(Oakley et al, 1999). Each of these subunits in the dimer has two domains. The dimer
contacts are primarily between domain I of one subunit and domain II of the other

subunit (Armstrong, 1997). In the A, M and P classes these interactions form a lockand-key motif (Sayed et al, 2000). The monomeric subunits from different classes do
not have compatible interfaces and therefore do not form dimers (Armstrong, 1997).
There are two glutathione binding sites per GST dimer. These sites are termed the

G-sites and are formed by domain I of each subunit (Allardyce et al, 1999). There ar

also two sites for the binding of the hydrophobic substrates, termed the H-sites. Th

sites are formed mainly by domain II. The G-site in different isoenzymes is similar,

whereas there is much more variation in the H-site. Presumably the variation in H-si

improves the ability to bind to different substrates. The H-site of the P class enzy

relatively open. The C-terminal helix found only in A class enzymes appears to cover
the substrate in the H-site when glutathione is present in the G-site (Allardyce et

1999; Dirr and Wallace, 1999; Nieslanik et al, 1999). The H-site in these enzymes is

therefore not nearly as open as in the P class enzymes. This C-terminal helix is als

thought to increase the specificity for more hydrophobic substrates (Allardyce et al
1999; Dirr and Wallace, 1999).

Chapter 5: Noncovalent complexes of G S T

193

The position of glutathione in the G-site is very similar in the different classes of
GSTs, even though individual interactions vary (Armstrong, 1997). The G-site relies
heavily on electrostatic interactions and virtually all of the hydrogen bonding sites

glutathione are utilised (Sinning et al, 1993). The majority of H-site interactions ar
hydrophobic, but protein hydrogen bonds and hydration effects do enable interactions
with polar atoms of a substrate (Micaloni et al, 2000; Cameron et al, 1995).

Another site in GSTs that is less well characterised is the ligandin site. It has been

reported that there are two distinct non-substrate binding sites (Dirr and Wallace, 199

The most widely recognised site is in the cleft formed between the two subunits of the

dimer (Dirr and Wallace, 1999; Wallace and Dirr, 1999). The second site exists on each
subunit and is close to the tryptophan residue at position 20 of GST Al (Dirr and

Wallace, 1999). The same group also reported that stabilisation of the C-terminal heli
of A class enzymes appears to impact on both these non-substrate binding sites (Dirr
and Wallace, 1999).
Catalytic mechanism of GSH conjugation
It has been well documented that the G-site of GSTs contains a serine or tyrosine

residue that is critical for the catalysis of glutathione conjugation (Armstrong, 1997)

A, M, P and S classes a conserved tyrosine is utilised. The T class uses a serine resi
The hydroxyl group from these residues is believed to activate the thiol group of
glutathione to promote nucleophilic attack on the hydrophobic electrophile (Allardyce
al, 1999). This activation occurs through a decrease in the pKa of the thiol group
(Nieslanik and Atkins, 2000; Dietze et al, 1996b; Armstrong, 1997). In solution, the

pKa of glutathione is approximately 9.3 but at the active site of GST the pKa is reduc
to between 6.5 and 6.9 (Dietze et al, 1996b), such that the predominant species at

physiological pH is the thiolate anion, GS" (Dietze et al, 1996b; Armstrong, 1997). Th
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hydroxyl group stabilises the thiolate anion through a hydrogen bond (Cameron et al,
1995; Widersten et al, 1996; Oakley et al, 1999; Dietze et al, 1996a; Nieslanik and

Atkins, 2000). Site-directed mutagenesis has shown that substitution of a phenylalanine

in place of the tyrosine at position 9 in Al results in a decrease in the rate of catal

for the substrate chloro-2,4-dinitrobenzene (kcat 58s"1 for wild-type and 0.34s"1 for th
Y9F mutant)(Allardyce et al, 1999).
In addition to this tyrosine residue, the A class enzymes also have a conserved

arginine residue that further stabilises the glutathione thiolate (Widersten et al, 19

Armstrong, 1997; Sinning et al, 1993). These two interactions are known as first sphere
interactions since they are directly co-ordinated to the sulphur atom of glutathione

(Armstrong, 1997). Additional interactions that are distal to the sulphur atom (so-call
second sphere interactions) also stabilise the thiolate anion. An example of a second
sphere interaction could include electrostatic effects introduced by dipoles from a
helices (Armstrong, 1997). These types of interactions have not been as well
documented as the first sphere interactions.
Inhibition of GSTs

GSTs have the ability to metabolise alkylating agents, which are used in cancer therapy
and have been implicated in the development of drug resistance to other therapeutics
(Armstrong, 1997; Oakley et al, 1999). For this reason there has been significant

interest in GST inhibitors. The drug sulfasalazine inhibits A, M and P class GSTs. It h

also been shown to increase the cytotoxic effects of an alkylating agent in cancer cell
that exhibited elevated levels of GST PI (Oakley et al, 1999). A similar enhancement
has been seen with the GST inhibitor ethacrynic acid (Armstrong, 1997). The
administration of GST inhibitors has shown a cytotoxic effect on healthy cells and
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therefore their therapeutic use is limited. Inhibitors have, however, been crucial in the
establishment of the structure of these enzymes.
Glutathione conjugates (GSR) with hydrophobic R groups are potent inhibitors of
GSTs. These types of inhibitors can occupy both the G-site and the H-site of GSTs,

depending on the size of the R group. S-alkylglutathiones have been used characteri
structures of GST. Examples include, X-ray crystallography of the S-nonylGSH in
complex with PI (Oakley et al, 1999), S-hexylGSH in complex with PI (Oakley et al,
1997) and S-benzylGSH in complex with Al (Sinning et al, 1993), NMR spectroscopy
of S-hexylGSH in complex with M2 (McCallum et al, 2000) and fluorescence studies

with S-alkylGSHs of increasing chain lengths (Dietze et al, 1996b). Three S-alkylGS
were chosen for examining the behaviour of these complexes by mass spectrometry.
These were S-propylGSH (GS-prop), S-hexylGSH (GS-hex) and S-decylGSH (GS-dec).
Previous mass spectrometric studies of glutathione S-transferase
A previous study of GST Al by non-denaturing ESI-MS revealed the formation of a
dimer of GST that was apparent in the gas phase (Ishigai et al, 2000). The binding

reduced glutathione (GSH), oxidised glutathione (GSSG) and two different inhibitors
was also investigated. Complexes formed between dimeric Al and the ligands was
observed by ESI-MS. It was interesting that these investigators found the addition
GSH resulted in a mass increase of 340 Da rather than the molecular weight of GSH

(307.3 Da). It was proposed that the additional mass was from the specific retentio
water molecules with the ligand. Observations of water molecules in gas phase

noncovalent complexes have been reported previously (Benjamin et al, 1998; Green et

al, 1999; Fabris and Fenselau, 1999) but this water retention does not appear to be

consistent in all complexes and may be dependent on how rapidly the water molecules
are exchanged in the condensed phase (Loo et al, 1998b). The GST enzyme has been
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widely investigated in solution and crystal structures and E S I - M S has revealed G S T
complexes in the gas phase. This system is therefore suitable for use as a model in
investigation of the gas phase behaviour of noncovalent complexes.

5.1.4 Aims
The aims of this project were to extend the results of the earlier study by Ishigai

on the non-covalent complexes of GST and seek to clarify some of the questions raise
by that study. Furthermore, the GST enzyme has been well characterised by
spectroscopic methods (including high resolution NMR), X-ray crystallography and

kinetic studies and is therefore an ideal model system for investigating the behavi
noncovalent complexes in the gaseous environment of a mass spectrometer.
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5.2 RESULTS
5.2.1 Molecular mass determination, conventional electrospray conditions
The GST proteins used in this study were first analysed under denaturing nanoESI
conditions (i.e. 50% aqueous acetonitrile with 0.2% formic acid) to confirm their

molecular masses and assess the purity of the samples. The resulting spectra are show
in Figure 5.1 and the measured molecular masses are given in Table 5.1. The A class

GSTs (Figure 5.1 A-C) each showed a major series of peaks corresponding to protonate
molecular ions with charges ranging from approximately 17+ to 39+. For the P class
GST (Figure 5.ID) the charge distribution ranged from 16+ to 26+. In Al and Alw an

extra series of molecular ions was detected. The experimental mass of Al was 25500.6
± 0.5 Da, which was in good agreement with the theoretical mass of 25499.9 Da. The

extra component in this sample was of lower abundance and it was therefore difficult

establish an accurate mass. The mass calculated was 25845 ± 0.5 Da, i.e. 345 Da above
the native protein4. The experimentally determined mass for Al^ was 25483.3 ± 0.9
Da, very close to the theoretical mass of 25483.9 Da. The extra component in this
spectrum was also of low abundance. The calculated mass of this extra component was
25336 ± 1 Da, which corresponds to a mass 147 Da lower than Al717. The spectrum of

Alcs did not appear to contain either of these extra components and the experimentally
determined mass (25483.6 ± 0.3 Da) was once again in close agreement with the
theoretical mass of 25483.9 Da.
The two modified forms of Al have the same molecular mass, because both the

cysteine-to-serine substitution and the tyrosine-to-phenylalanine substitution resul
difference in mass of 16 Da lower than the native protein. The modifications could

The origin of this extra component or adduct is not immediately obvious but the high abundance of the native
protein suggests that the unknown adduct was a minor component of the sample and m a y be of little relevance.
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therefore not be confirmed by mass alone, so the presence of these modifications was
confirmed by tryptic digestion and M S / M S analyses of the resulting peptides (see 5.2.2
below).

Protein

Theoretical
mass

Experimental mass

Other components

G S T Al(wild type)

25499.9

25500.6 ± 0.5

25845.3 ± 0.5

G S T A1(C112S)

25483.9

25483.6 ± 0.3

-

G S T A1(Y9F)

25483.9

25483.3 ± 0.9

25336 ± 1

G S T PI

23224.7

23225.8 ± 0.3

23356.8 ± 0.2

Table 5.1 Theoretical and experimental molecular masses of glutathione S-transferases.
The third column lists extra components that were detected in the spectra.
The experimentally determined mass of the most abundant species in the PI
spectrum (Figure 5.ID) was 23356.8 ± 0.3 Da. A second component was determined to
have a mass of 23225.8 ± 0.2 Da, which was in closer agreement with the theoretical
molecular mass of 23224.7 Da. The difference between the two components was 131
Da. The residue mass of the amino acid methionine is also 131 Da. The sequence of
G S T PI has an N-terminal initiator methionine, which is normally cleaved to give the
native

protein

sequence

(Swiss

Prot,

accession

number

P09211,

http://au.expasy.org/sprot). T o determine whether the component of mass 23356.8 D a
was due to the presence of an initiator methionine, tryptic digestion of the protein and
M S / M S analysis of the resulting peptides was also performed (see 5.2.2 below). The
20+ charge state in Figure 5.1 is labelled with 'PI' and 'PIMet' to indicate the two
different components.
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Figure 5.1
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Figure 5.1 E S I - M S spectra of G S T under denaturing conditions ( 5 0 % C H 3 C N (aq) with
0 . 1 % formic acid). Protein concentration was between 1 and 5 pmol/uL.
A ) wild-type A l , cone voltage 4 0 V ; B ) A l c s , cone voltage gradient of 25-120Vfromm / z
600-2200; C ) A 1 Y F , cone voltage 4 0 V ; D ) PI, cone voltage gradient of 25-120V from m/z
600-2200.
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5.2.2 Confirmation of modifications in glutathione S-transferases
The three proteins Alcs, A1YF and PI were cleaved with trypsin and the resulting
peptides were analysed by nanoESI-MS and MS/MS procedures. The sequences of Al
and PI are given in Figures 5.2 and 5.3, respectively. The tryptic peptide T15 from

digest of Al (Figure 5.2) contained cysteine 112, which is replaced with a serine re

in the Alcs protein. The mass of this peptide is 3084.58 Da for the wild-type Al prot
but with the C112S modification the peptide molecular mass is 3068.61 Da. From the

ESI-MS spectrum of the digest of A1CS (data not shown), a triply charged precursor at
m/z 1023.86 was chosen for MS/MS. This ion had a measured molecular mass of
3068.56 Da, which is in close agreement with the expected mass for T15. The MS/MS
spectrum of the m/z 1023.86 precursor is shown in Figure 5.4 The ion at m/z 686.36

corresponded to Ye" (the last six amino acids of the peptide, i.e. SPPEEK). The ion a
m/z 599.32 corresponded to Y5", i.e. the C-terminal sequence PPEEK. These ions
confirmed the presence of a serine in place of the cysteine residue at position 112.
The substitution of a phenylalanine for tyrosine 9 in Al resulted in a mass shift of
the T2 tryptic peptide from Al (Figure 5.2). T2 from the wild-type protein has a
molecular mass of 919.47 Da, whereas T2 from the protein A1YF has a molecular mass
of 903.47 Da. ESI-MS of a tryptic digest of A1YF showed a doubly charged ion a m/z
453.2, which corresponds to a molecular mass of 903.4 Da (data not shown). The
MS/MS spectrum of this precursor is shown in Figure 5.5. This small peptide had an
expected sequence of LHFFNAR (Figure 5.2). The full sequence was confirmed with
the Y ion and complementary B ion series. Figure 5.5 shows the Y ion series and the
mass difference between Y5" and Y4", which corresponds to phenylalanine, is labelled
'F'.
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9

2

AEKPK LHFFNAR GR MESTR
T1

T2

T3

T4

WLLAAAGVEFEEK FIK SAEDLDK LR
T5

T6

T7

T8

NDGYLMFQQVPMVEIDGMK LVQTR
T10

T9

AILNYIASK YNLYGK DIK ER
T11

T12

T13

T14
"12

AUDMYlEGIADLGEMlLLLPVgPPEEK
T15
DAK LALIK EK \K NR YFPAFEK
T16

T17

T18 T19 T20

T21

VLK SHGQDYLVGNK LSR
T22

T23

T24

ADIHLVELLYYVEELDSSLISSFPLLK
T25

ALK IB ISNLPTVK K FLQPGSPR
T26

T27

T28

T29

T30

KPPMDEK SLEEAR K IFR F
T31

T32

T33 T34 T35

Figure 5.2 The sequence of G S T A l with peptides generated from a theoretical
digest with trypsin labelled (Tl to T35). The initiator methionine, which is
considered amino acid 1 in the literature, is not pictured so thefirstamino acid is
labelled 2. The tyrosine at position 9 and the cysteine at position 112 are labelled
as these are the two positions which were modified to give A l ™ and A l c s . These
modifications are contained in tryptic peptides T 2 and T15, respectively.
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PPYTVVYFPVR GR CAALR
T2

T1

T3

MLLADQGQSWK EEVVTVETWQEGSLK
T4

T5

ASCLYGQLPK FQDGDLTLYQSNTILR
T6

T7

HLGR TLGLYGK
T8

T9

DQQEAALVDMVNDGVEDLR CK
T10

T11

YISLIYTNYEAGK DDYVK
TT2

Ti3

ALPGQLKPFETLLSQNQGGK
T14

TFIVGDQISFADYNLLDLLLIHEVLAPGC
T15

LDAFPLLSAYVGR LSARPK LK
T15

T16

T17

AFLASPEYVNLPINGNGK Q
T18

T19

Figure 5.3 The sequence of G S T PI with peptides generated from a theoretical
digest with trypsin labelled (Tl to T19). The initiator methionine, which is
considered amino acid 1 in the literature, is not pictured so thefirstamino acid is
labelled 2.
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Figure 5.4 M S / M S spectrum of m/z 1023.86 (3+) (T15) from a tryptic digest of Al c s . Only
the region below the precursor is displayed. The Cys—»Ser modification at position 112 was
confirmed from the Y ion series shown. The difference between Y5" and Ye" corresponded
to the serine residue of interest.
Ys"
IOOI

H

*

Y4"
YI"

Y6"(2+)
Y3"

,j,ii J I I I J M

50100

150

JUU
200

jl),.,,t,U4.l
300
350

250

Y6'
u.. ,.i.450 u.U
500

400

550

.v...4„A650

600

J™ m/z
700

750

IYF

800

Figure 5.5 M S / M S spectmm of m/z 453.2 (2+) (T2) from a tryptic digest of Al . The
Tyj._4.phe modification at position 9 was confirmed from the Y ion series shown. The
difference between Y 4 " and Y 5 " corresponded to the phenylalanine residue of interest.
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Figure 5.6 M S / M S spectra for confirmation of the PI N-terminal initiator methionine.
A) MS/MS spectrum of m/z 669.4 (2+) from a tryptic digest of PI.
B) MS/MS spectrum of m/z 734.9 (2+) from a tryptic digest of PI.
The region above m/z 1250 is enlarged by a factor of 10 in both spectra. See text for de
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The main species in the spectrum of PI acquired under denaturing conditions was

proposed to be from the intact protein with the initiator methionine present at the N

terminus. The mass of the N-terminal tryptic peptide (Tl, Figure 5.3) of PI without t
initiator methionine is 1336.72 Da. With the initiator methionine present, Tl has a
of 1467.76 Da. ESI-MS of a digest of the PI sample (data not shown) showed doubly
charged ions at m/z 734.9 and m/z 669.4, which correspond to peptides of masses
1467.8 and 1336.8 Da, respectively. The MS/MS spectra of these two precursors are

shown in Figure 5.6. The region above m/z 1250 in Figure 5.6B clearly shows the ion a
m/z 1337.8, which corresponds to Yn" of the sequence MPPYTVVYFPVR. The ion at

m/z 1240.7 in both spectra corresponds to Yio", which is the same for each peptide. T
immonium ion of methionine (m/z 104) was present only in the MS/MS spectrum of the
m/z 734.9 ion. Another difference between the spectra was the peak at m/z 229.1 from
the precursor of m/z 734.9, which corresponded to the B2 ion (MP) of
MPPYTVVYFPVR. The presence of the initiator methionine was therefore clearly
evident from these spectra.

5.2.3 Non-denaturing electrospray ionisation mass spectrometry of glutathione Stransferases
The ability to transfer noncovalent complexes to the gas phase for analysis required
careful control of the mass spectrometry ionisation conditions. Specific tuning
parameters on the QTof, such as the focus voltage and pusher time were set the same
each time (see Chapter 2, Materials and Methods). An elevated pressure in the source

was achieved by partially closing the in-line isolation valve of the rotary pump at t

start of each new session on the instrument. To determine the appropriate level to w
the pumping needed to be reduced, a solution of caesium iodide (2 mg/mL) was sprayed
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and monitored in the peak window of the M a s s L y n x ™ software. The rotary pumping
was fine-tuned to maximise the peaks visible in the region m/z 3000-3600 without
introducing excessive background noise. Once the pressure was set, caesium iodide
used to calibrate the instrument.
NanoESI5 mass spectra of the each of the GSTs under non-denaturing conditions
(i.e. lOmM ammonium acetate, pH 7.4) are shown in Figure 5.7 over the m/z range
2800 to 3700. For the A class GSTs protonated dimers with charges from 14+ to 17+

were observed. For the P class enzyme the 13+ ion was more abundant and the 17+ io
was not observed (Figure 5.7D). The ESI-MS spectrum of Al (Figure 5.7A) showed the

most abundant species was the dimer (Al-1). An additional series of ions was appare

which yielded a mass 337 Da higher than the GST dimer. A third series, which appea

to be heterogeneous, was also evident but the low abundance and heterogeneity mean

was difficult to accurately measure the mass of this species; however, this series
likely arose from the addition of two molecules of mass 337 Da. The mass spectrum
previously reported for this protein also showed an additional component of
approximately 340 Da (Ishigai et al, 2000).
The mass spectra of the modified forms of GST Al showed fewer components
than the wild-type enzyme. In the spectrum of Al^ (Figure 5.7C) a small amount of
another dimeric species was apparent with a mass 147 Da below the dimer of Al^.

This may be attributed to the formation of a dimer between Al*7 and a truncated for

of the same protein, seen in the ESI-MS spectrum under denaturing conditions (Figu

5.1, section 5.2.1). Dimers formed between two molecules of the truncated protein w

5

NanoESI was used throughout this work. From herein ESI therefore refers to nanoESI. 'Standard ESI' refers to
nanoESI performed under non-denaturing conditions
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Figure 5.7 Non-denaturing ESI-MS spectra of A ) wild-type Al, B) Al c s , C) A l ^ a n d D )
PI. Protein concentration 5pmol/mL in l O m M N H 4 C H 3 C O O . The charge on the ions is
shown above each group of peaks.

Chapter 5: Noncovalent complexes of G S T

208

not apparent, presumably because of the relatively low abundance of this form of the
protein.
The presence of two proteins that differed only by an N-terminal methionine in
the PI protein sample was evident from ESI-MS spectra obtained under standard
(denaturing) conditions (Figure 5.1 and 5.4). With these two forms present, three
possible dimers could be formed. The spectrum of PI acquired under non-denaturing
conditions (Figure 5.7D) clearly showed three dimers of different masses, namely
46449 ± 1 Da, 46583.0 ± 0.7 Da and 46713 ± 2 Da, which correspond to the Pl/Pl,
Pl/PlMet and PIMet/PlMet dimers successively. The abundance of each of these

dimers in the non-denaturing spectrum reflected the abundance indicated by denaturi
ESI-MS (Figure 5. ID). The PIMet protein was the most abundant, and dimers of this
protein gave rise to the most abundant ion series in Figure 5.7D. The second most
abundant series was from dimers formed between PI and PIMet, whereas the Pl/Pl
dimer was of lowest abundance.

5.2.4 Addition of glutathione to GSTs
To simplify the interpretation and discussion, the complexes reported herein are
represented by the notation [dimer + ligand]. Spectra from ESI-MS under nondenaturing conditions of a mixture of glutathione (GSH) with Al in molar ratios of
and 1:5 are shown in Figure 5.8B and C. Without added GSH, the spectrum of Al
showed three ion series (Figure 5.8A), which corresponded to the dimer and two
additional adducts. The presence of the additional adducts in this spectrum (b and
was addressed above and was also noted by Ishigai et al (Ishigai et al, 2000). The

addition of GSH to Al resulted in the disappearance of the ions from b and c (Figur
5.8B) and the appearance of two new ion series (Figure 5.8C). These new ion series
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corresponded to the addition of one and two molecules of G S H to the A l dimer (series d

and e respectively, Figure 5.8C). The mass added to the dimer from the addition of

was 307 Da (Figure 5.8C). Hence, the GSH effectively displaced the adduct of 337 D

providing evidence that this ion series arose from an adduct with a small molecule
rather than a modified protein.
The addition of the reduced form of glutathione (GSH) to Al has been
investigated previously and it was found that when GSH was added three complexes
were apparent (Ishigai et al, 2000). The dimeric form of Al was the most abundant
species. The second component had a molecular mass that was approximately 340 Da
above that of the dimer. The third component appeared to be heterogenous, and was

possibly partly from the addition of two 340 Da entities to the dimer. As noted ab
the mass of GSH is 307.3 Da, therefore to account for the difference in mass they

observed, Ishigai et al. proposed that the additional mass arose from the presenc
water molecules (Ishigai et al, 2000).
The spectra shown in Figure 5.9 are from non-denaturing ESI-MS of GSH mixed

with each of the A class GSTs in a five molar excess of GSH. In each of the spectr
dimer was apparent, along with the addition of multiple GSH molecules (307.3 Da).

most abundant component in the spectrum of Al with GSH (Figure 5.9A) was the dimer
of Al without any bound GSH. The most abundant component in the spectrum of the
mixture of Alcs and GSH was the complex [Alcsdimer + GSH] (series b, Figure 5.9B).
The spectrum of the mixture of Al^ and GSH revealed [Al^dimer + 2GSH] (series c,
Figure 5.9C) to be the most abundant complex. The presence of the second dimer in

spectrum of Al^ was also apparent as a small ion series in-between the abundant io
from the major series.
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Figure 5.8 ESI-MS spectra of A l (wild-type) + G S H under non-denaturing conditions
A ) wild-type A l without added G S H , B ) A l + G S H (molar ratio 1:1), C ) A l + G S H (molar
ratio 1:5).
In each of the spectra the lower case letters correspond to the following: a: [Al dimer], b:
[Al dimer + 337 Da], c: [Al dimer + approximately 600 to 700 Da], d: [Al dimer + G S H ] ,
e:[Al dimer + 2 G S H ] .
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Figure 5.9 ESI-MS spectra of G S T + G S H (molar ratio 1:5) under non-denaturing
conditions
A ) wild-type A l + G S H , B) A l c s + GSH, C) A 1 Y F + G S H
In each of the spectra the lower case letters correspond to the following: a: [dimer], b:
[dimer + G S H ] , c: [dimer + 2GSH], d: [dimer + 3GSH], e:[dimer + 4GSH]
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The differences in the ion abundances seen in the spectra in Figure 5.9 m a y be

attributed to different concentrations of protein in the samples. The concentration
Al, A1YF and PI were estimated via different methods (see Chapter 2) prior to

desalting. Alcs was received as a lyophilised powder and did not require desalting. F

this reason, the concentration was most accurate for Alcs whereas for the other prote

the concentration may have varied from that estimated. Nevertheless, it is interest
note that, with a molar excess of GSH, the dimer with two molecules of GSH was not
generally the most abundant complex.
Spectra from mixtures of GSH and PI were complicated by the presence of the

three different dimers, Pl/Pl, Pl/PlMet and PIMet/PlMet, seen in Figure 5.7. The ESI
mass spectrum of PI and GSH in a five molar excess of GSH showed complexes with
each of the three dimers and GSH (data not shown). The two most abundant ion series
were from the dimers of Pl/PlMet and PIMet/PlMet. The next most abundant complex
was [PIMet/PlMet + GSH]. Even with the five-fold excess, the complexes formed
between the dimer and only one molecule of GSH remained the most abundant
components.

5.2.5 Addition of S-alkylglutathione inhibitors to GSTs

Three different S-alkylglutathiones were used to investigate the binding of inhibit
GSTs. S-alkylglutathiones were chosen to prevent covalent adduct formation through
the free thiol group of the GSH moiety. The ESI-MS spectra of a mixture of Alcs and

S-propylglutathione (GS-prop) under non-denaturing conditions are presented in Figu

5.10. With a molar ratio of 1:1 (Alcs:GS-prop) the three ion series present resulted
the complexes [Alcsdimer] (series a, Figure 5.10A), [Alcsdimer + GS-prop] (series b,
Figure 5.10A) and [Alcsdimer + 2GS-prop] (series c, Figure 5.10A). The spectrum
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from the mixture with a five-fold excess of GS-prop (Figure 5.1 OB) showed an increase
in the abundance of [Alcsdimer + 2GS-prop] and the appearance of a fourth
component, which corresponded to the complex [Alcsdimer + 3GS-prop] (series d,
Figure 5.10B). The dimer without any bound GS-prop was of very low intensity in
Figure 5.1 OB and the most abundant complex was [Alcsdimer + 2GS-prop].
Figure 5.11 shows ESI-MS spectra from the addition of GS-hex to the A class

enzymes in a molar ratio of 1:5 (Al:GS-hex). In each of the spectra, the most inte
series of peaks was from the complex [dimer + 2GS-hex]. A smaller series was also
apparent from the complex [dimer + 3GS-hex]. In the spectrum of GSH with Al**

(Figure 5.11C) a third component of relatively low abundance was also visible. Thi
component corresponds to the dimer between Al^ and truncated Al^ with two bound
molecules of GS-hex. The addition of GS-hex to the GSTs revealed a very clear ion

series, with [dimer + 2GS-hex] proving to be the most abundant complex, even at lo
molar ratios of ligand to GST.
The ESI-MS spectra of GS-dec with Alcs and GS-dec with Al^ acquired under

non-denaturing conditions are presented in Figure 5.12. The complex [dimer + 2 S-

was by far the most abundant component in both spectra, with only a relatively sma
amount of the complex [dimer + 3GS-dec] apparent. Ion series from the dimer alone
and the complex of dimer with one molecule of GS-dec were not apparent in these
spectra.
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Figure 5.10 E S I - M S spectra of G S T A l,cs + GS-prop under non-denaturing conditions. A )
A l c s + GS-prop (molar ratio 1:1), B ) A l c s + GS-prop (molar ratio 1:5)
In each of the spectra the lower case letters correspond to the following: a: [Al cs dimer], b:
[Al cs dimer + GS-prop], c: [Al cs dimer + 2GS-prop], d: [Al cs dimer + 3GS-prop]
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Figure 5.11 E S I - M S spectra from the addition of GS-hex to each of the alpha class
enzymes under non-denaturing conditions. The ion charge is displayed at the top of the
figure and the 16+ molecular ions are labelled with the identity of the complex.
A ) wild-type A l + GS-hex (molar ratio 1:5)
B ) A l c s + GS-hex (molar ratio 1:5)
C ) A 1 Y F + GS-hex (molar ratio 1:5)
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Spectrum A : A 1 Y F + GS-dec (molar ratio 1:5)
Spectrum B: A l c s + GS-dec (molar ratio 1:5)
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5.2.6 Competition experiments

The binding properties of S-alkylGSH inhibitors were further assessed in competiti

experiments in which two different inhibitors were added to GST and ESI-MS analysis

of the mixtures was performed under non-denaturing conditions. Spectra acquired fr
a mixture in which GS-hex was added to a solution already containing Alcs and GSH

are shown in Figure 5.13. These spectra were obtained from mixtures with increasing
molar ratios of GS-hex over the protein. The spectrum in Figure 5.13A was acquired
when the enzyme (Alcs) was in excess over the inhibitor (GS-hex) and the substrate
(GSH) was in excess over the enzyme. Even with this deficiency of GS-hex, the most
abundant ion series was from the complex [Alcsdimer + 2GS-hex] (series c, Figure
5.13A). The complexes [Alcsdimer + GS-hex] (series a) and [Alcsdimer + GSH +
2GS-hex] (series d) were also significantly abundant with the deficiency of GS-hex
(Figure 5.13A). The ion [Alcsdimer + GSH + GS-hex + 16H+]16+ was the only ion
apparent from the complex [Alcsdimer + GSH + GS-hex] (series b, Figure 5.13A).
When the molar ratio of GS-hex was increased, the spectra showed a decrease in the

relative abundance of series a and b (Figure 5.13B and C). The spectrum from a mola
ratio of 1:10:10 (Alcs:GSH:GS-hex) showed that the most abundant component was

again [Alcsdimer + 2GS-hex]. Additional ion series were visible in this spectrum th

were not apparent at the lower molar ratios of GS-hex. These were from the complexe
[Alcsdimer + 3GS-hex] (series e), [Alcsdimer + GSH + 3GS-hex] (series f) and

[Alcsdimer + 4GS-hex] (series g) (Figure 5.13C). In each of the spectra in Figure 5

the relatively high abundance of [Alcsdimer + 2GS-hex] over the other complexes was
very clear and suggested preferential binding of GS-hex over GSH.
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Figure 5.13 ESI-MS spectra from mixtures of Al c s , G S H and GS-hex acquired under nondenaturing conditions.
A ) A l,cs
^ + G S H + GS-hex (molar ratio 2:20:1)
cs
B) A l + G S H + GS-hex (molar ratio 1:10:1)
C) A l c s + G S H + GS-hex (molar ratio 1:10:10)
In each of the spectra the lower case letters correspond to the following: a: [Alcsdimer +
GS-hex] , b: [Alcsdimer + G S H + GS-hex], c: [Al cs dimer+ 2GS-hex], d: [Alcsdimer +
G S H + 2GS-hex], e:[ Al cs dimer + 3GS-hex], f:[Alcsdimer + G S H + 3GS-hex],
g:[Alcsdimer + 4GS-hex].
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Figure 5.14 shows spectra from three different mixtures of GS-prop, GS-hex and
Alcs. The relatively high abundance of the complex [Alcsdimer + 2GS-hex] was again
apparent (ion series e), even with a deficiency of GS-hex (Figure 5.14A). The
complexes [Alcsdimer + GS-prop] (series b) and [Alcsdimer + GS-hex] (series c),
[Alcsdimer + GS-prop + GS-hex] (series d) and [Alcsdimer + 2GS-prop + GS-hex]
(series f) were apparent at a molar ratio of 2:15:1 (Alcs:GS-prop:GS-hex) (Figure
5.14A). These complexes were not evident in the spectra acquired from the mixtures
with higher molar ratios of GS-hex (Figure 5.14B and C).
The complex [Alcsdimer + GS-prop + 2GS-hex] (series g) was seen in the spectra
of each of the mixtures of GS-prop, GS-hex and Alcs. A second complex with three
ligands bound to the dimer was [Alcsdimer + 3GS-hex], which was apparent at a molar
ratio of 1:5:5 (Al :GS-prop:GS-hex) ( series h, Figure 5.14C). Since there are only

sites for ligand binding on the Alcs dimer, the presence of a third ligand may arise
non-specific binding.
Figure 5.15 shows the ESI-MS spectra of a mixture of GS-hex, GS-dec and Al^
(Figure 5.15A) and a mixture of GS-hex, GS-dec and Alcs (Figure 5.15B). Both the
spectra were acquired with a molar ratio of 1:5:5 (protein:GS-hex:GS-dec). The most

abundant ion series in these spectra was from the complex [dimer + 2GS-dec] (serie
Also of high relative abundance was the ion series from the complex [dimer + GS-hex

GS-dec] (series b). The complex [dimer + 2GS-hex] was also apparent (series a) but
complex was not nearly as abundant as in the previous competition experiments

(Figures 5.13 and 5.14). The complexes [dimer + 2GS-hex + GS-dec] (series d), [dimer

+ GS-hex + 2GS-dec] (series e) and [dimer + 3GS-dec] (series f) were also apparent a

were possibly a result of non-specific binding of a third inhibitor molecule to th
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Figure 5.14 ESI-MS spectra from mixtures of A l c s , GS-prop and GS-hex acquired under
non-denaturing conditions.
A ) A l c s + GS-prop + GS-hex (molar ratio 2:15:1)
B ) A l c s + GS-prop + GS-hex (molar ratio 1:5:1)
C) A l c s + GS-prop + GS-hex (molar ratio 1:5:5)
In each of the spectra the lower case letters correspond to the following: a: [Alcsdimer], b:
[Al cs dimer + GS-prop], c: [Alcsdimer + GS-hex], d: [Alcsdimer + GS-prop + GS-hex],
e:[ Al cs dimer + 2GS-hex], f:[Alcsdimer + 2GS-prop + GS-hex], g:[Alcsdimer + GS-prop
+ 2GS-hex], h:[Alcsdimer + 3GS-hex].
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Figure 5.15 ESI-MS spectra of the mixture resulting from the addition of GS-hex and G S dec to the modified A-class enzymes (Al c s and A 1 Y F ) under non-denaturing conditions.
The charge on the ions are displayed at the top of the figure.
A ) A 1 Y F + GS-hex + GS-dec (molar ratio 1:5:5)
B ) A l c s + GS-hex + GS-dec (molar ratio 1:5:5)
In each of the spectra the lower case letters correspond to the following: a: [dimer + 2GShex] , b: [dimer + GS-hex + GS-dec], c: [dimer + 2GS-dec], d: [dimer + 2GS-hex + G S dec], e: [dimer + GS-hex + 2GS-dec], f: [dimer + 3GS-dec].
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5.2.7 M S / M S of glutathione S-transferase noncovalent complexes
MS/MS is useful for a number of purposes in the analysis of noncovalent complexes,
particularly when the identity of components in a complex may not be clear from the
mass of the complex alone. Using MS/MS, the complex can be dissociated into its

component parts to identify the separate binding partners. MS/MS can also be used to

exclude any covalent modifications to proteins. If a covalent modification were pres
gentle CAD would be likely to disrupt noncovalent interactions first, leaving the
covalent bonds intact. An example of this is presented below.
Spectra from MS/MS of the 16+ ion of the Alcs dimer (i.e. [Alcs dimer +

16H+]16+) are displayed in Figure 5.16. With a voltage of 40 V applied to the collisio

cell there was no apparent fragmentation of the precursor (Figure 5.16A). Increasing

collision cell voltage resulted in the appearance of two different ion series. The f
consisting of the peaks at m/z 2125, 2318 and 2550, corresponded to the monomeric
form of Alcs. The second series was from a fragment of monomeric Al (peaks at m/z

1627,1860 and 2170) that had a molecular mass of 13012.8 ± 0.5 Da. Ishigai et al. al
reported a fragment of approximately 13 kDa in the MS/MS spectrum of Al (Ishigai et

al, 2000). Allowing for a 5 Da uncertainty in the mass, there are 11 possible region
Alcs to which the fragment could correspond. The identity of this fragment could not
confirmed by the molecular mass alone but known properties of peptide fragmentation
allowed the probable identity of the fragment to be proposed. One of the possible
fragments was from amino acids 109-221 with a molecular mass 13010.3 Da. This
corresponds to the C-terminal portion of the protein after cleavage adjacent to the

proline residue at position 109. Preferential cleavage adjacent to proline residues

been documented previously (Loo et al, 1993; Loo et al, 1998b). The fragment seen by

Ishigai et al. was also proposed to be a result of fragmentation at proline 109 (Is
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al, 2000). This region includes the C112S modification and therefore the fragment
mass was different to that observed by Ishigai et al.
Figure 5.17 shows MS/MS spectra of the 16+ ion of the complex [Al™dimer +

2GS-hex] at different collision cell voltages. Each inset displays an enlarged region

containing the peaks observed in the region above the precursor. The peak at m/z 3425
was from the precursor with one less proton and the loss of one GS-hex molecule. The
peak at m/z 3399 was from the precursor with one less proton and the loss of two GShex molecules, i.e. the 15+ ion of the dimer stripped of ligands. As can be seen from

spectra, the loss of one GS-hex (m/z 3425) was apparent at a collision cell voltage o
V (Figure 5.17A). At 50 V the loss of one (m/z 3425) and two (m/z 3399) GS-hex

molecules was apparent (Figure 5.17B). In the spectra acquired at collision cell volt
above 50 V, the 15+ ion from the loss of only one GS-hex (m/z 3425) was no longer

evident. The spectra also showed a similar trend for the 16+ ions. At a collision cell

voltage of 50 V, the loss of both one and two GS-hex molecules was apparent (labelled

w and v, respectively, Figure 5.17B). Increasing collision cell voltages resulted in t
disappearance of the peak corresponding to the loss of one GS-hex from the complex

and an increase in the Al™ dimer stripped of ligands (v, Figure 5.17C-E). In the spec
acquired with collision cell voltages of 50 V and higher, peaks from the monomeric
form of Al™ were apparent (m/z 2125, 2318, 2550 and 2833). These were equivalent to
those seen in the MS/MS spectra of the Alcs dimer (Figure 5.16), which is of the same
mass as Al™. It is important to note that there was no evidence of the monomer with

GS-hex bound. This suggested that the GS-hex only binds to the protein in its dimeric

form. The spectrum acquired at a collision cell voltage of 80 V also showed peaks fro
a fragment of Al™ (m/z 1645 and 1862, Figure 5.17E). The measured molecular mass
of the fragment was 13028.9 ± 0.6 Da, which was of higher mass than the fragment
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[Al™dimer] and [Al™dimer + GS-hex].
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observed in the M S / M S spectra of the A l c s dimer but very similar to that seen by

Ishigai et al. (13026.4 Da) (Ishigai et al, 2000). This is in agreement with the pr

fragmentation at proline 109. The Al™ protein has the same sequence as the wild-typ
Al from position 109 to the C-terminus, whereas the Alcs protein contains the
modification at position 112. To confirm this proposed sequence, further MS/MS
experiments would be required.
MS/MS was also used to confirm the identity of complexes in mixtures of two
ligands with the dimer. The MS/MS spectra in Figure 5.18 were acquired from the

precursor at m/z 3255 that was apparent in the spectrum of a mixture of Alcs, GSH an

GS-hex (Figure 5.13). The insets show an enlarged section from m/z 3170 to m/z 3275

In each of the spectra, except at a collision cell voltage of 50 V, the precursor w

clearly visible. The first peak to become apparent below the precursor was from the

of GSH (307 Da) from the precursor (z, Figure 5.18A). This suggested that, in the g

phase, GSH was dissociated from the complex more readily than the other ligands. At

collision cell voltages of 30 V and 40 V the following components were apparent: [A
dimer], [Alcs dimer + GSH], [Alcs dimer + GS-hex], [Alcs dimer + GSH + GS-hex]

and [Alcs dimer + 2GS-hex]. The predominant peak in the spectrum at a collision cell
voltage of 50 V was from the Alcs dimer without any attached ligands (m/z 3187,
labelled v, Figure 5.18D). The masses of the fragments observed in the spectra and

knowledge of the ligands present in the sample enabled assignment of each of the pe
and confirmation of the precursor identity, [Alcsdimer + GSH + 2GS-hex].
Figure 5.19 shows MS/MS spectra from a precursor of m/z 3239 that was
assigned as the complex [Alcsdimer + GS-hex + GS-dec]. The insets show an expanded
section including the precursor and a region below the precursor. The fragments
produced from MS/MS were most apparent at a collision cell voltage of 50 V and
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corresponded to [Al dimer] (v), [Al cs dimer + GS-hex] (w) and [Al cs dimer + G S dec] (x). The dimer in the absence of ligands was the most abundant component at a

voltage of 50 V (Figure 5.19C). It is interesting that the complex [Alcsdimer + GS-de

was more abundant than [Alcsdimer + GS-hex] at collision cell voltages of 45 V and 50
V suggesting that, in the gas phase, GS-hex was removed more readily from the

complex than GS-dec. Also visible in the spectrum at 50 V in the lower m/z region we
peaks from the monomeric form of Alcs.
To investigate the gas phase properties of complexes with three ligands, further
MS/MS experiments were undertaken. The S-alkylGSH inhibitors have been shown to
simultaneously occupy the G and H-site of GST, resulting in the stoichiometry 1:2

(dimer:inhibitor). The presence of additional ligands may therefore be the result o
specific binding. Figure 5.20 shows MS/MS spectra of the 15+ ion of complex

[Alcsdimer + 3GS-hex] at collision cell voltages of 35 V and 45 V. At a collision cel

voltage of 35 V the loss of a single molecule of GS-hex was apparent (Figure 5.20A).

There was no evidence of the loss of any further ligands in this spectrum. Increasi
voltage by 5 V resulted in the appearance of peaks corresponding to the loss of two

all three of the GS-hex molecules. These results suggested that displacement of the
molecule of GS-hex in the complex [Alcs + 3GS-hex] required less energy than that

required for the displacement of the first two molecules of GS-hex. Figure 5.21 show
comparison of the spectra from MS/MS of the 15+ ions of the complexes [Alcsdimer +
2GS-hex] and [Alcsdimer + 3GS-hex] at a collision cell voltage of 35 V. Under the
same conditions, MS/MS of the complex [Alcsdimer + 3GS-hex] revealed the loss of
one molecule of GS-hex whereas MS/MS of the complex [Alcsdimer + 2GS-hex] did

not show the loss of any molecules of GS-hex. The results suggested that less energy
was required to displace a single molecule of GS-hex from the complex [Alcsdimer +
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Figure 5.20 Spectra from M S / M S of [Alcsdimer + 3GS-hex + 15H + ] 1 D + (m/z 3477).
Collision offset A ) 35V, B ) 4 0 V
The loss of only one molecule of GS-hex was apparent in spectrum A whilst in spectrum B
the loss of one, two and three molecules of GS-hex were apparent.
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3GS-hex] than was required to displace a single molecule from the complex [Al cs dimer
+ 2GS-hex].

5.2.8 In-source collision activated dissociation of noncovalent complexes

Collision-activated dissociation in the source (in-source CAD) is achieved by inc
the voltage on the sampling cone. A major difference between this process and an
MS/MS experiment is that mass selection is not performed prior to fragmentation.
Figure 5.22 shows the effect of in-source CAD on the spectra of a mixture of Alcs

GSH in a molar ratio of 1:10 (A1CS:GSH). The spectra displayed were acquired at co

voltages of 65, 85, 105, 125 and 145 V. At a cone voltage of 65 V, three ion serie
apparent and these were from the complexes [Alcsdimer] (a), [Alcsdimer + GSH] (b)
and [Alcsdimer + 2GSH] (c). The most abundant series was from [Alcsdimer + GSH].
With increasing cone voltages, the abundance of the complexes [Al dimer + GSH]
and [Alcsdimer + 2GSH] decreased and the dimer with no bound ligands was the
predominant species (Figure 5.22C-E). In the spectra acquired at cone voltages of
and 145V the ion series from [Alcsdimer + GSH] and [Alcsdimer + 2GSH] were of
very low intensity. At cone voltages of 85 V and above monomeric Alcs was also
apparent (labelled M, Figure 5.22B-E).
The effect of in-source CAD on the spectra of a mixture of Alcs and GS-dec

(molar ratio 1:5) is shown in Figure 5.23. In each of the spectra the most abunda
of ions was from the complex [Alcsdimer + 2GS-dec]. This further reinforces the
notion of a strong, selective complex being formed between the dimer and two
molecules of GS-dec. At a cone voltage of 125 V other series were apparent in

increasing relative abundance. These series were from the complexes [Alcsdimer] an
[Alcsdimer + GS-dec]. Monomeric Alcs (m/z 2318, 2549, 2833) was of higher
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abundance with increasing cone voltage and the monomer with one molecule GS-dec
bound was also apparent (Figure 5.23E). The presence of monomer with GS-dec bound

suggested that the interactions between the inhibitor and an individual monomer were

sufficiently strong to maintain a complex even when the dimeric structure of the pr
was disrupted.

5.2.9 Effect of increased collision cell voltage

In MS/MS spectra, the collision cell voltage is used to further accelerate the precu
ion and cause more energetic collisions with the collision gas. By increasing the

collision cell voltage without prior mass selection the entire m/z range of ions can

undergo CAD in the gas cell. Figure 5.24 shows the effect of increasing the collisio
cell voltage on the spectra of a mixture of Alcs, GSH and GS-hex in a molar ratio of

2:20:1. The spectrum acquired at a collision cell voltage of 30 V was similar to tha
acquired at a voltage of 10 V (data not shown).
The most abundant ion series in the spectrum acquired at 30 V was from the
complex [Alcsdimer + 2GS-hex] (series c, Figure 5.24A). This component was also the
most abundant at a voltage of 40 V. The abundance of [Alcsdimer + GS-hex] (series b)

and [Alcsdimer] (series a) increased when the voltage was increased from 30 V to 40 V

(Figure 5.24B). At a voltage of 50 V, the dimer with no bound ligands (series a) was
most abundant series. The complex [Alcsdimer + 2GS-hex] was, however, still quite
prominent. When the collision cell voltage was increased to 60 V the complex
[Alcsdimer + GSH + 2GS-hex] (series d) was no longer apparent. Monomeric Alc:

was also visible in the spectra acquired at collision cell voltages of 50 V and 60 V
increase in collision cell voltage showed a general trend of increasing loss of the
hex molecules bound to the Alcs dimer and loss of dimeric structure.
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Figure 5.23 Spectra from in-source C A D of a mixture of A l c s + GS-dec (molar ratio 1:5)
Cone voltage A ) 105V, B ) 115V, C ) 125V, D ) 135V, E) 145V
In spectrum E the lower case letters correspond to the following: a: [Alcsdimer], b:
[Alcsdimer + GS-dec]
The peaks labelled M and M * in spectrum E correspond to molecular ions of the monomer
A l and the molecular ions of [monomeric A l c s + GS-dec] respectively.
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under non-denaturing conditions with increasing collision offset
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The peaks labelled M correspond to molecular ions of the monomer Al c s
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5.2.10 Titrations of G S T A1-1(C112S) with various ligands

To further characterise the binding properties of the ligands, titrations were perfo
with Alcs and the ligands GSH, GS-prop and GS-hex. The results from these titrations

are displayed in Figures 5.25, 5.26 and 5.27. Each of the graphs shows the total peak
height of a given component relative to the sum of peaks heights of all components.6
The relative abundances are shown for the Alcs dimer alone and the Alcs dimer with
one, two, three and four ligands bound. Figure 5.25 shows the relative abundances of
the components from the addition of GSH to Alcs. The data showed a decrease in the
amount of the Alcs dimer with increasing molar excess of GSH. The relative abundance
of the other components increased with molar excess. It is important to note that

plotting the component peak height sum relative to the peak height sum of all ions do
introduce a tendency in the graphs to slope downwards at higher molar excesses of
ligands, owing to the appearance of complexes with multiple ligands bound at the

higher molar ratios. Hence, even if a particular complex increases in abundance rela
to the Alcs dimer, the presence of other complexes will reduce its abundance relative

the sum of peak heights of all ions. The peak height of the Alcs dimer could not be us
to normalise the data, as in some circumstances it was not present.
A comparison of the titrations of each of the different ligands is presented in

Figure 5.26. There are notable differences between the three ligands. First, examinin
the Alcs dimer without any bound ligands showed that in each case the relative
abundance of the dimer decreased with increasing molar excess of ligand. This

decrease, however, occurred at lower molar excess of ligand in the case of GS-prop as

6

T o obtain the 'percentage of total intensity', the s u m of peak heights of all the ions for a given component was
divided by the s u m of peak heights of all ions. While recognising that the peak heights alone don't correlate
exactly with the abundance of complexes in solution owing to ionisation and detection differences, the percentage
total intensity is herein referred to as the 'relative abundance'.
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opposed to G S H . Even more dramatic was the decrease of the A l c s dimer in the plot of
Alcs with GS-hex. At a ten-fold molar excess of GS-hex the series from the Al^

dimer was no longer apparent. This rapid decrease can be seen more clearly in Figure
5.27, which is an expanded portion of the same GS-hex curve seen in Figure 5.26.
Examining the data from the complex of the Alcs dimer with one ligand showed a
similar enhancement of the trend from GSH to GS-hex. In the titration with GSH the

complex [Alcsdimer + GSH] (purple line) increased to 43% of total intensity and then
began to decrease. The corresponding species in the GS-prop titration reached a
maximum at a lower molar excess of ligand (2-fold as opposed to 15-fold) and then
decreased more rapidly. This decrease appears not to be a consequence of the effect
extra complexes (mentioned above) as it was much more dramatic than the slow

decrease seen in Figure 5.26. Presumably the decrease can be attributed to the highe

molar excess allowing both the sites on the dimer to be accommodated, leaving only a

low proportion with a single site occupied. This effect was even more dramatic in th
titration with GS-hex. The expanded section in Figure 5.27 shows that the maximum
relative abundance of [Alcsdimer + GS-hex] was reached at a molar excess of Alcs
rather than an excess of ligand, as was seen with the other ligands. The complex

[Alcsdimer + GS-hex] seemed to maintain some baseline level throughout the titration

(up to a forty-fold molar excess of ligand). The green line in each of the graphs sh
the relative abundance of the dimer with two ligands. The titration with GSH showed

steady increase in the relative abundance of this complex. Figure 5.25 shows that at
higher molar excesses of GSH this began to decrease. As mentioned above, this may
have arisen from additional components from non-specific ligand binding. The

equivalent complex in the titration of GST with GS-prop revealed a more rapid increa
with maximum relative abundance at a ten-fold molar excess of GS-prop. Again the
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slow decrease was seen in this curve, possibly owing to the increase in non-specific

binding at these high molar excesses of ligand. The titration with GS-hex revealed th
the maximum was reached at lower molar excess compared to the GS-prop titration. In
this titration the highest relative abundance of [Alc dimer + 2GS-hex] was seen at a
two-fold excess of GS-hex over Alcs. The slow decrease was again seen with
increasing proportions of the complexes with more than two GS-hex molecules bound
to the Alcs dimer.
The relative abundance from complexes with three and four molecules of ligands

are displayed in blue and orange respectively. In all the titration experiments neit
these complexes were present initially. In each of the cases they showed an increase
with increasing excess of the ligands. The most notable difference between the
behaviour of these two species and the species with one or two ligands, was apparent

the titrations with GS-prop and GS-hex. With both these ligands, the binding of one a
two molecules reached a defined maximum prior to a steady decrease. The complexes
with three and four ligands did not display this behaviour across the range of molar
ratios examined. The other notable point from the graphs of these two components was

their increase in relative abundance as the relative abundance of the complexes with
and two ligands decreased. The presence of the complexes with three and four ligands

bound did affect the graphs of the other components quite significantly and should be
taken into account when interpreting the results.

s
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Figure 5.25 Graph of relative intensity of complexes of A l c s dimer and G S H versus the
molar excess of G S H . The percentage total intensity on the y-axis is the intensity of the
complex relativetothe total intensity of all components.
The coloured lines correspond to the following complexes:
Red: [Alcsdimer], Purple: [Alcsdimer + G S H ] , Green: [Alcsdimer + 2GSH], Blue:
[Alcsdimer + 3GSH], Orange: [Alcsdimer + 4 G S H ]
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5.2.11 Formation of G S T dimers within a class but not between different classes

It has been noted that dimers of GST form between proteins of the same class but do

form between proteins from different classes. Hence, a dimer can form between Al an
A2 to give the dimeric structure noted as GST Al-2. Dimers should therefore not be
able to form between PI and Al proteins. To determine whether mass spectrometry

could confirm this a mixture of the P class enzyme and an A class enzyme was analys

under non-denaturing conditions. A typical spectrum from this experiment is shown i

Figure 5.28. This spectrum was processed using MaxEnt™ software to convert the data

to a mass scale from a mass-to-charge scale. The presence of the Alcsdimer, and of t

PI dimer is clear. PI showed the three different dimers as in Figure 5.7D. These we
Pl/Pl (A), Pl/PlMet (B) and PIMet/PlMet (C) (Figure 5.28). Heterodimers of PI and
Alcs would have masses of 48709 Da (Al/Pl) and 48804 Da (Al/PlMet). There was
no evidence of these masses in the spectrum, which reinforced the proposition that
cross-class heterodimers are not formed between monomers of GST.

Chapter 5: Noncovalent complexes of GST

244

GST A M

100i

46500

,, , ,U,,,... ,^|
47000
47500

ilfiUWn, m ^ h i ft**"
48000
48500

'•"Vi^V'f^

49000

U
49500

\ •>•*'

• CS

v

, |i.i„,ll>i»jliU>H«.ti.vwii,iiiii,
50000
50500
51000

mass

Figure 5.28 M a x E n t ™ l spectrum of a mixture of A l u a and PI.
The three different dimers of PI are labelled A: Pl/Pl, B: Pl/PlMet and C: PIMet/PlMet
There was no evidence of heterodimers of A l c s and PI, which would have masses of
48709 D a and 48840 Da.
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5.3 DISCUSSION
5.3.1 ESI-MS spectra of proteins acquired under non-denaturing conditions
For electrospray mass spectrometry analyses of proteins, a solution of the analyte in

50% aqueous organic solvent (usually acetonitrile or methanol) that has been acidified
with a weak acid such as acetic or formic acid is generally used. In these solvents a
protein cannot normally maintain its secondary or tertiary structure and is therefore

present in an unfolded or partially unfolded form (Loo, 1997). Protons that are readily

available from the acidified solution attach to the accessible sites of the unfolded p
and the resulting spectra show an envelope of a large number of multiply charged ions.
The molecular mass can then be calculated from the m/z of each ion and an average
taken. This provides a more accurate mass than would be achieved with a single
molecular ion.
To transfer noncovalent complexes from the condensed phase into the gas phase

the secondary and tertiary elements of structure must be preserved hi the solution fro
which the analyte is sprayed. The solutions used are chosen to represent conditions
close to physiological conditions (i.e. aqueous solutions of neutral pH). With the

maintenance of structure, the sites where protons would be likely to attach are general
much less accessible. In neutral, or weakly basic solutions there are fewer protons

available for protonation. Therefore the spectra characteristically have a smaller m/z
range of ions and the charges observed are lower. The resulting m/z range at which the
protein molecular ions are seen is usually higher than under denaturing conditions. If
quaternary structure involves complexes of more than one protein, the increase in
molecular mass also results in complexes being observed at higher m/z ranges. Under
denaturing conditions the m/z range in which ions of the GSTs were observed was m/z
700-1800, with charges ranging from 17+ to 30+. The spectra of GSTs acquired under
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non-denaturing conditions showed a smaller range (m/z 3000-3600) with charges
ranging from 14+ to 17+. The spectra of GST proteins therefore demonstrated the
expected characteristic differences of ESI-MS spectra of proteins acquired under
denaturing and non-denaturing conditions (Przybylski and Glocker, 1996; Loo, 1997).

5.3.2 Effect of gas and voltage on ESI-MS spectra acquired under non-denaturing
conditions

It has been documented, and was observed in this work, that noncovalent complexes ar
sensitive to source voltages, source temperature and pressure (Loo, 1997; Smith and
Light-Wahl, 1993; Przybylski and Glocker, 1996; Tahallah et al, 2001). The optimal
source temperature for GST dimers was found to be approximately 50°C. At higher
temperatures, the dimeric structure started to break down and monomeric protein

increased in abundance. It was found that changes in the desolvation gas flow in the

source, the collision gas pressure or in the backing or rough pumping influenced the

spectra in a number of ways. These changes included a general increase or decrease i
the abundance across the whole spectrum, changes in the relative abundance of one
component compared to another, changes in the distribution of charges and in the
amount of monomeric protein present. The magnitude of the changes varied and was
also dependent on cone voltage and capillary voltage. The general trend was that
harsher conditions, particularly in the high-pressure source region, resulted in a
decreased abundance of the noncovalent complexes. Restricting the in-line isolation
valve on the rotary pump of the QTof ™ influenced the pressure in different regions

the mass spectrometer and was difficult to monitor accurately. The interdependence o

voltage and pressure made it difficult to establish identical conditions each time t
instrument was tuned for these experiments. Therefore comparisons between
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experiments performed on different days had to be interpreted with caution. For
experiments that required comparisons between different mixtures, the samples were
run under the same conditions on the same day. This minimised variations in
experimental conditions and ensured reproducibility of the results obtained.

5.3.3 Complexes formed from the addition of GSH to GST
Previous studies with glutathione bound to GST showed that the complex exists with
two molecules of glutathione bound to the dimer (Armstrong, 1997; Sinning et al,
1993; Cameron et al, 1995; Oakley et al, 1997). A similar result was expected to be
apparent in ESI-MS spectra acquired under non-denaturing conditions. Ishigai et al.
reported that the most abundant complex from the addition of glutathione to Al was
[A 1 dimer + GSH] (Ishigai et al, 2000). The results presented in this chapter also
showed this complex to be the most abundant with Al, Alcs and PI. The only protein
that did show the expected complex [dimer + 2GSH] to be the most abundant was the
modified A class enzyme Al^. The relative abundances of complexes in the spectra
from a mixture of GSH and Al^ did not show a dramatic preference for the binding of

two ligands, as seen with the addition of GS-hex to the same protein. It is possible,
however, that the difference between Al^ and the other proteins was a result of
uncertainty in the protein concentrations.
Owing to the confusing results obtained from the addition of GSH to the three A
class proteins, and the contrast with the results from the addition of S-alkylGSHs,

titrations were performed to attempt to better understand the binding characteristic
these ligands. These titration experiments are discussed in section 5.3.6.
The addition of GSH to GST Al in the results presented by Ishigai et al. (Ishigai
et al, 2000) showed a different increase in the mass than was seen in similar
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experiments presented in the current work. Ishigai et al reported the addition of 340 D a
to the dimer w h e n G S H was added to A l (Ishigai et al, 2000). The molecular mass of
glutathione is 307.3 D a and in the current work an addition of 307 D a to the dimer of
A l was observed. Furthermore, the same additional mass was also seen for the proteins
A l c s , A l ^ and PI and components arising from multiple additions of 307 D a were also
detected. In contrast to the reproducible masses obtained from the addition of G S H , the
spectrum of A l without added G S H acquired under non-denaturing conditions (Figure
5.7) showed a series of ions from the addition of 337 Da. A similar adduct was also
evident in the spectra from Ishigai et al. (Ishigai et al, 2000). Under denaturing
conditions the spectrum of A l also showed a second component, which was 345 D a
above the mass of A l , but it was of very low relative abundance (Figure 5.1). The
presence of a glutathione complex prior to the addition of any free glutathione has been
attributed to the preparation of the A l protein because affinity chromatography with
glutathione as the eluant was used (Oxford Biomedical Research, Michigan, U.S.A.)
(Ishigai et al, 2000). Therefore residual glutathione m a y still have been present in the
solution. A l c s , A l ™ and PI were prepared without an affinity column and did not show
the additional component in the spectra without added G S H , which further indicates that
the presence of the extra component in the spectrum of A l arose from the purification
technique. The reason for the addition of 337 D a in this spectrum and not in the
spectrum with additional free G S H is unclear. Ishigai et al. observed an increase in the
abundance of the complex [Aldimer + 340] when G S H was added to Al. The results
presented here show that the adduct of 337 D a was effectively displaced by G S H alone
(307 Da).
T o account for the higher mass observed (i.e. 340 D a instead of 307 Da), Ishigai
et al. proposed that the complex of A l with G S H included additional small molecules,
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possibly two molecules of water (Ishigai et al, 2000). The data presented here do not
support this conclusion. Further work is required to identify the precise origin of
component. The inclusion of water molecules in gas phase complexes seen by ESI-MS
has been reported previously (Benjamin et al, 1998; Green et al, 1999; Fabris and

Fenselau, 1999) but the reproducibility of spectra with complexes containing water i
yet unknown and this an area that requires further investigation.

5.3.4 Effect of the tyrosine to phenylalanine modification

The tyrosine-to-phenylalanine substitution has been shown to have a dramatic effect o

the catalytic activity of GST but does not appear to change the binding of GSH to GST
(Allardyce et al, 1999). In contrast, the substitution has been shown to impact the
binding of ligands such as S-dinitrophenylglutathione (Allardyce et al, 1999). The
effect of the Y9F substitution on the ESI-MS spectra presented was not obvious. The
addition of GSH to Al^ resulted in a different spectrum to the spectra obtained from

mixture of GSH and Al (wild-type) or Alcs (Figure 5.9). It was, however, possible that
the difference may have arisen from concentration differences in the initial protein
solutions. The Al^ protein was the only GST that showed the complex [dimer +
2GSH] to be the most abundant component in the spectra from a mixture of GSH and
GST. This may be a consequence of a decrease in the dissociation of GSH from this

protein but further experiments would be required to draw conclusions from these data
about the binding of GSH to Al^ under ESI-MS conditions.
Previous results from the binding of hydrophobic ligands to the wild type Al and
Al^ indicated that loss of the hydroxyl group improved the binding of these ligands
(Allardyce et al, 1999; Nieslanik and Atkins, 2000). The S-alkylGSH ligands may have
been expected to bind to A1YF with a lower dissociation constant than the complexes
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. The binding of GS-hex was used to probe any apparent differences.

The spectra from the addition of GS-hex to the A class GSTs (Figure 5.11) showed th

binding of GS-hex to each of the proteins clearly favoured the formation of the co
[dimer + 2GS-hex]. The spectra from these experiments did not reveal any obvious

difference in the binding of GS-hex between these proteins. Similarly the formatio
complexes between GS-dec and dimers of Al or Al (Figure 5.12) indicated strong,

selective binding of two GS-dec molecules to the dimers. The selectivity and stren

the interactions may have concealed any small differences in the binding of the li

to these proteins. MS alone was not sufficient to reveal differences between the b

characteristics of hydrophobic ligands to GSTs. To further examine whether differe
between the complexes [Alcsdimer + 2GS-hex] and [Al^dimer + 2GS-hex] could be
detected by mass spectrometry, MS/MS was performed on these complexes. The spectra
in Figure 5.17 show the results from MS/MS of the 16+ ion of the complex [Al^dimer
+ 2GS-hex]. The results from MS/MS of the equivalent ion from [Al dimer + 2GS-

hex] acquired on the same day did not show any difference to those seen in Figure 5

(data not shown). It is probable that the gas phase behaviour of these complexes is

identical to their condensed phase behaviour, which may explain why a difference in
binding of GS-hex to Alw was not apparent. MS/MS was also performed on the
complexes [Al^dimer + GSH] and [Alcsdimer + GSH] (data not shown) and no

apparent difference was observed in the spectra of these complexes either. Althoug
speculative to infer that MS/MS results reflect the condensed phase binding
characteristics, there is some merit in examining the behaviour of these complexes
MS/MS. The absence of differences between the MS/MS spectra does not rule out
different binding properties in the complexes. Notable differences in the spectra
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however, suggest differences in binding that might also be relevant in the condensed
phase.

5.3.5 Effect of increasing chain length of S-alkylglutathiones
It has been well documented that glutathione conjugates of the form GSR (where R is
hydrophobic group) inhibit GSTs (Armstrong, 1997). Over three decades ago, S-

alkylglutathiones were reported to inhibit the enzyme glyoxalase and increasing chai
length resulted in stronger inhibition (Vince and Wadd, 1969). The results from
competition experiments with S-alkylGSH inhibitors indicated that binding of GST
proteins to longer chain S-alkylGSH inhibitors was preferred. With a mixture of GSprop and GS-hex the most abundant complex was [dimer + 2GS-hex], even when GSprop was fifteen times more concentrated than GS-hex and the protein concentration
was twice the GS-hex concentration (Figure 5.14). When GS-hex and GS-dec were
added to Alcs and Al^, ESI-MS of the mixture showed the complex [dimer + 2GSdec] was the most abundant component.
The S-alkylGSH inhibitors have the ability to occupy the G-site and the H-site

simultaneously (Armstrong, 1997; Oakley et al, 1997). The GSH moiety is contained in

the G-site whilst the hydrophobic alkyl chain lies in the H-site. Presumably the lon

chain inhibitors are able to better occupy the H-site as well as the G-site and ther

utilise binding contacts more efficiently. GS-prop did not show the clear spectra th

GS-hex and GS-dec revealed. This may reflect a lower ability of this ligand to use b

the sites. Docking simulations by Koehler et al have shown that the hydrophobic cavi

of the H-site was only partially occupied with the alkyl chain of S-butylGSH (GS-but

whereas GS-hex filled the site (Koehler et al, 1997). This could account for the low

affinity of the shorter chain S-alkylGSH inhibitors. Using the fluorescent propertie
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tyrosine, it has been shown that with increasing chain length of S-alkylGSH inhibitors,

the environment around tyrosine 9 in the dimer of Al becomes less exposed to solvent
and more hydrophobic (Dietze et al, 1996b). This also suggests that the active site
more fully occupied by the longer alkyl chains.
The crystal structures of S-nonylGSH in complex with the dimer of GST PI

revealed that the nonyl chain was found in the same position as the hexyl chain of G

hex from a previously published structure (Oakley et al, 1999). The three extra carb
units in the nonyl chain occupied a hydrophobic pocket. The presence of additional
contacts with the extra units on a hydrophobic chain would presumably increase the

binding of the ligand to the dimer. Oakley et al. reported that the S-nonylGSH inhib
made 87 van der Waals contacts, 3 salt links and 24 hydrogen bonds with the enzyme
(Oakley etal, 1999).
It has also been hypothesised that the H-site would be able to accommodate

approximately nine carbon units (Sinning et al, 1993). With chains longer than 9 uni

the cleft in the dimer interface could be partially filled as well, possibly increas
binding affinity by additional contacts in this cleft.
The increased binding affinity of GST for the longer chain S-alkylGSH inhibitors
was also apparent from the MS/MS spectra of the complex [Alcsdimer + S-hex + Sdec] (Figure 5.19). The loss of GS-hex was more abundant than the loss of GS-dec,

particularly at a collision cell voltage of 45 V. This suggested that the GS-hex was

bound less strongly than the GS-dec. With the absence of solvent molecules in the ga
phase, hydrophobic interactions are not expected to be as relevant as they are in

condensed phase. The strong binding of these S-alkylGSH inhibitors has been attribut
to hydrophobic interactions between the H-site of the GST dimer and the hydrophobic

alkyl chain. That MS/MS of these complexes showed differences in the energy required
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to displace the ligands, suggests that there is still some effect from the difference in

hydrophobicity. Alternatively, other interactions may also be important in the bindin
these S-alkylGSH inhibitors to GST. These may include van der Waals interactions
(such as those reported for S-nonylGSH bound to GST PI (Oakley et al, 1999)) and

steric effects. The A class GSTs possess a C-terminal helix that is thought to cover t
H-site whilst the G-site is occupied (Allardyce et al, 1999; Dirr and Wallace, 1999;
Nieslanik et al, 1999). This structural element, if preserved in the gas phase, may
stabilise the S-alkylGSH molecules in the gas phase complexes. With GS-dec it is also

possible that the alkyl chain is partially bound in the cleft between the two monomers
increasing the binding strength through interactions at that point.

5.3.6 Non-specific binding

The possibility of non-specific binding was evident for a number of the complexes seen
in the ESI-MS spectra. The spectra of complexes formed between GSH and GST did
not show the same specific binding that was seen in spectra of complexes between GST
and GS-hex. With the addition of ligands to the GSTs, complexes with more than two
molecules of the ligand in complex with the dimer were frequently observed. GST has

only two catalytic sites, each made up of a G-site and an H-site. The binding of a thi
ligand therefore is presumed to be the result of non-specific binding.
To examine further the possibility of non-specific binding in the complexes
formed between GSH and GST, titrations were performed with Alcs and GSH. These
were compared to titrations of GS-prop with Alcs, and of GS-hex with Alcs. The
changes evident in the graphs were more obvious in the titration of GS-hex with Alcs

(Figure 5.26). Trends that were apparent in the GS-hex titration were also apparent in

the GS-prop titration but occurred more gradually with increasing concentration of GS-
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prop. It was more difficult to see the same trends in the titration with G S H . The G S H
titration (Figure 5.25) did reveal some trends that were apparent in the titrations with
GS-prop and GS-hex (Figure 5.26). The decrease in the relative intensity of the Alcs
dimer was clearly evident up to an eighty-fold molar excess of GSH. The relative
intensity of the complex [Alcsdimer + GSH] also showed a similar trend in reaching a
maximum at fifteen-fold molar excess and thereafter decreasing. This trend was seen
over a higher range of ligand molar excess compared to the titrations of GS-prop and
GS-hex. It was difficult to see the same trend with the complex [Alcsdimer + 2GSH]. It
should be noted, however, that in the titration with GS-prop it was also difficult to
pc

assess the trend in the complex [Al dimer + 2GS-prop] even though it did appear to
follow behaviour similar to [Al dimer + 2GS-hex]. From these titrations it was
difficult to conclude that the binding of GSH to GST was specific but the behaviour of
the complex [Alcsdimer + GSH] did suggest that there was at least some specific
binding present, albeit weaker than that seen for the S-alkylGSH ligands.
The titrations also provided information on the behaviour of the complexes with
more than two ligands bound. Over the range of molar ratios examined, the graphs of

the relative intensities of [dimer + 31igands] and [dimer + 41igands] did not reflect the
trends seen for the complexes with one or two ligands. The titrations alone could not
lead to the conclusion that the binding of the third ligand was due to non-specific
interactions. Other experiments were undertaken to investigate differences between
complexes with two ligands versus complexes with three ligands. MS/MS, in-source
CAD and increases in the collision cell voltage under otherwise normal non-denaturing
MS conditions were experiments that were used to explore the specificity of the
complexes.
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M S / M S of the complex [Al dimer + 3GS-hex] revealed the loss of a single
molecule of GS-hex occurred at a lower collision cell voltage than that required to

displace two and three molecules of GS-hex (Figure 5.20). This suggests that one lig
is displaced more easily from the complex [Alcsdimer + 3GS-hex] than the remaining
two. A comparison of the complexes [Alcsdimer + 2GS-hex] and [Alcsdimer + 3GS-

hex] at the same collision cell voltage (Figure 5.21) showed the loss of one molecu
GS-hex from the latter complex but not from the complex with two GS-hex molecules.

These data indicate that in the gas phase a single ligand is displaced from the com
[Alcsdimer + 3GS-hex] more easily than from the complex [Alcsdimer + 2GS-hex]. It

appears, therefore, that the third GS-hex molecule was bound less tightly than the f

two molecules, consistent with the notion that this ligand was not bound at a specif
site or sites.
po

In-source C A D of the complexes formed from the addition of G S H to A l l
showed a general decrease in the complexes formed between GST and GSH over the

range of increasing cone voltages. The dimer stripped of ligands was the only remain
complex at a voltage of 145 V (Figure 5.22). The appearance of monomeric GST also

increased with increasing voltage. These results indicated that the loss of glutath
from the complexes occurred prior to dissociation of the dimer into monomers. This

observation was also reported by Ishigai et al. (Ishigai et al, 2000). Differences i
loss of glutathione from [Alcsdimer + 2GSH] and [Alcsdimer + 3GSH] were not
apparent in the spectra.
In contrast, the strong binding of GS-dec to dimeric Alcs was evident in the

spectra from in-source dissociation of these complexes (Figure 5.23). Even at a cone
voltage of 145 V the complex [Alcsdimer + 2GS-dec] was the most abundant complex.

There was very little change in the spectra from cone voltages up to 125 V (except f
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). The binding of one and two molecules of GS-dec

was obviously very strong and specific. The presence of monomeric A1CS with GS-dec
bound also suggested that the binding was very strong. It is unlikely that the
monomer/GS-dec complex was from a covalent modification, as MS/MS of a complex
containing GS-dec did not show the monomer/GS-dec adduct (Figure 5.19).

An interesting effect was seen in the spectra from a mixture of Alcs, GSH and GS-hex
when the collision offset was increased in an MS experiment under non-denaturing
conditions (Figure 5.24). The spectrum changed dramatically upon changing the
collision cell voltage from 40 V to 50 V since the most abundant complex was
[Alcsdimer + 2GS-hex] at 40 V and [Alcsdimer] at 50 V. The most interesting feature
of the spectrum at 50 V was that even though the dimer in the absence of ligand was
pr

most abundant complex, the complex [Al dimer + 2GS-hex] was still of high
abundance, and was actually the most abundant complex of the 17+ ions. The
intermediate series from the complex [Alcsdimer + GS-hex] was of much lower

abundance. This suggests that, once conditions were sufficiently energetic for liga
be stripped from the complex, both GS-hex molecules were removed, rather than just
one. The relative abundance of the complex [Alcsdimer + GSH + 2GS-hex] did not
appear to change significantly on changing the collision cell voltage from 30 V to

At a voltage of 60 V this complex was no longer apparent. If the third ligand in the
complex [Alcsdimer + GSH + 2GS-hex] were the result of non-specific binding it

would be expected to be lost from the spectrum at quite low collision energies. The

suggest that the third ligand was displaced at similar energies to the first two li

which may indicate that the third ligand was also present in a specific binding mode
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The possibility of three ligands bound in specific sites on G S T m a y be attributed
by the ligandin function of the enzyme. The GSTs are known to possess the ability to
bind larger hydrophobic molecules (usually >400 Da) in the cleft between the two
dimers (Oakley et al, 1999). This ligandin function is believed to be involved in

sequestering, storing and transporting lipophilic molecules. The site for ligandin b
is close to the active site and possibly partially overlaps this site (Oakley et al,

is possible, however, that the ligandin binding-site can be occupied even when the G-

site and H-site are occupied. This means that with the larger S-alkylGSHs, such as GS

hex and GS-dec, additional molecules could bind in the ligandin site whilst the cata
sites (G-site and H-site) of the dimer were occupied. Furthermore, with competition
experiments between GSH and GS-hex there are a number of possibilities that could

account for the addition of more than two ligands. First, GSH could be present in one
catalytic site, GS-hex in the other catalytic site and another molecule of GS-hex in

ligandin site. Alternatively, GS-hex does not require both the G-site and H-site of t
catalytic site so GSH could be bound in the G-site whilst GS-hex was bound in the Hsite. This would allow for the binding of two molecules of GSH (the G-sites), two

molecules of GS-hex (the H-sites) and a further molecule of GS-hex in the cleft betwe
the two molecules. The large number of bound ligands was not observed in the

competition experiment so it is unlikely that this option for multiple ligand binding
accounts for the unexpected high relative abundance of the complex [Al dimer + GSH
+ 2GS-hex] at low collision offsets (Figure 5.24).

5.3.7 Dimer formation revealed by mass spectrometry
The ability of ESI-MS to clearly show that spectra from a mixture of GSTs from
different classes did not form heterodimers was a simple but important result. The
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ability to detect dimers of G S T with a method that is rapid and sensitive could prove to

be very useful in investigation of interactions that are important for dimer formatio
The three A class GSTs were all of the isotype Al and therefore were effectively
homodimers in terms of the binding interfaces between monomeric units. This was also
true for dimers between PI and PI Met. ESI-MS could, however, be used very
effectively to provide fast, and detailed information on any heterodimers that form

between different isotypes within a class. If a particular combination of isotypes fr
the same GST class did not form heterodimers, sequence comparisons might suggest

residues that are critical for interactions between the subunits. Furthermore, sitemutagenesis could be used to investigate whether particular residues are crucial for
dimer formation. ESI-MS provides a fast method for determining whether dimers are
able to form between particular mutated proteins.

5.3.8 Conclusion: The applicability of ESI-MS to study non-covalent interactions
of GST

The ESI-MS analysis of the glutathione S-transferase system showed varied results. Th
GS-hex and GS-dec inhibitors clearly showed that the most abundant complex arose

from the binding of two molecules of inhibitor to the dimer, as was expected from the
known structure of GST. The spectra from GSH did not show the same clear results
although complexes of GSH with GST were detected. The contrasting results between
the substrate and inhibitors reinforce the notion that the analysis of noncovalent
complexes by ESI-MS should be interpreted with caution.
The spectra from complexes of GST with the S-alkylGSH inhibitors appeared to
reflect the condensed-phase characteristics of these complexes. The binding of SalkylGSH inhibitors relies on both electrostatic interactions in the G-site and
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hydrophobic interactions, predominantly in the H-site. The increase in binding affinity

with increasing chain length of S-alkylGSHs is attributed to the increased hydrophobi

interactions. Hydrophobic interactions are thought to be diminished in the gas phase,
whilst electrostatic interactions are thought to be strengthened (Wu et al, 1997;
Robinson et al, 1996; Loo, 1997; Chung et al, 1999; Last and Robinson, 1999; Loo
and Sannes-Lowry, 1998). The results obtained here for the GST enzyme system are not
wholly consistent with this theory. The complexes between GST and GSH are known to
be dependent on electrostatic interactions and yet ESI-MS spectra of these complexes

suggest that the condensed phase abundance of the complexes is not maintained through

transfer to the gas phase. The increase in binding affinity of longer chain S-alkylGS

inhibitors has been attributed to hydrophobic interactions and yet the abundances of

gas phase ions reflects the increase in binding affinity seen in the condensed phase

though hydrophobic interactions are expected to have less impact in the gas-phase. Th

possibility exists that other interactions are also present that explain the apparen
binding of S-alkylGSH inhibitors to GST in the gas-phase. Alternatively, the
abundances of complexes in the condensed phase are reflected in the ESI-MS spectra,
even though the complexes rely on hydrophobic interactions. The differences between
the ion abundances seen for GSH and GST versus the S-alkylGSH inhibitors and GST
suggest that important interactions between the inhibitors and GST enable these
complexes to be transferred to the gas phase more efficiently.
The use of ESI-MS for the analysis of noncovalent complexes is very promising.
Some systems have been shown to reflect the known behaviour of the condensed phase
complexes, such as the GST/S-alkylGSH system presented here. There are, however,
also examples of systems in which the condensed phase and gas-phase complexes
behave differently, as seen here for the GST/GSH system. The observation of these
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contrasts between ligands of the same enzyme highlights the caution required when

ESI-MS is used for elucidating the structure of noncovalent complexes. Understanding

of the process occurring when the complexes are transferred to the gas-phase may ass

in interpreting changes from condensed phase behaviour to the gas-phase spectra. Wit
improved understanding of these processes, ESI-MS may be a powerful tool for
elucidation of the quaternary structure of protein complexes. As it stands, ESI-MS
provides complementary information to that obtained from other techniques for
structure determination and is a fast and sensitive method for obtaining high mass
accuracy information on the stoichiometry of complexes. The gas-phase abundances of

complexes are useful for obtaining information on the gas-phase binding properties a

have often been found to reflect the condensed phase characteristics. Further analys
with model systems will continue to improve our understanding of the mechanisms
involved and the increasing number of examples analysed by ESI-MS may assist in

interpretation of spectra from protein complexes that have not been well characteri
solution.

CHAPTER SIX: CONCLUSIONS

Protein analysis by mass spectrometry has dramatically increased since the advent of
MALDI and ESI. These two ionisation methods have resulted in the rapid expansion of

biomolecular mass spectrometry and have had an important influence on fields such as
immunology, biochemistry, virology, molecular biology, biotechnology and the new
area of 'proteomics'.
The coupling of ESI to tandem mass spectrometers vastly increased the amount of
information that could be obtained from proteins and peptides. With molecular mass
and sequence information, the capability of identifying proteins from sequence
databases is enormous. For novel proteins that have not yet been sequenced, ESI-MS
also has a large potential for de novo peptide and protein sequencing, particularly
advances in automation.
The identification of proteins following 2-dimensional electrophoresis has come
to rely on mass spectrometry. The speed, sensitivity and mass accuracy of MS are

advantageous for the identification of proteins from the small amount of material th
displayed on a gel. An interesting application of proteomics, the identification of
proteins from mitochondria before and after low conductance permeability (LC-PT),
was presented in Chapter 3. A number of known mitochondrial-matrix proteins were
identified in the supernatant from mitochondria that had not undergone LC-PT. Two

possible explanations were proposed for the presence of these matrix proteins. These

proteins either resulted from the loss of mitochondrial membrane integrity in a smal
population of the mitochondria, or from the controlled release of proteins from

mitochondria that are functioning normally. Further work is required to determine th
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reasons for the presence of matrix proteins in the supernatant. O n e of the problems
encountered in this work was the identification of peroxisomal proteins in the
mitochondrial preparations. The contamination of an organelle preparation with other
cellular components is a common problem and careful methods must be used to avoid

this problem in proteomics applications. Although the separation and identification o
mitochondrial proteins was obtained in the work presented in Chapter 3, poor

reproducibility made reliable assignment of interesting proteins extremely difficult.
laborious procedures, high probability of contamination and difficulty in obtaining
equivalent staining intensity demonstrated some of the challenges associated with 2dimensional electrophoresis. The introduction of highly automated procedures has
improved gel reproducibility and minimised contamination introduced through human
handling. Access to automated procedures, however, is generally limited to large,

specialist laboratories. It is likely that conventional proteomics projects will beco
more confined to these types of laboratories.
Functional proteomics is an area of proteomics that has developed more recently
and is well suited to laboratories with a lower capability for high throughput. A

significant amount of information can be obtained through the identification of prote
that associate with a known protein. In the work presented in Chapter 4, affinity
chromatography followed by ion exchange chromatography and nanoESI-MS/MS was
used to identify proteins that associate with the T cell surface protein CD4. The
identification of CD4 and p56lck established that the method was appropriate for the

isolation of CD4 and co-associating molecules. The identification of other proteins s

as tubulin and myosin was of interest and preliminary studies with tubulin have shown

promising results (Sloane, 2000). The significance of these and other identified prot
is yet to be determined. Further development of the method may reveal whether these
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identifications have biological relevance. In the longer term, the data presented here

provides a basis for the identification of further binding partners of CD4, which may
help to reveal potential targets in the treatment of HIV and other immune disorders.
The applicability of MS to the analysis of noncovalent complexes formed between

biopolymers and ligands has been an area of much interest. A consequence of the gentl
conditions of ESI-MS is that complexes of this type can be maintained intact through
transfer to the gas phase. The degree to which the behaviour of gas phase complexes
reflects condensed phase properties is not yet clear. Complexes of the protein
glutathione S-transferase (GST) have been studied in detail by NMR, X-ray
crystallography and other methods, and therefore provide a useful model for MS
studies. ESI-MS revealed the formation of homodimers of GST, as expected from

NMR, X-ray crystallography and other studies (this work and (Ishigai et al, 2000)). T
formation of heterodimers between GST proteins from different enzyme classes was not

observed in this work. This observation is in agreement with the literature. ESI-MS o
mixture of an S-alkylglutathione with GST showed the binding of two molecules of the
S-alkylglutathione to the protein dimer was preferred. Furthermore, the strength of

binding of S-alkylglutathione inhibitors to the GST dimers was shown to increase with
increasing alkyl chain length. The binding of glutathione to GST, however, did not

clearly show the expected stoichiometry of two ligands per dimer. The reasons for thi
discrepancy are not immediately apparent. Nonetheless, the results demonstrated that
ESI-MS is a powerful technique for the analysis of noncovalent complexes and has the
advantages of speed, sensitivity and the ability to measure molecular mass with high
accuracy. The results also demonstrated that the data must be interpreted with care.
With further understanding of the structure and behaviour of complexes as they are
transferred to the gas phase, differences between results obtained from ESI-MS and
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other techniques might be accounted for. Model proteins will continue to provide
important data for understanding these mechanisms.
The value of ESI-MS in current protein chemistry has been clearly demonstrated.
The sensitivity, mass accuracy, mass resolution and rapid generation of data are
unsurpassed by other techniques for protein identification in proteomics. The use of
ESI-MS to provide complementary information to that obtained from other techniques

for quaternary structure determination has also proved to be valuable in many studies.

Recent developments in data acquisition and processing, and in instrument design, have
created an important role for mass spectrometry in many biological applications.
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